@article{Yengo2022,
author = {Yengo, Loic and Vedantam, Sailaja and Marouli, Eirini and Sidorenko, Julia and Bartell, Eric and Sakaue, Saori and Graff, Marielisa and Eliasen, Anders U and Jiang, Yunxuan and Raghavan, Sridharan and Miao, Jenkai and Arias, Joshua D and Mukamel, Ronen E and Spracklen, Cassandra N and Yin, Xianyong and Chen, Shyh-Huei and Ferreira, Teresa and Yingjie, J I and Karedera, Tugce and L{\"u}ll, Kreete and Lin, Kuang and Malden, Deborah E and Medina-Gomez, Carolina and Machado, Moara and Moore, Amy and R{\"u}eger, Sina and Ahluwalia, Tarunveer S and Akiyama, Masato and Allison, Matthew A and Alvarez, Marcus and Andersen, Mette K and Ani, Alireza and Appadurai, Vivek and Arbeeva, Liubov and Bhaskar, Seema and Bielak, Lawrence F and Bollepalli, Sailalitha and Bonnycastle, Lori L and Bork-Jensen, Jette and Bradfield, Jonathan P and Bradford, Yuki and Braund, Peter S and Brody, Jennifer A and Burgdorf, Kristoffer S and Cade, Brian E and Cai, Hui and Cai, Qiuyin and Campbell, Archie and Ca{\~n}adas-Garre, Marisa and Catamo, Eulalia and Chai, Jin-Fang and Chai, Xiaoran and Chang, Li-Ching and Chang, Yi-Cheng and Chen, Chien-Hsiun and Chesi, Alessandra and Choi, Seung Hoan and Chung, Ren-Hua and Cocca, Massimiliano and Concas, Maria Pina and Couture, Christian and Cuellar-Partida, Gabriel and Danning, Rebecca and Warwick Daw, E and Degenhard, Frauke and Delgado, Graciela E and Delitala, Alessandro and Demirkan, Ay{\c s}e and Deng, Xuan and Devineni, Poornima and Dietl, Alexander and Dimitriou, Maria and Dimitrov, Latchezar and Dorajoo, Rajkumar and Ekici, Arif B and Engmann, Jorgen E and Fairhurst-Hunter, Zammy and Farmaki, Aliki-Eleni and Faul, Jessica D and Fernandez-Lopez, Juan-Carlos and Forer, Lukas and Francescatto, Margherita and Freitag-Wolf, Sandra and Fuchsberger, Christian and Galesloot, Tessel E and Gao, Yan and Gao, Zishan and Geller, Frank and Giannakopoulou, Olga and Giulianini, Franco and Gjesing, Anette P and Goel, Anuj and Gordon, Scott D and Gorski, Mathias and Graham, Sarah E and Grove, Jakob and Guo, Xiuqing and Gustafsson, Stefan and Haessler, Jeffrey and Hansen, Thomas F and Havulinna, Aki and Haworth, Simon J and He, Jing and Heard-Costa, Nancy and Hebbar, Prashantha and Hindy, George and Ho, Yuk-Lam A and Hofer, Edith and Holliday, Elizabeth and Horn, Katrin and Hornsby, Whitney E and Hottenga, Jouke-Jan and Huang, Hongyan and Huang, Jie and Huerta-Chagoya, Alicia and Huffman, Jennifer E and Hung, Yi-Jen and Huo, Shaofeng and Hwang, Mi Yeong and Iha, Hiroyuki and Ikeda, Daisuke D and Isono, Masato and Jackson, Anne U and J{\"a}ger, Susanne and Jansen, Iris E and Johansson, Ingegerd and Jonas, Jost B and Jonsson, Anna and J{\o}rgensen, Torben and Kalafati, Ioanna-Panagiota and Kanai, Masahiro and Kanoni, Stavroula and K{\aa}rhus, Line L and Kasturiratne, Anuradhani and Katsuya, Tomohiro and Kawaguchi, Takahisa and Kember, Rachel L and Kentistou, Katherine A and Kim, Han-Na and Kim, Young Jin and Kleber, Marcus E and Knol, Maria J and Kurbasic, Azra and Lauzon, Marie and Le, Phuong and Lea, Rodney and Lee, Jong-Young and Leonard, Hampton L and Li, Shengchao A and Li, Xiaohui and Li, Xiaoyin and Liang, Jingjing and Lin, Honghuang and Lin, Shih-Yi and Liu, Jun and Liu, Xueping and Lo, Ken Sin and Long, Jirong and Lores-Motta, Laura and Luan, Jian'an and Lyssenko, Valeriya and Lyytik{\"a}inen, Leo-Pekka and Mahajan, Anubha and Mamakou, Vasiliki and Mangino, Massimo and Manichaikul, Ani and Marten, Jonathan and Mattheisen, Manuel and Mavarani, Laven and McDaid, Aaron F and Meidtner, Karina and Melendez, Tori L and Mercader, Josep M and Milaneschi, Yuri and Miller, Jason E and Millwood, Iona Y and Mishra, Pashupati P and Mitchell, Ruth E and M{\o}llehave, Line T and Morgan, Anna and Mucha, Soeren and Munz, Matthias and Nakatochi, Masahiro and Nelson, Christopher P and Nethander, Maria and Nho, Chu Won and Nielsen, Aneta A and Nolte, Ilja M and Nongmaithem, Suraj S and Noordam, Raymond and Ntalla, Ioanna and Nutile, Teresa and Pandit, Anita and Christofidou, Paraskevi and P{\"a}rna, Katri and Pauper, Marc and Petersen, Eva R B and Petersen, Liselotte V and Pitk{\"a}nen, Niina and Pola{\v s}ek, Ozren and Poveda, Alaitz and Preuss, Michael H and Pyarajan, Saiju and Raffield, Laura M and Rakugi, Hiromi and Ramirez, Julia and Rasheed, Asif and Raven, Dennis and Rayner, Nigel W and Riveros, Carlos and Rohde, Rebecca and Ruggiero, Daniela and Ruotsalainen, Sanni E and Ryan, Kathleen A and Sabater-Lleal, Maria and Saxena, Richa and Scholz, Markus and Sendamarai, Anoop and Shen, Botong and Shi, Jingchunzi and Shin, Jae Hun and Sidore, Carlo and Sim, Xueling and Sitlani, Colleen M and Slieker, Roderick C and Smit, Roelof A J and Smith, Albert V and Smith, Jennifer A and Smyth, Laura J and Southam, Lorraine and Steinthorsdottir, Valgerdur and Sun, Liang and Takeuchi, Fumihiko and Tallapragada, Divya Sri Priyanka and Taylor, Kent D and Tayo, Bamidele O and Tcheandjieu, Catherine and Terzikhan, Natalie and Tesolin, Paola and Teumer, Alexander and Theusch, Elizabeth and Thompson, Deborah J and Thorleifsson, Gudmar and Timmers, Paul R H and Trompet, Stella and Turman, Constance and Vaccargiu, Simona and van der Laan, Sander W and van der Most, Peter J and van Klinken, Jan B and van Setten, Jessica and Verma, Shefali S and Verweij, Niek and Veturi, Yogasudha and Wang, Carol A and Wang, Chaolong and Wang, Lihua and Wang, Zhe and Warren, Helen R and Wei, Wen Bin and Wickremasinghe, Ananda R and Wielscher, Matthias and Wiggins, Kerri L and Winsvold, Bendik S and Wong, Andrew and Wu, Yang and Wuttke, Matthias and Xia, Rui and Xie, Tian and Yamamoto, Ken and Yang, Jingyun and Yao, Jie and Young, Hannah and Yousri, Noha A and Yu, Lei and Zeng, Lingyao and Zhang, Weihua and Zhang, Xinyuan and Zhao, Jing-Hua and Zhao, Wei and Zhou, Wei and Zimmermann, Martina E and Zoledziewska, Magdalena and Adair, Linda S and Adams, Hieab H H and Aguilar-Salinas, Carlos A and Al-Mulla, Fahd and Arnett, Donna K and Asselbergs, Folkert W and {\AA}svold, Bj{\o}rn Olav and Attia, John and Banas, Bernhard and Bandinelli, Stefania and Bennett, David A and Bergler, Tobias and Bharadwaj, Dwaipayan and Biino, Ginevra and Bisgaard, Hans and Boerwinkle, Eric and B{\"o}ger, Carsten A and B{\o}nnelykke, Klaus and Boomsma, Dorret I and B{\o}rglum, Anders D and Borja, Judith B and Bouchard, Claude and Bowden, Donald W and Brandslund, Ivan and Brumpton, Ben and Buring, Julie E and Caulfield, Mark J and Chambers, John C and Chandak, Giriraj R and Chanock, Stephen J and Chaturvedi, Nish and Chen, Yii-Der Ida and Chen, Zhengming and Cheng, Ching-Yu and Christophersen, Ingrid E and Ciullo, Marina and Cole, John W and Collins, Francis S and Cooper, Richard S and Cruz, Miguel and Cucca, Francesco and Adrienne Cupples, L and Cutler, Michael J and Damrauer, Scott M and Dantoft, Thomas M and de Borst, Gert J and de Groot, Lisette C P G M and De Jager, Philip L and de Kleijn, Dominique P V and de Silva, H Janaka and Dedoussis, George V and den Hollander, Anneke I and Du, Shufa and Easton, Douglas F and Elders, Petra J M and Heather Eliassen, A and Ellinor, Patrick T and Elmst{\aa}hl, S{\"o}lve and Erdmann, Jeanette and Evans, Michele K and Fatkin, Diane and Feenstra, Bjarke and Feitosa, Mary F and Ferrucci, Luigi and Ford, Ian and Fornage, Myriam and Franke, Andre and Franks, Paul W and Freedman, Barry I and Gasparini, Paolo and Gieger, Christian and Girotto, Giorgia and Goddard, Michael E and Golightly, Yvonne M and Gonzalez-Villalpando, Clicerio and Gordon-Larsen, Penny and Grallert, Harald and Grant, Struan F A and Grarup, Niels and Griffiths, Lyn and Groop, Leif and Gudnason, Vilmundur and Haiman, Christopher and Hakonarson, Hakon and Hansen, Torben and Hartman, Catharina A and Hattersley, Andrew T and Hayward, Caroline and Heckbert, Susan R and Heng, Chew-Kiat and Hengstenberg, Christian and Hewitt, Alex W and Hishigaki, Haretsugu and Hoyng, Carel B and Huang, Paul L and Huang, Wei and Hunt, Steven C and Hveem, Kristian and Hypp{\"o}nen, Elina and Iacono, William G and Ichihara, Sahoko and Arfan Ikram, M and Isasi, Carmen R and Jackson, Rebecca D and Jarvelin, Marjo-Riitta and Jin, Zi-Bing and J{\"o}ckel, Karl-Heinz and Joshi, Peter K and Jousilahti, Pekka and Wouter Jukema, J and K{\"a}h{\"o}nen, Mika and Kamatani, Yoichiro and Kang, Kui Dong and Kaprio, Jaakko and Kardia, Sharon L R and Karpe, Fredrik and Kato, Norihiro and Kee, Frank and Kessler, Thorsten and Khera, Amit V and Khor, Chiea Chuen and Kiemeney, Lambertus A L and Kim, Bong-Jo and Kim, Eung Kwon and Kim, Hyung-Lae and Kirchhof, Paulus and Kivimaki, Mika and Koh, Woon-Puay and Koistinen, Heikki A and Kolovou, Genovefa D and Kooner, Jaspal S and Kooperberg, Charles and K{\"o}ttgen, Anna and Kovacs, Peter and Kraaijeveld, Adriaan and Kraft, Peter and Krauss, Ronald M and Kumari, Meena and Kutalik, Zoltan and Laakso, Markku and Lange, Leslie A and Langenberg, Claudia and Launer, Lenore J and Le Marchand, Loic and Lee, Hyejin and Lee, Nanette R and Lehtim{\"a}ki, Terho and Li, Huaixing and Li, Liming and Lieb, Wolfgang and Lin, Xu and Lind, Lars and Linneberg, Allan and Liu, Ching-Ti and Liu, Jianjun and Loeffler, Markus and London, Barry and Lubitz, Steven A and Lye, Stephen J and Mackey, David A and M{\"a}gi, Reedik and Magnusson, Patrik K E and Marcus, Gregory M and Vidal, Pedro Marques and Martin, Nicholas G and M{\"a}rz, Winfried and Matsuda, Fumihiko and McGarrah, Robert W and McGue, Matt and McKnight, Amy Jayne and Medland, Sarah E and Mellstr{\"o}m, Dan and Metspalu, Andres and Mitchell, Braxton D and Mitchell, Paul and Mook-Kanamori, Dennis O and Morris, Andrew D and Mucci, Lorelei A and Munroe, Patricia B and Nalls, Mike A and Nazarian, Saman and Nelson, Amanda E and Neville, Matt J and Newton-Cheh, Christopher and Nielsen, Christopher S and N{\"o}then, Markus M and Ohlsson, Claes and Oldehinkel, Albertine J and Orozco, Lorena and Pahkala, Katja and Pajukanta, P{\"a}ivi and Palmer, Colin N A and Parra, Esteban J and Pattaro, Cristian and Pedersen, Oluf and Pennell, Craig E and Penninx, Brenda W J and Perusse, Louis and Peters, Annette and Peyser, Patricia A and Porteous, David J and Posthuma, Danielle and Power, Chris and Pramstaller, Peter P and Province, Michael A and Qi, Qibin and Qu, Jia and Rader, Daniel J and Raitakari, Olli T and Ralhan, Sarju and Rallidis, Loukianos S and Rao, Dabeeru C and Redline, Susan and Reilly, Dermot F and Reiner, Alexander P and Rhee, Sang Youl and Ridker, Paul M and Rienstra, Michiel and Ripatti, Samuli and Ritchie, Marylyn D and Roden, Dan M and Rosendaal, Frits R and Rotter, Jerome I and Rudan, Igor and Rutters, Femke and Sabanayagam, Charumathi and Saleheen, Danish and Salomaa, Veikko and Samani, Nilesh J and Sanghera, Dharambir K and Sattar, Naveed and Schmidt, B{\"o}rge and Schmidt, Helena and Schmidt, Reinhold and Schulze, Matthias B and Schunkert, Heribert and Scott, Laura J and Scott, Rodney J and Sever, Peter and Shiroma, Eric J and Benjamin Shoemaker, M and Shu, Xiao-Ou and Simonsick, Eleanor M and Sims, Mario and Singh, Jai Rup and Singleton, Andrew B and Sinner, Moritz F and Gustav Smith, J and Snieder, Harold and Spector, Tim D and Stampfer, Meir J and Stark, Klaus J and Strachan, David P and t Hart, Leen M and Tabara, Yasuharu and Tang, Hua and Tardif, Jean-Claude and Thanaraj, Thangavel A and Timpson, Nicholas J and T{\"o}njes, Anke and Tremblay, Angelo and Tuomi, Tiinamaija and Tuomilehto, Jaakko and Tusi{\'e}-Luna, Maria-Teresa and Uitterlinden, Andre G and van Dam, Rob M and van der Harst, Pim and Van der Velde, Nathalie and van Duijn, Cornelia M and van Schoor, Natasja and Vitart, Veronique and V{\"o}lker, Uwe and Vollenweider, Peter and V{\"o}lzke, Henry and Vrieze, Scott and Wacher-Rodarte, Niels H and Walker, Mark and Wang, Ya Xing and Wareham, Nicholas J and Watanabe, Richard M and Watkins, Hugh and Weir, David R and Werge, Thomas M and Widen, Elisabeth and Wilkens, Lynne R and Willemsen, Gonneke and Willett, Walter C and Wilson, James F and Wong, Tien-Yin and Woo, Jeong-Taek and Wright, Alan F and Wu, Jer-Yuarn and Xu, Huichun and Yajnik, Chittaranjan S and Yokota, Mitsuhiro and Yuan, Jian-Min and Zeggini, Eleftheria and Zemel, Babette S and Zheng, Wei and Zhu, Xiaofeng and Zmuda, Joseph M and Zonderman, Alan B and Zwart, John-Anker and {23andMe Research Team} and {VA Million Veteran Program} and {DiscovEHR (DiscovEHR and MyCode Community Health Initiative)} and {eMERGE (Electronic Medical Records and Genomics Network)} and {Lifelines Cohort Study} and {Regeneron Genetics Center} and {The PRACTICAL Consortium} and {Understanding Society Scientific Group} and Chasman, Daniel I and Cho, Yoon Shin and Heid, Iris M and McCarthy, Mark I and Ng, Maggie C Y and O'Donnell, Christopher J and Rivadeneira, Fernando and Thorsteinsdottir, Unnur and Sun, Yan V and Shyong Tai, E and Boehnke, Michael and Deloukas, Panos and Justice, Anne E and Lindgren, Cecilia M and Loos, Ruth J F and Mohlke, Karen L and North, Kari E and Stefansson, Kari and Walters, Robin G and Winkler, Thomas W and Young, Kristin L and Loh, Po-Ru and Yang, Jian and Esko, T{\~o}nu and Assimes, Themistocles L and Auton, Adam and Abecasis, Goncalo R and Willer, Cristen J and Locke, Adam E and Berndt, Sonja I and Lettre, Guillaume and Frayling, Timothy M and Okada, Yukinori and Wood, Andrew R and Visscher, Peter M and Hirschhorn, Joel N},
doi = {10.1101/2022.01.07.475305},
journal = {bioRxiv},
month = {jan},
title = {A saturated map of common genetic variants associated with human height from 5.4 million individuals of diverse ancestries},
year = {2022},
keywords = {preprint},
abstract = {Common SNPs are predicted to collectively explain 40-50\% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes. Here we show, using GWAS data from 5.4 million individuals of diverse ancestries, that 12,111 independent SNPs that are significantly associated with height account for nearly all of the common SNP-based heritability. These SNPs are clustered within 7,209 non-overlapping genomic segments with a median size of ~90 kb, covering ~21\% of the genome. The density of independent associations varies across the genome and the regions of elevated density are enriched for biologically relevant genes. In out-of-sample estimation and prediction, the 12,111 SNPs account for 40\% of phenotypic variance in European ancestry populations but only ~10\%-20\% in other ancestries. Effect sizes, associated regions, and gene prioritization are similar across ancestries, indicating that reduced prediction accuracy is likely explained by linkage disequilibrium and allele frequency differences within associated regions. Finally, we show that the relevant biological pathways are detectable with smaller sample sizes than needed to implicate causal genes and variants. Overall, this study, the largest GWAS to date, provides an unprecedented saturated map of specific genomic regions containing the vast majority of common height-associated variants.}
}
@article{Lo_Faro2021,
author = {Lo Faro, Valeria and Bhattacharya, Arjun and Zhou, Wei and Zhou, Dan and Wang, Ying and Lall, Kristi and Kanai, Masahiro and Lopera Maya, Esteban A and Straub, Peter and Pawar, Priyanka and Tao, Ran and Zhong, Xue and Namba, Shinichi and {Global Biobank Meta-analysis Initiative} and Sanna, Serena and Nolte, Ilja M and Okada, Yukinori and Ingold, Nathan and MacGregor, Stuart and Snieder, Harold and Surakka, Ida and Willer, Cristen J and Martin, Alicia and Brantley, Milam A and Gamazon, Eric R and Jansonius, Nomdo M and Joos, Karen and Cox, Nancy J and Hirbo, Jibril},
doi = {10.1101/2021.12.16.21267891},
journal = {medRxiv},
month = {dec},
title = {Genome-wide association meta-analysis identifies novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation},
year = {2021},
keywords = {preprint},
abstract = {Primary open-angle glaucoma (POAG) is a complex eye disease characterized by progressive loss of optic nerve function that, if untreated, ultimately leads to irreversible blindness. To date, the biological mechanisms causing POAG are still unclear. There is disparity in POAG prevalence, clinical presentations, and outcomes across ancestries. Here, we aim to identify unique genetics that underlies risk to POAG and evaluate the potential connection with vascular mechanisms. We performed POAG meta-analysis across 15 biobanks that are part of the Global Biobank Meta-analysis Initiative, with two previously published multi-ancestry analyses for a total of 1,478,037 individuals from six ancestries (46,325 cases and 1,431,712 controls). A total of 109 genome-wide significantly associated loci (p<5e-8) were identified, 18 of which were novel. Three of these novel loci are ancestry-specific, two African- specific and the third specific to northern Europeans. We also identified five sex-specific novel loci, four of which are African-specific and one European-specific. To explore biological implications underlying these variant-trait associations, we performed gene enrichment analysis, gene prioritization analysis and transcriptome-wide association studies (TWAS) implicating genes related to vascular-related functions, blood vessels, angiogenesis, and cancer. A fifth of TWAS-prioritized genes with vascular-related and/or cell senescence/proliferation functional roles or have been implicated in vascular or neoplastic diseases are primary ciliary related genes. We further performed extensive statistical validation analysis of genes in the SIX6 and well-known CDKN2B-AS1 loci, previously implicated in POAG, cardiovascular diseases, and cancers across multiple ancestries. We found evidence of significant interaction between SIX6 rs33912345 and causal variants in chr9p21.3, with concomitant effect on expression of a primary cilia gene CDKN2A and CDKN2B at the CDKN2B-AS1 locus. Phenome-wide association analysis of POAG genetic risk burden across five biobanks and genetic correlation analysis also show the shared biology between POAG and vascular and neoplastic traits. In summary, our findings suggest that some POAG risk variants may be ancestry-specific, sex-specific, or both. Our findings further support the contribution of vascular and proliferation genes in POAG and suggest potential involvement of primary cilia in POAG pathogenesis.}
}
@article{Kanoni2021,
author = {Kanoni, Stavroula and Graham, Sarah E and Wang, Yuxuan and Surakka, Ida and Ramdas, Shweta and Zhu, Xiang and Clarke, Shoa L and Bhatti, Konain Fatima and Vedantam, Sailaja and Winkler, Thomas W and Locke, Adam E and Marouli, Eirini and Zajac, Greg J M and Wu, Kuan-Han H and Ntalla, Ioanna and Hui, Qin and Klarin, Derek and Hilliard, Austin T and Wang, Zeyuan and Xue, Chao and Thorleifsson, Gudmar and Helgadottir, Anna and Gudbjartsson, Daniel F and Holm, Hilma and Olafsson, Isleifur and Hwang, Mi Yeong and Han, Sohee and Akiyama, Masato and Sakaue, Saori and Terao, Chikashi and Kanai, Masahiro and Zhou, Wei and Brumpton, Ben M and Rasheed, Humaira and Havulinna, Aki S and Veturi, Yogasudha and Pacheco, Jennifer Allen and Rosenthal, Elisabeth A and Lingren, Todd and Feng, Qiping and Kullo, Iftikhar J and Narita, Akira and Takayama, Jun and Martin, Hilary C and Hunt, Karen A and Trivedi, Bhavi and Haessler, Jeffrey and Giulianini, Franco and Bradford, Yuki and Miller, Jason E and Campbell, Archie and Lin, Kuang and Millwood, Iona Y and Rasheed, Asif and Hindy, George and Faul, Jessica D and Zhao, Wei and Weir, David R and Turman, Constance and Huang, Hongyan and Graff, Mariaelisa and Choudhury, Ananyo and Sengupta, Dhriti and Mahajan, Anubha and Brown, Michael R and Zhang, Weihua and Yu, Ketian and Schmidt, Ellen M and Pandit, Anita and Gustafsson, Stefan and Yin, Xianyong and Luan, Jian'an and Zhao, Jing-Hua and Matsuda, Fumihiko and Jang, Hye-Mi and Yoon, Kyungheon and Medina-Gomez, Carolina and Pitsillides, Achilleas and Hottenga, Jouke Jan and Wood, Andrew R and Ji, Yingji and Gao, Zishan and Haworth, Simon and Mitchell, Ruth E and Chai, Jin Fang and Aadahl, Mette and Bjerregaard, Anne A and Yao, Jie and Manichaikul, Ani and Hwu, Chii-Min and Hung, Yi-Jen and Warren, Helen R and Ramirez, Julia and Bork-Jensen, Jette and Karhus, Line L and Goel, Anuj and Sabater-Lleal, Maria and Noordam, Raymond and Mauro, Pala and Matteo, Floris and McDaid, Aaron F and Marques-Vidal, Pedro and Wielscher, Matthias and Trompet, Stella and Sattar, Naveed and Mollehave, Line T and Munz, Matthias and Zeng, Lingyao and Huang, Jianfeng and Yang, Bin and Poveda, Alaitz and Kurbasic, Azra and Lamina, Claudia and Forer, Lukas and Scholz, Markus and Galesloot, Tessel E and Bradfield, Jonathan P and Ruotsalainen, Sanni E and Daw, E Warwick and Zmuda, Joseph M and Mitchell, Jonathan S and Fuchsberger, Christian and Christensen, Henry and Brody, Jennifer A and Vazquez-Moreno, Miguel and Feitosa, Mary F and Wojczynski, Mary K and Wang, Zhe and Preuss, Michael and Mangino, Massimo and Christofidou, Paraskevi and Verweij, Niek and Benjamins, Jan W and Engmann, Jorgen and Tsao, Noah L and Verma, Anurag and Slieker, Roderick C and Lo, Ken Sin and Zilhao, Nuno R and Le, Phuong and Kleber, Marcus E and Delgado, Graciela E and Huo, Shaofeng and Ikeda, Daisuke D and Iha, Hiroyuki and Yang, Jian and Liu, Jun and Demirkan, Ay{\c s}e and Leonard, Hampton L and Marten, Jonathan and Frank, Mirjam and Schmidt, Borge and Smyth, Laura J and Canadas-Garre, Marisa and Wang, Chaolong and Nakatochi, Masahiro and Wong, Andrew and Hutri-Kahonen, Nina and Sim, Xueling and Xia, Rui and Huerta-Chagoya, Alicia and Fernandez-Lopez, Juan Carlos and Lyssenko, Valeriya and Nongmaithem, Suraj S and Bayyana, Swati and Stringham, Heather M and Irvin, Marguerite R and Oldmeadow, Christopher and Kim, Han-Na and Ryu, Seungho and Timmers, Paul Rhj and Arbeeva, Liubov and Dorajoo, Rajkumar and Lange, Leslie A and Prasad, Gauri and Lores-Motta, Laura and Pauper, Marc and Long, Jirong and Li, Xiaohui and Theusch, Elizabeth and Takeuchi, Fumihiko and Spracklen, Cassandra N and Loukola, Anu and Bollepalli, Sailalitha and Warner, Sophie C and Wang, Ya Xing and Wei, Wen B and Nutile, Teresa and Ruggiero, Daniela and Sung, Yun Ju and Chen, Shufeng and Liu, Fangchao and Yang, Jingyun and Kentistou, Katherine A and Banas, Bernhard and Nardone, Giuseppe Giovanni and Meidtner, Karina and Bielak, Lawrence F and Smith, Jennifer A and Hebbar, Prashantha and Farmaki, Aliki-Eleni and Hofer, Edith and Lin, Maoxuan and Concas, Maria Pina and Vaccargiu, Simona and van der Most, Peter J and Pitkanen, Niina and Cade, Brian E and van der Laan, Sander W and Chitrala, Kumaraswamy Naidu and Weiss, Stefan and Bentley, Amy R and Doumatey, Ayo P and Adeyemo, Adebowale A and Lee, Jong Young and Petersen, Eva R B and Nielsen, Aneta A and Choi, Hyeok Sun and Nethander, Maria and Freitag-Wolf, Sandra and Southam, Lorraine and Rayner, Nigel W and Wang, Carol A and Lin, Shih-Yi and Wang, Jun-Sing and Couture, Christian and Lyytikainen, Leo-Pekka and Nikus, Kjell and Cuellar-Partida, Gabriel and Vestergaard, Henrik and Hidalgo, Bertha and Giannakopoulou, Olga and Cai, Qiuyin and Obura, Morgan O and van Setten, Jessica and Liang, Jingjing and Tang, Hua and Terzikhan, Natalie and Shin, Jae Hun and Jackson, Rebecca D and Reiner, Alexander P and Martin, Lisa Warsinger and Chen, Zhengming and Li, Liming and Kawaguchi, Takahisa and Thiery, Joachim and Bis, Joshua C and Launer, Lenore J and Li, Huaixing and Nalls, Mike A and Raitakari, Olli T and Ichihara, Sahoko and Wild, Sarah H and Nelson, Christopher P and Campbell, Harry and Jager, Susanne and Nabika, Toru and Al-Mulla, Fahd and Niinikoski, Harri and Braund, Peter S and Kolcic, Ivana and Kovacs, Peter and Giardoglou, Tota and Katsuya, Tomohiro and de Kleijn, Dominique and de Borst, Gert J and Kim, Eung Kweon and Adams, Hieab H H and Ikram, M Arfan and Zhu, Xiaofeng and Asselbergs, Folkert W and Kraaijeveld, Adriaan O and Beulens, Joline W J and Shu, Xiao-Ou and Rallidis, Loukianos S and Pedersen, Oluf and Hansen, Torben and Mitchell, Paul and Hewitt, Alex W and Kahonen, Mika and Perusse, Louis and Bouchard, Claude and Tonjes, Anke and Chen, Yii-Der Ida and Pennell, Craig E and Mori, Trevor A and Lieb, Wolfgang and Franke, Andre and Ohlsson, Claes and Mellstrom, Dan and Cho, Yoon Shin and Lee, Hyejin and Yuan, Jian-Min and Koh, Woon-Puay and Rhee, Sang Youl and Woo, Jeong-Taek and Heid, Iris M and Stark, Klaus J and Zimmermann, Martina E and Volzke, Henry and Homuth, Georg and Evans, Michele K and Zonderman, Alan B and Polasek, Ozren and Pasterkamp, Gerard and Hoefer, Imo E and Redline, Susan and Pahkala, Katja and Oldehinkel, Albertine J and Snieder, Harold and Biino, Ginevra and Schmidt, Reinhold and Schmidt, Helena and Bandinelli, Stefania and Dedoussis, George and Thanaraj, Thangavel Alphonse and Kardia, Sharon L R and Peyser, Patricia A and Kato, Norihiro and Schulze, Matthias B and Girotto, Giorgia and Boger, Carsten A and Jung, Bettina and Joshi, Peter K and Bennett, David A and De Jager, Philip L and Lu, Xiangfeng and Mamakou, Vasiliki and Brown, Morris and Caulfield, Mark J and Munroe, Patricia B and Guo, Xiuqing and Ciullo, Marina and Jonas, Jost B and Samani, Nilesh J and Kaprio, Jaakko and Pajukanta, Paivi and Tusie-Luna, Teresa and Aguilar-Salinas, Carlos A and Adair, Linda S and Bechayda, Sonny Augustin and de Silva, H Janaka and Wickremasinghe, Ananda R and Krauss, Ronald M and Wu, Jer-Yuarn and Zheng, Wei and den Hollander, Anneke I and Bharadwaj, Dwaipayan and Correa, Adolfo and Wilson, James G and Lind, Lars and Heng, Chew-Kiat and Nelson, Amanda E and Golightly, Yvonne M and Wilson, James F and Penninx, Brenda and Kim, Hyung-Lae and Attia, John and Scott, Rodney J and Rao, D C and Arnett, Donna K and Walker, Mark and Koistinen, Heikki A and Chandak, Giriraj R and Mercader, Josep M and Tusie-Luna, Teresa and Aguilar-Salinas, Carlos A and Villalpando, Clicerio Gonzalez and Orozco, Lorena and Fornage, Myriam and Tai, E Shyong and van Dam, Rob M and Lehtimaki, Terho and Chaturvedi, Nish and Yokota, Mitsuhiro and Liu, Jianjun and Reilly, Dermot F and McKnight, Amy Jayne and Kee, Frank and Jockel, Karl-Heinz and McCarthy, Mark I and Palmer, Colin N A and Vitart, Veronique and Hayward, Caroline and Simonsick, Eleanor and van Duijn, Cornelia M and Jin, Zi-Bing and Qu, Jia and Hishigaki, Haretsugu and Lin, Xu and Marz, Winfried and Gudnason, Vilmundur and Tardif, Jean-Claude and Lettre, Guillaume and t Hart, Leen M and Elders, Petra J M and Rader, Daniel J and Damrauer, Scott M and Kumari, Meena and Kivimaki, Mika and van der Harst, Pim and Spector, Tim D and Loos, Ruth J F and Province, Michael A and Parra, Esteban J and Cruz, Miguel and Psaty, Bruce M and Brandslund, Ivan and Pramstaller, Peter P and Rotimi, Charles N and Christensen, Kaare and Ripatti, Samuli and Widen, Elisabeth and Hakonarson, Hakon and Grant, Struan F A and Kiemeney, Lambertus Alm and de Graaf, Jacqueline and Loeffler, Markus and Kronenberg, Florian and Gu, Dongfeng and Erdmann, Jeanette and Schunkert, Heribert and Franks, Paul W and Linneberg, Allan and Jukema, J Wouter and Khera, Amit V and Mannikko, Minna and Jarvelin, Marjo-Riitta and Kutalik, Zoltan and Francesco, Cucca and Mook-Kanamori, Dennis O and Willems van Dijk, Ko and Watkins, Hugh and Strachan, David P and Grarup, Niels and Sever, Peter and Poulter, Neil and Chuang, Lee-Ming and Rotter, Jerome I and Dantoft, Thomas M and Karpe, Fredrik and Neville, Matt J and Timpson, Nicholas J and Cheng, Ching-Yu and Wong, Tien-Yin and Khor, Chiea Chuen and Li, Hengtong and Sabanayagam, Charumathi and Peters, Annette and Gieger, Christian and Hattersley, Andrew T and Pedersen, Nancy L and Magnusson, Patrik K E and Boomsma, Dorret I and Willemsen, Allegonda H M and Cupples, L Adrienne and van Meurs, Joyce B J and Ikram, Arfan and Ghanbari, Mohsen and Gordon-Larsen, Penny and Huang, Wei and Kim, Young Jin and Tabara, Yasuharu and Wareham, Nicholas J and Langenberg, Claudia and Zeggini, Eleftheria and Kuusisto, Johanna and Laakso, Markku and Ingelsson, Erik and Abecasis, Goncalo and Chambers, John C and Kooner, Jaspal S and de Vries, Paul S and Morrison, Alanna C and Hazelhurst, Scott and Ramsay, Michele and North, Kari E and Daviglus, Martha and Kraft, Peter and Martin, Nicholas G and Whitfield, John B and Abbas, Shahid and Saleheen, Danish and Walters, Robin G and Holmes, Michael V and Black, Corri and Smith, Blair H and Baras, Aris and Justice, Anne E and Buring, Julie E and Ridker, Paul M and Chasman, Daniel I and Kooperberg, Charles and Tamiya, Gen and Yamamoto, Masayuki and van Heel, David A and Trembath, Richard C and Wei, Wei-Qi and Jarvik, Gail P and Namjou, Bahram and Hayes, M Geoffrey and Ritchie, Marylyn D and Jousilahti, Pekka and Salomaa, Veikko and Hveem, Kristian and Asvold, Bjorn Olav and Kubo, Michiaki and Kamatani, Yoichiro and Okada, Yukinori and Murakami, Yoshinori and Kim, Bong-Jo and Thorsteinsdottir, Unnur and Stefansson, Kari and Zhang, Jifeng and Chen, Y Eugene and Ho, Yuk-Lam and Lynch, Julie A and Rader, Daniel and Tsao, Philip S and Chang, Kyong-Mi and Cho, Kelly and O'Donnell, Christopher J and Gaziano, John M and Wilson, Peter and Frayling, Timothy M and Hirschhorn, Joel N and Kathiresan, Sekar and Mohlke, Karen L and {Million Veteran Program} and {Global Lipids Genetics Consortium} and Sun, Yan V and Morris, Andrew P and Boehnke, Michael and Brown, Christopher D and Natarajan, Pradeep and Deloukas, Panos and Willer, Cristen J and Assimes, Themistocles L and Peloso, Gina M},
doi = {10.1101/2021.12.15.21267852},
journal = {medRxiv},
month = {dec},
title = {Implicating genes, pleiotropy and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis},
year = {2021},
keywords = {preprint},
abstract = {Genetic variants within nearly 1,000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry meta-analysis (N=1,654,960) of blood lipids to prioritize putative causal genes for 2,286 lipid associations by combining six gene prediction methods and assigning a confidence score. We assign, most confidently, 118 candidate causal genes and identify potential drug targets including bona-fide (PCSK9) and putative (PNLIP and ARF6) genes. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically-predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3-5\% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Taken together, our findings provide insights into the mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk.}
}
@article{Ramdas2021,
author = {Ramdas, Shweta and Judd, Jonathan and Graham, Sarah E and Kanoni, Stavroula and Wang, Yuxuan and Surakka, Ida and Wenz, Brandon and Clarke, Shoa L and Chesi, Alessandra and Wells, Andrew and Bhatti, Konain Fatima and Vedantam, Sailaja and Winkler, Thomas W and Locke, Adam E and Marouli, Eirini and Zajac, Greg J M and Wu, Kuan-Han H and Ntalla, Ioanna and Hui, Qin and Klarin, Derek and Hilliard, Austin T and Wang, Zeyuan and Xue, Chao and Thorleifsson, Gudmar and Helgadottir, Anna and Gudbjartsson, Daniel F and Holm, Hilma and Olafsson, Isleifur and Hwang, Mi Yeong and Han, Sohee and Akiyama, Masato and Sakaue, Saori and Terao, Chikashi and Kanai, Masahiro and Zhou, Wei and Brumpton, Ben M and Rasheed, Humaira and Havulinna, Aki S and Veturi, Yogasudha and Pacheco, Jennifer Allen and Rosenthal, Elisabeth A and Lingren, Todd and Feng, Qiping and Kullo, Iftikhar J and Narita, Akira and Takayama, Jun and Martin, Hilary C and Hunt, Karen A and Trivedi, Bhavi and Haessler, Jeffrey and Giulianini, Franco and Bradford, Yuki and Miller, Jason E and Campbell, Archie and Lin, Kuang and Millwood, Iona Y and Rasheed, Asif and Hindy, George and Faul, Jessica D and Zhao, Wei and Weir, David R and Turman, Constance and Huang, Hongyan and Graff, Mariaelisa and Choudhury, Ananyo and Sengupta, Dhriti and Mahajan, Anubha and Brown, Michael R and Zhang, Weihua and Yu, Ketian and Schmidt, Ellen M and Pandit, Anita and Gustafsson, Stefan and Yin, Xianyong and Luan, Jian'an and Zhao, Jing-Hua and Matsuda, Fumihiko and Jang, Hye-Mi and Yoon, Kyungheon and Medina-Gomez, Carolina and Pitsillides, Achilleas and Hottenga, Jouke Jan and Wood, Andrew R and Ji, Yingji and Gao, Zishan and Haworth, Simon and Mitchell, Ruth E and Chai, Jin Fang and Aadahl, Mette and Bjerregaard, Anne A and Yao, Jie and Manichaikul, Ani and Lee, Wen-Jane and Chao, A and Warren, Helen R and Ramirez, Julia and Jensen, Jette Bork and Karhus, Line L and Goel, Anuj and Sabater-Lleal, Maria and Noordam, Raymond and Mauro, Pala and Matteo, Floris and McDaid, Aaron F and Marques-Vidal, Pedro and Wielscher, Matthias and Trompet, Stella and Sattar, Naveed and Mollehave, Line T and Munz, Matthias and Zeng, Lingyao and Huang, Jianfeng and Yang, Bin and Poveda, Alaitz and Kurbasic, Azra and Schonherr, Sebastian and Forer, Lukas and Scholz, Markus and Galesloot, Tessel E and Bradfield, Jonathan P and Ruotsalainen, Sanni E and Warwick Daw, E and Zmuda, Joseph M and Mitchell, Jonathan S and Fuchsberger, Christian and Christensen, Henry and Brody, Jennifer A and Le, Phuong and Feitosa, Mary F and Wojczynski, Mary K and Hemerich, Daiane and Preuss, Michael and Mangino, Massimo and Christofidou, Paraskevi and Verweij, Niek and Benjamins, Jan W and Engmann, Jorgen and Noah, Tsao L and Verma, Anurag and Slieker, Roderick C and Lo, Ken Sin and Zilhao, Nuno R and Kleber, Marcus E and Delgado, Graciela E and Huo, Shaofeng and Ikeda, Daisuke D and Iha, Hiroyuki and Yang, Jian and Liu, Jun and Demirkan, Ay{\c s}e and Leonard, Hampton L and Marten, Jonathan and Emmel, Carina and Schmidt, Borge and Smyth, Laura J and Canadas-Garre, Marisa and Wang, Chaolong and Nakatochi, Masahiro and Wong, Andrew and Hutri-Kahonen, Nina and Sim, Xueling and Xia, Rui and Huerta-Chagoya, Alicia and Fernandez-Lopez, Juan Carlos and Lyssenko, Valeriya and Nongmaithem, Suraj S and Sankareswaran, Alagu and Irvin, Marguerite R and Oldmeadow, Christopher and Kim, Han-Na and Ryu, Seungho and Timmers, Paul Rhj and Arbeeva, Liubov and Dorajoo, Rajkumar and Lange, Leslie A and Prasad, Gauri and Lores-Motta, Laura and Pauper, Marc and Long, Jirong and Li, Xiaohui and Theusch, Elizabeth and Takeuchi, Fumihiko and Spracklen, Cassandra N and Loukola, Anu and Bollepalli, Sailalitha and Warner, Sophie C and Wang, Ya Xing and Wei, Wen B and Nutile, Teresa and Ruggiero, Daniela and Sung, Yun Ju and Chen, Shufeng and Liu, Fangchao and Yang, Jingyun and Kentistou, Katherine A and Banas, Bernhard and Meidtner, Karina and Bielak, Lawrence F and Smith, Jennifer A and Hebbar, Prashantha and Farmaki, Aliki-Eleni and Hofer, Edith and Lin, Maoxuan and Concas, Maria Pina and Vaccargiu, Simona and van der Most, Peter J and Pitkanen, Niina and Cade, Brian E and van der Laan, Sander W and Chitrala, Kumaraswamy Naidu and Weiss, Stefan and Bentley, Amy R and Doumatey, Ayo P and Adeyemo, Adebowale A and Lee, Jong Young and Petersen, Eva R B and Nielsen, Aneta A and Choi, Hyeok Sun and Nethander, Maria and Freitag-Wolf, Sandra and Southam, Lorraine and Rayner, Nigel W and Wang, Carol A and Lin, Shih-Yi and Wang, Jun-Sing and Couture, Christian and Lyytikainen, Leo-Pekka and Nikus, Kjell and Cuellar-Partida, Gabriel and Vestergaard, Henrik and Hidalgo, Bertha and Giannakopoulou, Olga and Cai, Qiuyin and Obura, Morgan O and van Setten, Jessica and He, Karen Y and Tang, Hua and Terzikhan, Natalie and Shin, Jae Hun and Jackson, Rebecca D and Reiner, Alexander P and Martin, Lisa Warsinger and Chen, Zhengming and Li, Liming and Kawaguchi, Takahisa and Thiery, Joachim and Bis, Joshua C and Launer, Lenore J and Li, Huaixing and Nalls, Mike A and Raitakari, Olli T and Ichihara, Sahoko and Wild, Sarah H and Nelson, Christopher P and Campbell, Harry and Jager, Susanne and Nabika, Toru and Al-Mulla, Fahd and Niinikoski, Harri and Braund, Peter S and Kolcic, Ivana and Kovacs, Peter and Giardoglou, Tota and Katsuya, Tomohiro and de Kleijn, Dominique and de Borst, Gert J and Kim, Eung Kweon and Adams, Hieab H H and Arfan Ikram, M and Zhu, Xiaofeng and Asselbergs, Folkert W and Kraaijeveld, Adriaan O and Beulens, Joline W J and Shu, Xiao-Ou and Rallidis, Loukianos S and Pedersen, Oluf and Hansen, Torben and Mitchell, Paul and Hewitt, Alex W and Kahonen, Mika and Perusse, Louis and Bouchard, Claude and Tonjes, Anke and Chen, Yii-Der Ida and Pennell, Craig E and Mori, Trevor A and Lieb, Wolfgang and Franke, Andre and Ohlsson, Claes and Mellstrom, Dan and Cho, Yoon Shin and Lee, Hyejin and Yuan, Jian-Min and Koh, Woon-Puay and Rhee, Sang Youl and Woo, Jeong-Taek and Heid, Iris M and Stark, Klaus J and Zimmermann, Martina E and Volzke, Henry and Homuth, Georg and Evans, Michele K and Zonderman, Alan B and Polasek, Ozren and Pasterkamp, Gerard and Hoefer, Imo E and Redline, Susan and Pahkala, Katja and Oldehinkel, Albertine J and Snieder, Harold and Biino, Ginevra and Schmidt, Reinhold and Schmidt, Helena and Bandinelli, Stefania and Dedoussis, George and Thanaraj, Thangavel Alphonse and Peyser, Patricia A and Kato, Norihiro and Schulze, Matthias B and Girotto, Giorgia and Boger, Carsten A and Jung, Bettina and Joshi, Peter K and Bennett, David A and De Jager, Philip L and Lu, Xiangfeng and Mamakou, Vasiliki and Brown, Morris and Caulfield, Mark J and Munroe, Patricia B and Guo, Xiuqing and Ciullo, Marina and Jonas, Jost B and Samani, Nilesh J and Kaprio, Jaakko and Pajukanta, Paivi and Tusie-Luna, Teresa and Aguilar-Salinas, Carlos A and Adair, Linda S and Bechayda, Sonny Augustin and de Silva, H Janaka and Wickremasinghe, Ananda R and Krauss, Ronald M and Wu, Jer-Yuarn and Zheng, Wei and den Hollander, Anneke I and Bharadwaj, Dwaipayan and Correa, Adolfo and Wilson, James G and Lind, Lars and Heng, Chew-Kiat and Nelson, Amanda E and Golightly, Yvonne M and Wilson, James F and Penninx, Brenda and Kim, Hyung-Lae and Attia, John and Scott, Rodney J and Rao, D C and Arnett, Donna K and Walker, Mark and Scott, Laura J and Koistinen, Heikki A and Chandak, Giriraj R and Mercader, Josep M and Aguilar-Salinas, Carlos and Villalpando, Clicerio Gonzalez and Orozco, Lorena and Fornage, Myriam and Shyong Tai, E and van Dam, Rob M and Lehtimaki, Terho and Chaturvedi, Nish and Yokota, Mitsuhiro and Liu, Jianjun and Reilly, Dermot F and McKnight, Amy Jayne and Kee, Frank and Jockel, Karl-Heinz and McCarthy, Mark I and Palmer, Colin N A and Vitart, Veronique and Hayward, Caroline and Simonsick, Eleanor and van Duijn, Cornelia M and Jin, Zi-Bing and Lu, Fan and Hishigaki, Haretsugu and Lin, Xu and Marz, Winfried and Gudnason, Vilmundur and Tardif, Jean-Claude and Lettre, Guillaume and t Hart, Leen M and Elders, Petra J M and Rader, Daniel J and Damrauer, Scott M and Kumari, Meena and Kivimaki, Mika and van der Harst, Pim and Spector, Tim D and Loos, Ruth J F and Province, Michael A and Parra, Esteban J and Cruz, Miguel and Psaty, Bruce M and Brandslund, Ivan and Pramstaller, Peter P and Rotimi, Charles N and Christensen, Kaare and Ripatti, Samuli and Widen, Elisabeth and Hakonarson, Hakon and Kiemeney, Lambertus Alm and de Graaf, Jacqueline and Loeffler, Markus and Kronenberg, Florian and Gu, Dongfeng and Erdmann, Jeanette and Schunkert, Heribert and Franks, Paul W and Linneberg, Allan and Wouter Jukema, J and Khera, Amit V and Mannikko, Minna and Jarvelin, Marjo-Riitta and Kutalik, Zoltan and Francesco, Cucca and Mook-Kanamori, Dennis O and van Dijk, Ko Willems and Watkins, Hugh and Strachan, David P and Grarup, Niels and Sever, Peter and Poulter, Neil and Sheu, Wayne Huey-Herng and Rotter, Jerome I and Dantoft, Thomas M and Karpe, Fredrik and Neville, Matt J and Timpson, Nicholas J and Cheng, Ching-Yu and Wong, Tien-Yin and Khor, Chiea Chuen and Li, Hengtong and Sabanayagam, Charumathi and Peters, Annette and Gieger, Christian and Hattersley, Andrew T and Pedersen, Nancy L and Magnusson, Patrik K E and Boomsma, Dorret I and de Geus, Eco J C and Adrienne Cupples, L and van Meurs, Joyce B J and Ikram, Arfan and Ghanbari, Mohsen and Gordon-Larsen, Penny and Huang, Wei and Kim, Young Jin and Tabara, Yasuharu and Wareham, Nicholas J and Langenberg, Claudia and Zeggini, Eleftheria and Tuomilehto, Jaakko and Kuusisto, Johanna and Laakso, Markku and Ingelsson, Erik and Abecasis, Goncalo and Chambers, John C and Kooner, Jaspal S and de Vries, Paul S and Morrison, Alanna C and Hazelhurst, Scott and Ramsay, Michele and North, Kari E and Daviglus, Martha and Kraft, Peter and Martin, Nicholas G and Whitfield, John B and Abbas, Shahid and Saleheen, Danish and Walters, Robin G and Holmes, Michael V and Black, Corri and Smith, Blair H and Baras, Aris and Justice, Anne E and Buring, Julie E and Ridker, Paul M and Chasman, Daniel I and Kooperberg, Charles and Tamiya, Gen and Yamamoto, Masayuki and van Heel, David A and Trembath, Richard C and Wei, Wei-Qi and Jarvik, Gail P and Namjou, Bahram and Geoffrey Hayes, M and Ritchie, Marylyn D and Jousilahti, Pekka and Salomaa, Veikko and Hveem, Kristian and Asvold, Bjorn Olav and Kubo, Michiaki and Kamatani, Yoichiro and Okada, Yukinori and Murakami, Yoshinori and Kim, Bong-Jo and Thorsteinsdottir, Unnur and Stefansson, Kari and Zhang, Jifeng and Eugene Chen, Y and Ho, Yuk-Lam and Lynch, Julie A and Rader, Daniel and Tsao, Philip S and Chang, Kyong-Mi and Cho, Kelly and O'Donnell, Christopher J and Gaziano, John M and Wilson, Peter and Mohlke, Karen L and Frayling, Timothy M and Hirschhorn, Joel N and Kathiresan, Sekar and Boehnke, Michael and Natarajan, Pradeep and Grant, Struan F A and Sun, Yan V and Morris, Andrew P and Deloukas, Panos and Peloso, Gina and Assimes, Themistocles L and Willer, Cristen J and Zhu, Xiang and Brown, Christopher D},
doi = {10.1101/2021.12.07.470215},
journal = {bioRxiv},
month = {dec},
title = {A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids},
year = {2021},
keywords = {preprint},
abstract = {A major challenge of genome-wide association studies (GWAS) is to translate phenotypic associations into biological insights. Here, we integrate a large GWAS on blood lipids involving 1.6 million individuals from five ancestries with a wide array of functional genomic datasets to discover regulatory mechanisms underlying lipid associations. We first prioritize lipid-associated genes with expression quantitative trait locus (eQTL) colocalizations, and then add chromatin interaction data to narrow the search for functional genes. Polygenic enrichment analysis across 697 annotations from a host of tissues and cell types confirms the central role of the liver in lipid levels, and highlights the selective enrichment of adipose-specific chromatin marks in high-density lipoprotein cholesterol and triglycerides. Overlapping transcription factor (TF) binding sites with lipid-associated loci identifies TFs relevant in lipid biology. In addition, we present an integrative framework to prioritize causal variants at GWAS loci, producing a comprehensive list of candidate causal genes and variants with multiple layers of functional evidence. Two prioritized genes, CREBRF and RRBP1, show convergent evidence across functional datasets supporting their roles in lipid biology.}
}
@article{Graham2021,
author = {Graham, Sarah E and Clarke, Shoa L and Wu, Kuan-Han H and Kanoni, Stavroula and Zajac, Greg J M and Ramdas, Shweta and Surakka, Ida and Ntalla, Ioanna and Vedantam, Sailaja and Winkler, Thomas W and Locke, Adam E and Marouli, Eirini and Hwang, Mi Yeong and Han, Sohee and Narita, Akira and Choudhury, Ananyo and Bentley, Amy R and Ekoru, Kenneth and Verma, Anurag and Trivedi, Bhavi and Martin, Hilary C and Hunt, Karen A and Hui, Qin and Klarin, Derek and Zhu, Xiang and Thorleifsson, Gudmar and Helgadottir, Anna and Gudbjartsson, Daniel F and Holm, Hilma and Olafsson, Isleifur and Akiyama, Masato and Sakaue, Saori and Terao, Chikashi and Kanai, Masahiro and Zhou, Wei and Brumpton, Ben M and Rasheed, Humaira and Ruotsalainen, Sanni E and Havulinna, Aki S and Veturi, Yogasudha and Feng, Qiping and Rosenthal, Elisabeth A and Lingren, Todd and Pacheco, Jennifer Allen and Pendergrass, Sarah A and Haessler, Jeffrey and Giulianini, Franco and Bradford, Yuki and Miller, Jason E and Campbell, Archie and Lin, Kuang and Millwood, Iona Y and Hindy, George and Rasheed, Asif and Faul, Jessica D and Zhao, Wei and Weir, David R and Turman, Constance and Huang, Hongyan and Graff, Mariaelisa and Mahajan, Anubha and Brown, Michael R and Zhang, Weihua and Yu, Ketian and Schmidt, Ellen M and Pandit, Anita and Gustafsson, Stefan and Yin, Xianyong and Luan, Jian'an and Zhao, Jing-Hua and Matsuda, Fumihiko and Jang, Hye-Mi and Yoon, Kyungheon and Medina-Gomez, Carolina and Pitsillides, Achilleas and Hottenga, Jouke Jan and Willemsen, Gonneke and Wood, Andrew R and Ji, Yingji and Gao, Zishan and Haworth, Simon and Mitchell, Ruth E and Chai, Jin Fang and Aadahl, Mette and Yao, Jie and Manichaikul, Ani and Warren, Helen R and Ramirez, Julia and Bork-Jensen, Jette and K{\aa}rhus, Line L and Goel, Anuj and Sabater-Lleal, Maria and Noordam, Raymond and Sidore, Carlo and Fiorillo, Edoardo and McDaid, Aaron F and Marques-Vidal, Pedro and Wielscher, Matthias and Trompet, Stella and Sattar, Naveed and M{\o}llehave, Line T and Thuesen, Betina H and Munz, Matthias and Zeng, Lingyao and Huang, Jianfeng and Yang, Bin and Poveda, Alaitz and Kurbasic, Azra and Lamina, Claudia and Forer, Lukas and Scholz, Markus and Galesloot, Tessel E and Bradfield, Jonathan P and Daw, E Warwick and Zmuda, Joseph M and Mitchell, Jonathan S and Fuchsberger, Christian and Christensen, Henry and Brody, Jennifer A and Feitosa, Mary F and Wojczynski, Mary K and Preuss, Michael and Mangino, Massimo and Christofidou, Paraskevi and Verweij, Niek and Benjamins, Jan W and Engmann, Jorgen and Kember, Rachel L and Slieker, Roderick C and Lo, Ken Sin and Zilhao, Nuno R and Le, Phuong and Kleber, Marcus E and Delgado, Graciela E and Huo, Shaofeng and Ikeda, Daisuke D and Iha, Hiroyuki and Yang, Jian and Liu, Jun and Leonard, Hampton L and Marten, Jonathan and Schmidt, B{\"o}rge and Arendt, Marina and Smyth, Laura J and Ca{\~n}adas-Garre, Marisa and Wang, Chaolong and Nakatochi, Masahiro and Wong, Andrew and Hutri-K{\"a}h{\"o}nen, Nina and Sim, Xueling and Xia, Rui and Huerta-Chagoya, Alicia and Fernandez-Lopez, Juan Carlos and Lyssenko, Valeriya and Ahmed, Meraj and Jackson, Anne U and Irvin, Marguerite R and Oldmeadow, Christopher and Kim, Han-Na and Ryu, Seungho and Timmers, Paul R H J and Arbeeva, Liubov and Dorajoo, Rajkumar and Lange, Leslie A and Chai, Xiaoran and Prasad, Gauri and Lor{\'e}s-Motta, Laura and Pauper, Marc and Long, Jirong and Li, Xiaohui and Theusch, Elizabeth and Takeuchi, Fumihiko and Spracklen, Cassandra N and Loukola, Anu and Bollepalli, Sailalitha and Warner, Sophie C and Wang, Ya Xing and Wei, Wen B and Nutile, Teresa and Ruggiero, Daniela and Sung, Yun Ju and Hung, Yi-Jen and Chen, Shufeng and Liu, Fangchao and Yang, Jingyun and Kentistou, Katherine A and Gorski, Mathias and Brumat, Marco and Meidtner, Karina and Bielak, Lawrence F and Smith, Jennifer A and Hebbar, Prashantha and Farmaki, Aliki-Eleni and Hofer, Edith and Lin, Maoxuan and Xue, Chao and Zhang, Jifeng and Concas, Maria Pina and Vaccargiu, Simona and van der Most, Peter J and Pitk{\"a}nen, Niina and Cade, Brian E and Lee, Jiwon and van der Laan, Sander W and Chitrala, Kumaraswamy Naidu and Weiss, Stefan and Zimmermann, Martina E and Lee, Jong Young and Choi, Hyeok Sun and Nethander, Maria and Freitag-Wolf, Sandra and Southam, Lorraine and Rayner, Nigel W and Wang, Carol A and Lin, Shih-Yi and Wang, Jun-Sing and Couture, Christian and Lyytik{\"a}inen, Leo-Pekka and Nikus, Kjell and Cuellar-Partida, Gabriel and Vestergaard, Henrik and Hildalgo, Bertha and Giannakopoulou, Olga and Cai, Qiuyin and Obura, Morgan O and van Setten, Jessica and Li, Xiaoyin and Schwander, Karen and Terzikhan, Natalie and Shin, Jae Hun and Jackson, Rebecca D and Reiner, Alexander P and Martin, Lisa Warsinger and Chen, Zhengming and Li, Liming and Highland, Heather M and Young, Kristin L and Kawaguchi, Takahisa and Thiery, Joachim and Bis, Joshua C and Nadkarni, Girish N and Launer, Lenore J and Li, Huaixing and Nalls, Mike A and Raitakari, Olli T and Ichihara, Sahoko and Wild, Sarah H and Nelson, Christopher P and Campbell, Harry and J{\"a}ger, Susanne and Nabika, Toru and Al-Mulla, Fahd and Niinikoski, Harri and Braund, Peter S and Kolcic, Ivana and Kovacs, Peter and Giardoglou, Tota and Katsuya, Tomohiro and Bhatti, Konain Fatima and de Kleijn, Dominique and de Borst, Gert J and Kim, Eung Kweon and Adams, Hieab H H and Ikram, M Arfan and Zhu, Xiaofeng and Asselbergs, Folkert W and Kraaijeveld, Adriaan O and Beulens, Joline W J and Shu, Xiao-Ou and Rallidis, Loukianos S and Pedersen, Oluf and Hansen, Torben and Mitchell, Paul and Hewitt, Alex W and K{\"a}h{\"o}nen, Mika and P{\'e}russe, Louis and Bouchard, Claude and T{\"o}njes, Anke and Chen, Yii-Der Ida and Pennell, Craig E and Mori, Trevor A and Lieb, Wolfgang and Franke, Andre and Ohlsson, Claes and Mellstr{\"o}m, Dan and Cho, Yoon Shin and Lee, Hyejin and Yuan, Jian-Min and Koh, Woon-Puay and Rhee, Sang Youl and Woo, Jeong-Taek and Heid, Iris M and Stark, Klaus J and V{\"o}lzke, Henry and Homuth, Georg and Evans, Michele K and Zonderman, Alan B and Polasek, Ozren and Pasterkamp, Gerard and Hoefer, Imo E and Redline, Susan and Pahkala, Katja and Oldehinkel, Albertine J and Snieder, Harold and Biino, Ginevra and Schmidt, Reinhold and Schmidt, Helena and Chen, Y Eugene and Bandinelli, Stefania and Dedoussis, George and Thanaraj, Thangavel Alphonse and Kardia, Sharon L R and Kato, Norihiro and Schulze, Matthias B and Girotto, Giorgia and Jung, Bettina and B{\"o}ger, Carsten A and Joshi, Peter K and Bennett, David A and De Jager, Philip L and Lu, Xiangfeng and Mamakou, Vasiliki and Brown, Morris and Caulfield, Mark J and Munroe, Patricia B and Guo, Xiuqing and Ciullo, Marina and Jonas, Jost B and Samani, Nilesh J and Kaprio, Jaakko and Pajukanta, P{\"a}ivi and Adair, Linda S and Bechayda, Sonny Augustin and de Silva, H Janaka and Wickremasinghe, Ananda R and Krauss, Ronald M and Wu, Jer-Yuarn and Zheng, Wei and den Hollander, Anneke I and Bharadwaj, Dwaipayan and Correa, Adolfo and Wilson, James G and Lind, Lars and Heng, Chew-Kiat and Nelson, Amanda E and Golightly, Yvonne M and Wilson, James F and Penninx, Brenda and Kim, Hyung-Lae and Attia, John and Scott, Rodney J and Rao, D C and Arnett, Donna K and Walker, Mark and Koistinen, Heikki A and Chandak, Giriraj R and Yajnik, Chittaranjan S and Mercader, Josep M and Tusi{\'e}-Luna, Teresa and Aguilar-Salinas, Carlos A and Villalpando, Clicerio Gonzalez and Orozco, Lorena and Fornage, Myriam and Tai, E Shyong and van Dam, Rob M and Lehtim{\"a}ki, Terho and Chaturvedi, Nish and Yokota, Mitsuhiro and Liu, Jianjun and Reilly, Dermot F and McKnight, Amy Jayne and Kee, Frank and J{\"o}ckel, Karl-Heinz and McCarthy, Mark I and Palmer, Colin N A and Vitart, Veronique and Hayward, Caroline and Simonsick, Eleanor and van Duijn, Cornelia M and Lu, Fan and Qu, Jia and Hishigaki, Haretsugu and Lin, Xu and M{\"a}rz, Winfried and Parra, Esteban J and Cruz, Miguel and Gudnason, Vilmundur and Tardif, Jean-Claude and Lettre, Guillaume and 't Hart, Leen M and Elders, Petra J M and Damrauer, Scott M and Kumari, Meena and Kivimaki, Mika and van der Harst, Pim and Spector, Tim D and Loos, Ruth J F and Province, Michael A and Psaty, Bruce M and Brandslund, Ivan and Pramstaller, Peter P and Christensen, Kaare and Ripatti, Samuli and Wid{\'e}n, Elisabeth and Hakonarson, Hakon and Grant, Struan F A and Kiemeney, Lambertus A L M and de Graaf, Jacqueline and Loeffler, Markus and Kronenberg, Florian and Gu, Dongfeng and Erdmann, Jeanette and Schunkert, Heribert and Franks, Paul W and Linneberg, Allan and Jukema, J Wouter and Khera, Amit V and M{\"a}nnikk{\"o}, Minna and Jarvelin, Marjo-Riitta and Kutalik, Zoltan and Cucca, Francesco and Mook-Kanamori, Dennis O and van Dijk, Ko Willems and Watkins, Hugh and Strachan, David P and Grarup, Niels and Sever, Peter and Poulter, Neil and Rotter, Jerome I and Dantoft, Thomas M and Karpe, Fredrik and Neville, Matt J and Timpson, Nicholas J and Cheng, Ching-Yu and Wong, Tien-Yin and Khor, Chiea Chuen and Sabanayagam, Charumathi and Peters, Annette and Gieger, Christian and Hattersley, Andrew T and Pedersen, Nancy L and Magnusson, Patrik K E and Boomsma, Dorret I and de Geus, Eco J C and Cupples, L Adrienne and van Meurs, Joyce B J and Ghanbari, Mohsen and Gordon-Larsen, Penny and Huang, Wei and Kim, Young Jin and Tabara, Yasuharu and Wareham, Nicholas J and Langenberg, Claudia and Zeggini, Eleftheria and Kuusisto, Johanna and Laakso, Markku and Ingelsson, Erik and Abecasis, Goncalo and Chambers, John C and Kooner, Jaspal S and de Vries, Paul S and Morrison, Alanna C and North, Kari E and Daviglus, Martha and Kraft, Peter and Martin, Nicholas G and Whitfield, John B and Abbas, Shahid and Saleheen, Danish and Walters, Robin G and Holmes, Michael V and Black, Corri and Smith, Blair H and Justice, Anne E and Baras, Aris and Buring, Julie E and Ridker, Paul M and Chasman, Daniel I and Kooperberg, Charles and Wei, Wei-Qi and Jarvik, Gail P and Namjou, Bahram and Hayes, M Geoffrey and Ritchie, Marylyn D and Jousilahti, Pekka and Salomaa, Veikko and Hveem, Kristian and {\AA}svold, Bj{\o}rn Olav and Kubo, Michiaki and Kamatani, Yoichiro and Okada, Yukinori and Murakami, Yoshinori and Thorsteinsdottir, Unnur and Stefansson, Kari and Ho, Yuk-Lam and Lynch, Julie A and Rader, Daniel J and Tsao, Philip S and Chang, Kyong-Mi and Cho, Kelly and O'Donnell, Christopher J and Gaziano, John M and Wilson, Peter and Rotimi, Charles N and Hazelhurst, Scott and Ramsay, Mich{\`e}le and Trembath, Richard C and van Heel, David A and Tamiya, Gen and Yamamoto, Masayuki and Kim, Bong-Jo and Mohlke, Karen L and Frayling, Timothy M and Hirschhorn, Joel N and Kathiresan, Sekar and Boehnke, Michael and Natarajan, Pradeep and Peloso, Gina M and Brown, Christopher D and Morris, Andrew P and Assimes, Themistocles L and Deloukas, Panos and Sun, Yan V and Willer, Cristen J},
doi = {10.1038/s41586-021-04064-3},
journal = {Nature},
month = {dec},
number = {7890},
pages = {675--679},
title = {The power of genetic diversity in genome-wide association studies of lipids},
volume = {600},
year = {2021},
abstract = {Increased blood lipid levels are heritable risk factors of cardiovascular disease with varied prevalence worldwide owing to different dietary patterns and medication use1. Despite advances in prevention and treatment, in particular through reducing low-density lipoprotein cholesterol levels2, heart disease remains the leading cause of death worldwide3. Genome-wideassociation studies (GWAS) of blood lipid levels have led to important biological and clinical insights, as well as new drug targets, for cardiovascular disease. However, most previous GWAS4--23 have been conducted in European ancestry populations and may have missed genetic variants that contribute to lipid-level variation in other ancestry groups. These include differences in allele frequencies, effect sizes and linkage-disequilibrium patterns24. Here we conduct a multi-ancestry, genome-wide genetic discovery meta-analysis of lipid levels in approximately 1.65 million individuals, including 350,000 of non-European ancestries. We quantify the gain in studying non-European ancestries and provide evidence to support the expansion of recruitment of additional ancestries, even with relatively small sample sizes. We find that increasing diversity rather than studying additional individuals of European ancestry results in substantial improvements in fine-mapping functional variants and portability of polygenic prediction (evaluated in approximately 295,000 individuals from 7 ancestry groupings). Modest gains in the number of discovered loci and ancestry-specific variants were also achieved. As GWAS expand emphasis beyond the identification of genes and fundamental biology towards the use of genetic variants for preventive and precision medicine25, we anticipate that increased diversity of participants will lead to more accurate and equitable26 application of polygenic scores in clinical practice. A genome-wide association meta-analysis study of blood lipid levels in roughly 1.6 million individuals demonstrates the gain of power attained when diverse ancestries are included to improve fine-mapping and polygenic score generation, with gains in locus discovery related to sample size.},
pdf = {https://rdcu.be/cCWym},
pubmed = {34887591},
website = {https://csg.sph.umich.edu/willer/public/glgc-lipids2021/}
}
@article{Tsuo2021,
author = {Tsuo, Kristin and Zhou, Wei and Wang, Ying and Kanai, Masahiro and Namba, Shinichi and Gupta, Rahul and Majara, Lerato and Nkambule, Lethukuthula L and Okada, Yukinori and Morisaki, Takayuki and Neale, Benjamin and {Global Biobank Meta-analysis Initiative} and Daly, Mark J and Martin, Alicia},
doi = {10.1101/2021.11.30.21267108},
journal = {medRxiv},
month = {dec},
title = {Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity},
year = {2021},
keywords = {preprint},
abstract = {Asthma is a complex disease that affects millions of people and varies in prevalence by an order of magnitude across geographic regions and populations. However, the extent to which genetic variation contributes to these disparities is unclear, as studies probing the genetics of asthma have been primarily limited to populations of European (EUR) descent. As part of the Global Biobank Meta-analysis Initiative (GBMI), we conducted the largest genome-wide association study of asthma to date (153,763 cases and 1,647,022 controls) via meta-analysis across 18 biobanks spanning multiple countries and ancestries. Altogether, we discovered 180 genome-wide significant loci (p -8) associated with asthma, 49 of which are not previously reported. We replicate well-known associations such as IL1RL1 and STAT6, and find that overall the novel associations have smaller effects than previously-discovered loci, highlighting our substantial increase in statistical power. Despite the considerable range in prevalence among biobanks, from 3\% to 24\%, the genetic effects of associated loci are largely consistent across the biobanks and ancestries. To further investigate the polygenic architecture of asthma, we construct polygenic risk scores (PRS) using a multi-ancestry approach, which yields higher predictive power for asthma in non-EUR populations compared to PRS derived from previous asthma meta-analyses and using other methods. Additionally, we find considerable genetic overlap between asthma and chronic obstructive pulmonary disease (COPD) across ancestries but minimal overlap in enriched biological pathways. Our work underscores the multifactorial nature of asthma development and offers insight into the shared genetic architecture of asthma that may be differentially perturbed by environmental factors and contribute to variation in prevalence.}
}
@article{Bhattacharya2021,
author = {Bhattacharya, Arjun and Hirbo, Jibril B and Zhou, Dan and Zhou, Wei and Zheng, Jie and Kanai, Masahiro and {The Global Biobank Meta-analysis Initiative} and Daly, Mark J and Pasaniuc, Bogdan and Gamazon, Eric R and Cox, Nancy J},
doi = {10.1101/2021.11.24.21266825},
journal = {medRxiv},
month = {nov},
title = {Best practices of multi-ancestry, meta-analytic transcriptome-wide association studies: lessons from the Global Biobank Meta-analysis Initiative},
year = {2021},
keywords = {preprint},
abstract = {The Global Biobank Meta-analysis Initiative (GBMI), through its genetic and demographic diversity, provides a valuable opportunity to study population-wide and ancestry-specific genetic associations. However, with multiple ascertainment strategies and multi-ethnic study populations across biobanks, the GBMI provides a distinct set of challenges in implementing statistical genetics methods. Transcriptome-wide association studies (TWAS) are a popular tool to boost detection power for and provide biological context to genetic associations by integrating single nucleotide polymorphism to trait (SNP-trait) associations from genome-wide association studies (GWAS) with SNP-based predictive models of gene expression. TWAS presents unique challenges beyond GWAS, especially in a multi-biobank and meta-analytic setting like the GBMI. In this work, we present the GBMI TWAS pipeline, outlining practical considerations for ancestry and tissue specificity and meta-analytic strategies, as well as open challenges at every step of the framework. Our work provides a strong foundation for adding tissue-specific gene expression context to biobank-linked genetic association studies, allowing for ancestry-aware discovery to accelerate genomic medicine.}
}
@article{Wang_Y2021,
author = {Wang, Ying and Namba, Shinichi and Lopera-Maya, Esteban A and Kerminen, Sini and Tsuo, Kristin and Lall, Kristi and Kanai, Masahiro and Zhou, Wei and Wu, Kuan-Han H and Fave, Marie-Julie and Bhatta, Laxmi and Awadalla, Philip and Deelen, Patrick and Lo Faro, Valeria and Magi, Reedik and Murakami, Yoshinori and Brumpton, Ben M and Sanna, Serena and Uzunovic, Jasmina and Gamazon, Eric R and Cox, Nancy J and Surakka, Ida and Okada, Yukinori and Martin, Alicia R and Hirbo, Jibril},
doi = {10.1101/2021.11.18.21266545},
journal = {medRxiv},
month = {nov},
title = {Global biobank analyses provide lessons for computing polygenic risk scores across diverse cohorts},
year = {2021},
keywords = {preprint},
abstract = {With the increasing availability of biobank-scale datasets that incorporate both genomic data and electronic health records, many associations between genetic variants and phenotypes of interest have been discovered. Polygenic risk scores (PRS), which are being widely explored in precision medicine, use the results of association studies to predict the genetic component of disease risk by accumulating risk alleles weighted by their effect sizes. However, limited studies have thoroughly investigated best practices for PRS in global populations across different diseases. In this study, we utilize data from the Global-Biobank Meta-analysis Initiative (GBMI), which consists of individuals from diverse ancestries and across continents, to explore methodological considerations and PRS prediction performance in 9 different biobanks for 14 disease endpoints. Specifically, we constructed PRS using heuristic (pruning and thresholding, P+T) and Bayesian (PRS-CS) methods. We found that the genetic architecture, such as SNP-based heritability and polygenicity, varied greatly among endpoints. For both PRS construction methods, using a European ancestry LD reference panel resulted in comparable or higher prediction accuracy compared to several other non-European based panels; this is largely attributable to European descent populations still comprising the majority of GBMI participants. PRS-CS overall outperformed the classic P+T method, especially for endpoints with higher SNP-based heritability. For example, substantial improvements are observed in East-Asian ancestry (EAS) using PRS-CS compared to P+T for heart failure (HF) and chronic obstructive pulmonary disease (COPD). Notably, prediction accuracy is heterogeneous across endpoints, biobanks, and ancestries, especially for asthma which has known variation in disease prevalence across global populations. Overall, we provide lessons for PRS construction, evaluation, and interpretation using the GBMI and highlight the importance of best practices for PRS in the biobank-scale genomics era.}
}
@article{Zhou2021,
author = {Zhou, Wei and Kanai, Masahiro and Wu, Kuan-Han H and Humaira, Rasheed and Tsuo, Kristin and Hirbo, Jibril B and Wang, Ying and Bhattacharya, Arjun and Zhao, Huiling and Namba, Shinichi and Surakka, Ida and Wolford, Brooke N and Faro, Valeria Lo and Lopera-Maya, Esteban A and L{\"a}ll, Kristi and Fav{\'e}, Marie-Julie and Chapman, Sin{\'e}ad B and Karjalainen, Juha and Kurki, Mitja and Mutaamba, Maasha and Brumpton, Ben M and Chavan, Sameer and Chen, Tzu-Ting and Daya, Michelle and Ding, Yi and Feng, Yen-Chen A and Gignoux, Christopher R and Graham, Sarah E and Hornsby, Whitney E and Ingold, Nathan and Johnson, Ruth and Laisk, Triin and Lin, Kuang and Lv, Jun and Millwood, Iona Y and Palta, Priit and Pandit, Anita and Preuss, Michael and Thorsteinsdottir, Unnur and Uzunovic, Jasmina and Zawistowski, Matthew and Zhong, Xue and Campbell, Archie and Crooks, Kristy and De Bock, Geertruida h and Douville, Nicholas J and Finer, Sarah and Fritsche, Lars G and Griffiths, Christopher J and Guo, Yu and Hunt, Karen A and Konuma, Takahiro and Marioni, Riccardo E and Nomdo, Jansonius and Patil, Snehal and Rafaels, Nicholas and Richmond, Anne and Shortt, Jonathan A and Straub, Peter and Tao, Ran and Vanderwerff, Brett and Barnes, Kathleen C and Boezen, Marike and Chen, Zhengming and Chen, Chia-Yen and Cho, Judy and Smith, George Davey and Finucane, Hilary K and Franke, Lude and Gamazon, Eric and Ganna, Andrea and Gaunt, Tom R and Ge, Tian and Huang, Hailiang and Huffman, Jennifer and Lajonchere, Clara and Law, Matthew H and Li, Liming and Lindgren, Cecilia M and Loos, Ruth J F and MacGregor, Stuart and Matsuda, Koichi and Olsen, Catherine M and Porteous, David J and Shavit, Jordan A and Snieder, Harold and Trembath, Richard C and Vonk, Judith M and Whiteman, David and Wicks, Stephen J and Wijmenga, Cisca and Wright, John and Zheng, Jie and Zhou, Xiang and Awadalla, Philip and Boehnke, Michael and Cox, Nancy J and Geschwind, Daniel H and Hayward, Caroline and Hveem, Kristian and Kenny, Eimear E and Lin, Yen-Feng and M{\"a}gi, Reedik and Martin, Hilary C and Medland, Sarah E and Okada, Yukinori and Palotie, Aarno V and Pasaniuc, Bogdan and Sanna, Serena and Smoller, Jordan W and Stefansson, Kari and van Heel, David A and Walters, Robin G and Zoellner, Sebastian and {Biobank Japan} and {BioMe} and {BioVU} and {Canadian Partnership for Tomorrow} and {China Kadoorie Biobank Collaborative Group} and {Colorado Center for Personalized Medicine} and {deCODE Genetics} and {Estonian Biobank} and {FinnGen} and {Generation Scotland} and {Genes \& Health} and {LifeLines} and {Mass General Brigham Biobank} and {Michigan Genomics Initiative} and {QIMR Berghofer Biobank} and {Taiwan Biobank} and {The HUNT Study} and {UCLA ATLAS Community Health Initiative} and {UK Biobank} and Martin, Alicia R and Willer, Cristen J and Daly, Mark J and Neale, Benjamin M},
doi = {10.1101/2021.11.19.21266436},
journal = {medRxiv},
month = {nov},
title = {Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases},
year = {2021},
keywords = {preprint},
abstract = {Biobanks are being established across the world to understand the genetic, environmental, and epidemiological basis of human diseases with the goal of better prevention and treatments. Genome-wide association studies (GWAS) have been very successful at mapping genomic loci for a wide range of human diseases and traits, but in general, lack appropriate representation of diverse ancestries - with most biobanks and preceding GWAS studies composed of individuals of European ancestries. Here, we introduce the Global Biobank Meta-analysis Initiative (GBMI) -- a collaborative network of 19 biobanks from 4 continents representing more than 2.1 million consented individuals with genetic data linked to electronic health records. GBMI meta-analyzes summary statistics from GWAS generated using harmonized genotypes and phenotypes from member biobanks. GBMI brings together results from GWAS analysis across 6 main ancestry groups: approximately 33,000 of African ancestry either from Africa or from admixed-ancestry diaspora (AFR), 18,000 admixed American (AMR), 31,000 Central and South Asian (CSA), 341,000 East Asian (EAS), 1.4 million European (EUR), and 1,600 Middle Eastern (MID) individuals. In this flagship project, we generated GWASs from across 14 exemplar diseases and endpoints, including both common and less prevalent diseases that were previously understudied. Using the genetic association results, we validate that GWASs conducted in biobanks worldwide can be successfully integrated despite heterogeneity in case definitions, recruitment strategies, and baseline characteristics between biobanks. We demonstrate the value of this collaborative effort to improve GWAS power for diseases, increase representation, benefit understudied diseases, and improve risk prediction while also enabling the nomination of disease genes and drug candidates by incorporating gene and protein expression data and providing insight into the underlying biology of the studied traits.},
website = {https://www.globalbiobankmeta.org/}
}
@article{Polygenic_Risk_Score_Task_Force_of_the_International_Common_Disease_Alliance_2021,
author = {{Polygenic Risk Score Task Force of the International Common Disease Alliance}},
doi = {10.1038/s41591-021-01549-6},
journal = {Nature Medicine},
month = {nov},
number = {11},
pages = {1876--1884},
title = {Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps},
volume = {27},
year = {2021},
abstract = {Polygenic risk scores (PRSs) aggregate the many small effects of alleles across the human genome to estimate the risk of a disease or disease-related trait for an individual. The potential benefits of PRSs include cost-effective enhancement of primary disease prevention, more refined diagnoses and improved precision when prescribing medicines. However, these must be weighed against the potential risks, such as uncertainties and biases in PRS performance, as well as potential misunderstanding and misuse of these within medical practice and in wider society. By addressing key issues including gaps in best practices, risk communication and regulatory frameworks, PRSs can be used responsibly to improve human health. Here, the International Common Disease Alliance's PRS Task Force, a multidisciplinary group comprising expertise in genetics, law, ethics, behavioral science and more, highlights recent research to provide a comprehensive summary of the state of polygenic score research, as well as the needs and challenges as PRSs move closer to widespread use in the clinic. As polygenic risk scores move closer to widespread clinical use, this Perspective summarizes the benefits, risks and challenges to be overcome.},
pdf = {https://rdcu.be/cBoE2},
pubmed = {34782789}
}
@article{The_COVID-19_Host_Genetics_Initiative2021b,
author = {{The COVID-19 Host Genetics Initiative}},
doi = {10.1101/2021.11.08.21265944},
journal = {medRxiv},
month = {nov},
title = {Mapping the human genetic architecture of {COVID-19}: an update},
year = {2021},
keywords = {preprint},
abstract = {The Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a major public health threat especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity we formed the COVID19 Host Genetics Initiative. Here we present GWAS meta-analysis of up to 125,584 cases and over 2.5 million controls across 60 studies from 25 countries, adding 10 new genome-wide significant loci to the 13 we previously identified1. Genes in novel loci include SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity.},
website = {https://www.covid19hg.org/}
}
@article{Zheng2021,
author = {Zheng, Jie and Zhang, Yuemiao and Rasheed, Humaira and Walker, Venexia and Sugawara, Yuka and Li, Jiachen and Leng, Yue and Elsworth, Benjamin and Wootton, Robyn E and Fang, Si and Yang, Qian and Burgess, Stephen and Haycock, Philip C and Borges, Maria Carolina and Cho, Yoonsu and Carnegie, Rebecca and Howell, Amy and Robinson, Jamie and Thomas, Laurent F and Brumpton, Ben Michael and Hveem, Kristian and Hallan, Stein and Franceschini, Nora and Morris, Andrew P and K{\"{o}}ttgen, Anna and Pattaro, Cristian and Wuttke, Matthias and Yamamoto, Masayuki and Kashihara, Naoki and Akiyama, Masato and Kanai, Masahiro and Matsuda, Koichi and Kamatani, Yoichiro and Okada, Yukinori and Walters, Robin and Millwood, Iona Y and Chen, Zhengming and Davey Smith, George and Barbour, Sean and Yu, Canqing and {\AA}svold, Bj{\o}rn Olav and Zhang, Hong and Gaunt, Tom R},
doi = {10.1093/ije/dyab203},
journal = {International Journal of Epidemiology},
month = {oct},
title = {Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease},
year = {2021},
abstract = {BACKGROUND: This study was to systematically test whether previously reported risk factors for chronic kidney disease (CKD) are causally related to CKD in European and East Asian ancestries using Mendelian randomization. METHODS: A total of 45 risk factors with genetic data in European ancestry and 17 risk factors in East Asian participants were identified as exposures from PubMed. We defined the CKD by clinical diagnosis or by estimated glomerular filtration rate of 25 kg/m2. CONCLUSIONS: Eight cardiometabolic risk factors showed causal effects on CKD in Europeans and three of them showed causality in East Asians, providing insights into the design of future interventions to reduce the burden of CKD.},
medrxiv = {10.1101/2020.09.04.20188284},
pubmed = {34669934}
}
@article{Luo2021,
author = {Luo, Yang and Kanai, Masahiro and Choi, Wanson and Li, Xinyi and Sakaue, Saori and Yamamoto, Kenichi and Ogawa, Kotaro and Gutierrez-Arcelus, Maria and Gregersen, Peter K and Stuart, Philip E and Elder, James T and Forer, Lukas and Sch{\"o}nherr, Sebastian and Fuchsberger, Christian and Smith, Albert V and Fellay, Jacques and Carrington, Mary and Haas, David W and Guo, Xiuqing and Palmer, Nicholette D and Chen, Yii-Der Ida and Rotter, Jerome I and Taylor, Kent D and Rich, Stephen S and Correa, Adolfo and Wilson, James G and Kathiresan, Sekar and Cho, Michael H and Metspalu, Andres and Esko, Tonu and Okada, Yukinori and Han, Buhm and McLaren, Paul J and Raychaudhuri, Soumya},
doi = {10.1038/s41588-021-00935-7},
journal = {Nature Genetics},
month = {oct},
number = {10},
pages = {1504--1516},
title = {A high-resolution {HLA} reference panel capturing global population diversity enables multi-ancestry fine-mapping in {HIV} host response},
volume = {53},
year = {2021},
abstract = {Fine-mapping to plausible causal variation may be more effective in multi-ancestry cohorts, particularly in the MHC, which has population-specific structure. To enable such studies, we constructed a large (n = 21,546) HLA reference panel spanning five global populations based on whole-genome sequences. Despite population-specific long-range haplotypes, we demonstrated accurate imputation at G-group resolution (94.2\%, 93.7\%, 97.8\% and 93.7\% in admixed African (AA), East Asian (EAS), European (EUR) and Latino (LAT) populations). Applying HLA imputation to genome-wide association study data for HIV-1 viral load in three populations (EUR, AA and LAT), we obviated effects of previously reported associations from population-specific HIV studies and discovered a novel association at position 156 in HLA-B. We pinpointed the MHC association to three amino acid positions (97, 67 and 156) marking three consecutive pockets (C, B and D) within the HLA-B peptide-binding groove, explaining 12.9\% of trait variance. A high-resolution reference panel based on whole-genome sequencing data enables accurate imputation of HLA alleles across diverse populations and fine-mapping of HLA association signals for HIV-1 host response.},
code = {https://github.com/immunogenomics/HLA-TAPAS},
medrxiv = {10.1101/2020.07.16.20155606},
pdf = {https://rdcu.be/cyVza},
pubmed = {34611364}
}
@article{Kanai2021,
author = {Kanai, Masahiro and Ulirsch, Jacob C and Karjalainen, Juha and Kurki, Mitja and Karczewski, Konrad J and Fauman, Eric B and Wang, Qingbo S and Jacobs, Hannah and Aguet, Francois and Ardlie, Kristin G and Kerimov, Nurlan and Alasoo, Kaur and Benner, Christian and Ishigaki, Kazuyoshi and Sakaue, Saori and Reilly, Steven and {The BioBank Japan Project} and {FinnGen} and Kamatani, Yoichiro and Matsuda, Koichi and Palotie, Aarno and Neale, Benjamin M and Tewhey, Ryan and Sabeti, Pardis C and Okada, Yukinori and Daly, Mark J and Finucane, Hilary K},
doi = {10.1101/2021.09.03.21262975},
journal = {medRxiv},
month = {sep},
year = {2021},
title = {Insights from complex trait fine-mapping across diverse populations},
keywords = {selected},
abstract = {Despite the great success of genome-wide association studies (GWAS) in identifying genetic loci significantly associated with diseases, the vast majority of causal variants underlying disease-associated loci have not been identified. To create an atlas of causal variants, we performed and integrated fine-mapping across 148 complex traits in three large-scale biobanks (BioBank Japan, FinnGen, and UK Biobank; total n = 811,261), resulting in 4,518 variant-trait pairs with high posterior probability (> 0.9) of causality. Of these, we found 285 high-confidence variant-trait pairs replicated across multiple populations, and we characterized multiple contributors to the surprising lack of overlap among fine-mapping results from different biobanks. By studying the bottlenecked Finnish and Japanese populations, we identified 21 and 26 putative causal coding variants with extreme allele frequency enrichment (> 10-fold) in these two populations, respectively. Aggregating data across populations enabled identification of 1,492 unique fine-mapped coding variants and 176 genes in which multiple independent coding variants influence the same trait (i.e., with an allelic series of coding variants). Our results demonstrate that fine-mapping in diverse populations enables novel insights into the biology of complex traits by pinpointing high-confidence causal variants for further characterization.},
code = {https://github.com/mkanai/finemapping-insights},
data = {https://www.finucanelab.org/data}
}
@article{Sakaue2021,
author = {*Sakaue, Saori and *Kanai, Masahiro and Tanigawa, Yosuke and Karjalainen, Juha and Kurki, Mitja and Koshiba, Seizo and Narita, Akira and Konuma, Takahiro and Yamamoto, Kenichi and Akiyama, Masato and Ishigaki, Kazuyoshi and Suzuki, Akari and Suzuki, Ken and Obara, Wataru and Yamaji, Ken and Takahashi, Kazuhisa and Asai, Satoshi and Takahashi, Yasuo and Suzuki, Takao and Shinozaki, Nobuaki and Yamaguchi, Hiroki and Minami, Shiro and Murayama, Shigeo and Yoshimori, Kozo and Nagayama, Satoshi and Obata, Daisuke and Higashiyama, Masahiko and Masumoto, Akihide and Koretsune, Yukihiro and Ito, Kaoru and Terao, Chikashi and Yamauchi, Toshimasa and Komuro, Issei and Kadowaki, Takashi and Tamiya, Gen and Yamamoto, Masayuki and Nakamura, Yusuke and Kubo, Michiaki and Murakami, Yoshinori and Yamamoto, Kazuhiko and Kamatani, Yoichiro and Palotie, Aarno and Rivas, Manuel A and Daly, Mark J and Matsuda, Koichi and Okada, Yukinori},
doi = {10.1038/s41588-021-00931-x},
journal = {Nature Genetics},
month = {oct},
number = {10},
pages = {1415--1424},
title = {A cross-population atlas of genetic associations for 220 human phenotypes},
volume = {53},
year = {2021},
keywords = {selected},
abstract = {Current genome-wide association studies do not yet capture sufficient diversity in populations and scope of phenotypes. To expand an atlas of genetic associations in non-European populations, we conducted 220 deep-phenotype genome-wide association studies (diseases, biomarkers and medication usage) in BioBank Japan (n = 179,000), by incorporating past medical history and text-mining of electronic medical records. Meta-analyses with the UK Biobank and FinnGen (ntotal = 628,000) identified ~5,000 new loci, which improved the resolution of the genomic map of human traits. This atlas elucidated the landscape of pleiotropy as represented by the major histocompatibility complex locus, where we conducted HLA fine-mapping. Finally, we performed statistical decomposition of matrices of phenome-wide summary statistics, and identified latent genetic components, which pinpointed responsible variants and biological mechanisms underlying current disease classifications across populations. The decomposed components enabled genetically informed subtyping of similar diseases (for example, allergic diseases). Our study suggests a potential avenue for hypothesis-free re-investigation of human diseases through genetics. Genome-wide analyses in BioBank Japan, UK Biobank and FinnGen identify ~5,000 new loci associated with 220 human traits. Statistical decomposition of matrices of phenome-wide summary statistics further highlights variants underpinning diseases across populations.},
medrxiv = {10.1101/2020.10.23.20213652},
website = {https://pheweb.jp/},
pdf = {https://rdcu.be/cyG6p},
pr = {https://www.med.osaka-u.ac.jp/eng/activities/results/2021year/okada2021-10-01},
pubmed = {34594039}
}
@article{Griesemer2021,
author = {Griesemer, Dustin and Xue, James R and Reilly, Steven K and Ulirsch, Jacob C and Kukreja, Kalki and Davis, Joe R and Kanai, Masahiro and Yang, David K and Butts, John C and Guney, Mehmet H and Luban, Jeremy and Montgomery, Stephen B and Finucane, Hilary K and Novina, Carl D and Tewhey, Ryan and Sabeti, Pardis C},
doi = {10.1016/j.cell.2021.08.025},
journal = {Cell},
month = {sep},
number = {20},
pages = {5247--5260.e19},
title = {Genome-wide functional screen of {3'UTR} variants uncovers causal variants for human disease and evolution},
volume = {184},
year = {2021},
abstract = {3' untranslated region (3'UTR) variants are strongly associated with human traits and diseases, yet few have been causally identified. We developed the massively parallel reporter assay for 3'UTRs (MPRAu) to sensitively assay 12,173 3'UTR variants. We applied MPRAu to six human cell lines, focusing on genetic variants associated with genome-wide association studies (GWAS) and human evolutionary adaptation. MPRAu expands our understanding of 3'UTR function, suggesting that simple sequences predominately explain 3'UTR regulatory activity. We adapt MPRAu to uncover diverse molecular mechanisms at base pair resolution, including an adenylate-uridylate (AU)-rich element of LEPR linked to potential metabolic evolutionary adaptations in East Asians. We nominate hundreds of 3'UTR causal variants with genetically fine-mapped phenotype associations. Using endogenous allelic replacements, we characterize one variant that disrupts a miRNA site regulating the viral defense gene TRIM14 and one that alters PILRB abundance, nominating a causal variant underlying transcriptional changes in age-related macular degeneration.},
biorxiv = {10.1101/2021.01.13.424697},
pubmed = {34534445}
}
@article{Palmer2021,
author = {Palmer, Duncan S and Zhou, Wei and Abbott, Liam and Baya, Nik and Churchhouse, Claire and Seed, Cotton and Poterba, Tim and King, Daniel and Kanai, Masahiro and Bloemendal, Alex and Neale, Benjamin M},
doi = {10.1101/2021.08.15.456387},
journal = {bioRxiv},
month = {aug},
title = {Analysis of genetic dominance in the {UK} Biobank},
year = {2021},
keywords = {preprint},
abstract = {In classical statistical genetic theory, a dominance effect is defined as the deviation from a purely additive genetic effect for a biallelic variant. Dominance effects are well documented in model organisms. However, evidence in humans is limited to a handful of traits, particularly those with strong single locus effects such as hair color. We carried out the largest systematic evaluation of dominance effects on phenotypic variance in the UK Biobank. We curated and tested over 1,000 phenotypes for dominance effects through GWAS scans, identifying 175 loci at genome-wide significance correcting for multiple testing (P 0.05), we found no strong evidence of a contribution to phenotypic variance when accounting for multiple testing. Across the 267 continuous and 793 binary traits the median contribution was 5.73 $\times$ 10-4, with unbiased point estimates ranging from -0.261 to 0.131. Finally, we introduce dominance fine-mapping to explore whether the more rapid decay of dominance LD can be leveraged to find causal variants. These results provide the most comprehensive assessment of dominance trait variation in humans to date.}
}
@article{Reilly2021,
author = {Reilly, Steven K and Gosai, Sager J and Guiterrez, Alan and Ulirsch, Jacob C and Kanai, Masahiro and Berenzy, Daniel and Kales, Susan and Butler, Gina B and Gladden-Young, Adrianne and Finucane, Hilary K and Sabeti, Pardis C and Tewhey, Ryan},
doi = {10.1038/s41588-021-00900-4},
journal = {Nature Genetics},
month = {aug},
number = {8},
title = {Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using {HCR--FlowFISH}},
volume = {53},
pages = {1166--1176},
year = {2021},
abstract = {Effective interpretation of genome function and genetic variation requires a shift from epigenetic mapping of cis-regulatory elements (CREs) to characterization of endogenous function. We developed hybridization chain reaction fluorescence in situ hybridization coupled with flow cytometry (HCR--FlowFISH), a broadly applicable approach to characterize CRISPR-perturbed CREs via accurate quantification of native transcripts, alongside CRISPR activity screen analysis (CASA), a hierarchical Bayesian model to quantify CRE activity. Across >325,000 perturbations, we provide evidence that CREs can regulate multiple genes, skip over the nearest gene and display activating and/or silencing effects. At the cholesterol-level-associated FADS locus, we combine endogenous screens with reporter assays to exhaustively characterize multiple genome-wide association signals, functionally nominate causal variants and, importantly, identify their target genes. HCR--FlowFISH is a new approach to characterize CRISPR-perturbed cis-regulatory elements (CREs) via accurate quantification of native transcripts, alongside CRISPR activity screen analysis (CASA), a hierarchical Bayesian model to quantify CRE activity.},
biorxiv = {10.1101/2020.05.11.078675},
pdf = {https://rdcu.be/cqSX2},
pr = {https://www.jax.org/news-and-insights/2021/july/determining-the-function-of-genomic-regulatory-elements},
pubmed = {34326544}
}
@article{The_COVID-19_Host_Genetics_Initiative2021a,
author = {{The COVID-19 Host Genetics Initiative}},
doi = {10.1038/s41586-021-03767-x},
journal = {Nature},
month = {dec},
number = {7889},
pages = {472--477},
title = {Mapping the human genetic architecture of {COVID-19}},
volume = {600},
year = {2021},
keywords = {selected},
abstract = {The genetic makeup of an individual contributes to susceptibility and response to viral infection. While environmental, clinical and social factors play a role in exposure to SARS-CoV-2 and COVID-19 disease severity1,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. We describe the results of three genome-wide association meta-analyses comprised of up to 49,562 COVID-19 patients from 46 studies across 19 countries. We reported 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3--7. They also represent potentially actionable mechanisms in response to infection. Mendelian Randomization analyses support a causal role for smoking and body mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19, with unprecedented speed, was made possible by the community of human genetic researchers coming together to prioritize sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.},
medrxiv = {10.1101/2021.03.10.21252820},
pdf = {https://rdcu.be/cnZTx},
pr = {https://www.broadinstitute.org/news/large-genomic-analysis-highlights-covid-19-risk-factors},
pubmed = {34237774},
website = {https://www.covid19hg.org/}
}
@article{Ruotsalainen2021,
author = {Ruotsalainen, Sanni E and Surakka, Ida and Mars, Nina and Karjalainen, Juha and Kurki, Mitja and Kanai, Masahiro and Mishra, Pashupati P and Mishra, Binisha H and Sinisalo, Juha and Palta, Priit and Lehtimaki, Terho and Raitakari, Olli and {Estonian Biobank research team} and Milani, Lili and {The Biobank Japan Project} and Okada, Yukinori and {FinnGen} and Palotie, Aarno and Widen, Elisabeth and Daly, Mark J and Ripatti, Samuli},
doi = {10.1101/2021.06.23.21259381},
journal = {medRxiv},
month = {jun},
title = {Loss-of-function of {MFGE8} and protection against coronary atherosclerosis},
year = {2021},
keywords = {preprint},
abstract = {Cardiovascular diseases are the leading cause of premature death and disability worldwide, with both genetic and environmental determinants. While genome-wide association studies have identified multiple genetic loci associated with cardiovascular diseases, exact genes driving these associations remain mostly uncovered. Due to Finland's population history, many deleterious and high-impact variants are enriched in the Finnish population giving a possibility to find genetic associations for protein-truncating variants that likely tie the association to a gene and that would not be detected elsewhere. In FinnGen, a large Finnish biobank study, we identified an inframe insertion rs534125149 in MFGE8 to have protective effect against coronary atherosclerosis (OR = 0.75, p = 2.63E-16) and related endpoints. This variant is highly enriched in Finland (70-fold compared to Non-Finnish Europeans) with allele frequency of 3\% in Finland. The protective association was replicated in meta-analysis of biobanks of Japan and Estonian (OR = 0.75, p = 5.41E-7). Additionally, we identified a splice acceptor variant rs201988637 in MFGE8, independent of the rs534125149 and similarly protective in relation to coronary atherosclerosis (OR = 0.72, p = 7.94E-06) and related endpoints, with no significant risk-increasing associations. The protein-truncating variant was also associated with lower pulse pressure, pointing towards a function of MFGE8 in arterial stiffness and aging also in humans in addition to previous evidence in mice. In conclusion, our results show that inhibiting the production of lactadherin could lower the risk for coronary heart disease substantially.}
}
@article{Wang_QS2021,
author = {Wang, Qingbo S and Kelley, David R and Ulirsch, Jacob and Kanai, Masahiro and Sadhuka, Shuvom and Cui, Ran and Albors, Carlos and Cheng, Nathan and Okada, Yukinori and Aguet, Francois and Ardlie, Kristin G and MacArthur, Daniel G and Finucane, Hilary K},
doi = {10.1038/s41467-021-23134-8},
journal = {Nature Communications},
month = {jun},
number = {1},
pages = {1--11},
title = {Leveraging supervised learning for functionally informed fine-mapping of {cis-eQTLs} identifies an additional 20,913 putative causal {eQTLs}},
volume = {12},
year  = {2021},
abstract = {The large majority of variants identified by GWAS are non-coding, motivating detailed characterization of the function of non-coding variants. Experimental methods to assess variants' effect on gene expressions in native chromatin context via direct perturbation are low-throughput. Existing high-throughput computational predictors thus have lacked large gold standard sets of regulatory variants for training and validation. Here, we leverage a set of 14,807 putative causal eQTLs in humans obtained through statistical fine-mapping, and we use 6121 features to directly train a predictor of whether a variant modifies nearby gene expression. We call the resulting prediction the expression modifier score (EMS). We validate EMS by comparing its ability to prioritize functional variants with other major scores. We then use EMS as a prior for statistical fine-mapping of eQTLs to identify an additional 20,913 putatively causal eQTLs, and we incorporate EMS into co-localization analysis to identify 310 additional candidate genes across UK Biobank phenotypes. Finding causal variants and genes from GWAS loci results remains a challenge. Here, the authors train a model to predict if a variant affects nearby gene expression, and apply the method to identify new possible causal eQTLs and mechanisms of GWAS loci.},
biorxiv = {10.1101/2020.10.20.347294},
code = {https://github.com/FinucaneLab/Expression_Modifier_Score/},
data = {https://www.finucanelab.org/data},
pdf = {https://rdcu.be/cl4Pw},
pubmed = {34099641}
}
@article{Namkoong2021,
author = {Namkoong, Ho and Edahiro, Ryuya and Fukunaga, Koichi and Shirai, Yuya and Sonehara, Kyuto and Tanaka, Hiromu and Lee, Ho and Hasegawa, Takanori and Kanai, Masahiro and Naito, Tatsuhiko and Yamamoto, Kenichi and Saiki, Ryunosuke and Hyugaji, Takayoshi and Shimizu, Eigo and Katayama, Kotoe and Takahashi, Kazuhisa and Harada, Norihiro and Naito, Toshio and Hiki, Makoto and Matsushita, Yasushi and Takagi, Haruhi and Aoki, Ryousuke and Nakamura, Ai and Harada, Sonoko and Sasano, Hitoshi and Kabata, Hiroki and Masaki, Katsunori and Kamata, Hirofumi and Ikemura, Shinnosuke and Chubachi, Shotaro and Okamori, Satoshi and Terai, Hideki and Morita, Atsuho and Asakura, Takanori and Sasaki, Junichi and Morisaki, Hiroshi and Uwamino, Yoshifumi and Nanki, Kosaku and Mikami, Yohei and Uchida, Sho and Uno, Shunsuke and Ishihara, Rino and Matsubara, Yuta and Nishimura, Tomoyasu and Ogawa, Takanori and Ishiguro, Takashi and Isono, Taisuke and Shibata, Shun and Matsui, Yuma and Hosoda, Chiaki and Takano, Kenji and Nishida, Takashi and Kobayashi, Yoichi and Takaku, Yotaro and Takayanagi, Noboru and Ueda, Soichiro and Tada, Ai and Miyawaki, Masayoshi and Yamamoto, Masaomi and Yoshida, Eriko and Hayashi, Reina and Nagasaka, Tomoki and Arai, Sawako and Kaneko, Yutaro and Sasaki, Kana and Tagaya, Etsuko and Kawana, Masatoshi and Arimura, Ken and Takahashi, Kunihiko and Anzai, Tatsuhiko and Ito, Satoshi and Endo, Akifumi and Uchimura, Yuji and Miyazaki, Yasunari and Honda, Takayuki and Tateishi, Tomoya and Tohda, Shuji and Ichimura, Naoya and Sonobe, Kazunari and Sassa, Chihiro and Nakajima, Jun and Nakano, Yasushi and Nakajima, Yukiko and Anan, Ryusuke and Arai, Ryosuke and Kurihara, Yuko and Harada, Yuko and Nishio, Kazumi and Ueda, Tetsuya and Azuma, Masanori and Saito, Ryuichi and Sado, Toshikatsu and Miyazaki, Yoshimune and Sato, Ryuichi and Haruta, Yuki and Nagasaki, Tadao and Yasui, Yoshinori and Hasegawa, Yoshinori and Mutoh, Yoshikazu and Sato, Tomonori and Takei, Reoto and Hagimoto, Satoshi and Noguchi, Yoichiro and Yamano, Yasuhiko and Sasano, Hajime and Ota, Sho and Nakamori, Yasushi and Yoshiya, Kazuhisa and Saito, Fukuki and Yoshihara, Tomoyuki and Wada, Daiki and Iwamura, Hiromu and Kanayama, Syuji and Maruyama, Shuhei and Yoshiyama, Takashi and Ohta, Ken and Kokuto, Hiroyuki and Ogata, Hideo and Tanaka, Yoshiaki and Arakawa, Kenichi and Shimoda, Masafumi and Osawa, Takeshi and Tateno, Hiroki and Hase, Isano and Yoshida, Shuichi and Suzuki, Shoji and Kawada, Miki and Horinouchi, Hirohisa and Saito, Fumitake and Mitamura, Keiko and Hagihara, Masao and Ochi, Junichi and Uchida, Tomoyuki and Baba, Rie and Arai, Daisuke and Ogura, Takayuki and Takahashi, Hidenori and Hagiwara, Shigehiro and Nagao, Genta and Konishi, Shunichiro and Nakachi, Ichiro and Murakami, Koji and Yamada, Mitsuhiro and Sugiura, Hisatoshi and Sano, Hirohito and Matsumoto, Shuichiro and Kimura, Nozomu and Ono, Yoshinao and Baba, Hiroaki and Suzuki, Yusuke and Nakayama, Sohei and Masuzawa, Keita and Namba, Shinichi and Suzuki, Ken and Hizawa, Nobuyuki and Shiroyama, Takayuki and Miyawaki, Satoru and Kawamura, Yusuke and Nakayama, Akiyoshi and Matsuo, Hirotaka and Maeda, Yuichi and Nii, Takuro and Noda, Yoshimi and Niitsu, Takayuki and Adachi, Yuichi and Enomoto, Takatoshi and Amiya, Saori and Hara, Reina and Kishikawa, Toshihiro and Yamada, Shuhei and Kawabata, Shuhei and Kijima, Noriyuki and Takagaki, Masatoshi and Sasa, Noa and Ueno, Yuya and Suzuki, Motoyuki and Takemoto, Norihiko and Eguchi, Hirotaka and Fukusumi, Takahito and Imai, Takao and Fukushima, Munehisa and Kishima, Haruhiko and Inohara, Hidenori and Tomono, Kazunori and Kato, Kazuto and Takahashi, Meiko and Matsuda, Fumihiko and Hirata, Haruhiko and Takeda, Yoshito and Koh, Hidefumi and Manabe, Tadashi and Funatsu, Yohei and Ito, Fumimaro and Fukui, Takahiro and Shinozuka, Keisuke and Kohashi, Sumiko and Miyazaki, Masatoshi and Shoko, Tomohisa and Kojima, Mitsuaki and Adachi, Tomohiro and Ishikawa, Motonao and Takahashi, Kenichiro and Inoue, Takashi and Hirano, Toshiyuki and Kobayashi, Keigo and Takaoka, Hatsuyo and Watanabe, Kazuyoshi and Miyazawa, Naoki and Kimura, Yasuhiro and Sado, Reiko and Sugimoto, Hideyasu and Kamiya, Akane and Kuwahara, Naota and Fujiwara, Akiko and Matsunaga, Tomohiro and Sato, Yoko and Okada, Takenori and Hirai, Yoshihiro and Kawashima, Hidetoshi and Narita, Atsuya and Niwa, Kazuki and Sekikawa, Yoshiyuki and Nishi, Koichi and Nishitsuji, Masaru and Tani, Mayuko and Suzuki, Junya and Nakatsumi, Hiroki and Ogura, Takashi and Kitamura, Hideya and Hagiwara, Eri and Murohashi, Kota and Okabayashi, Hiroko and Mochimaru, Takao and Nukaga, Shigenari and Satomi, Ryosuke and Oyamada, Yoshitaka and Mori, Nobuaki and Baba, Tomoya and Fukui, Yasutaka and Odate, Mitsuru and Mashimo, Shuko and Makino, Yasushi and Yagi, Kazuma and Hashiguchi, Mizuha and Kagyo, Junko and Shiomi, Tetsuya and Fuke, Satoshi and Saito, Hiroshi and Tsuchida, Tomoya and Fujitani, Shigeki and Takita, Mumon and Morikawa, Daiki and Yoshida, Toru and Izumo, Takehiro and Inomata, Minoru and Kuse, Naoyuki and Awano, Nobuyasu and Tone, Mari and Ito, Akihiro and Nakamura, Yoshihiko and Hoshino, Kota and Maruyama, Junichi and Ishikura, Hiroyasu and Takata, Tohru and Odani, Toshio and Amishima, Masaru and Hattori, Takeshi and Shichinohe, Yasuo and Kagaya, Takashi and Kita, Toshiyuki and Ohta, Kazuhide and Sakagami, Satoru and Koshida, Kiyoshi and Hayashi, Kentaro and Shimizu, Tetsuo and Kozu, Yutaka and Hiranuma, Hisato and Gon, Yasuhiro and Izumi, Namiki and Nagata, Kaoru and Ueda, Ken and Taki, Reiko and Hanada, Satoko and Kawamura, Kodai and Ichikado, Kazuya and Nishiyama, Kenta and Muranaka, Hiroyuki and Nakamura, Kazunori and Hashimoto, Naozumi and Wakahara, Keiko and Koji, Sakamoto and Omote, Norihito and Ando, Akira and Kodama, Nobuhiro and Kaneyama, Yasunari and Maeda, Shunsuke and Kuraki, Takashige and Matsumoto, Takemasa and Yokote, Koutaro and Nakada, Taka-Aki and Abe, Ryuzo and Oshima, Taku and Shimada, Tadanaga and Harada, Masahiro and Takahashi, Takeshi and Ono, Hiroshi and Sakurai, Toshihiro and Shibusawa, Takayuki and Kimizuka, Yoshifumi and Kawana, Akihiko and Sano, Tomoya and Watanabe, Chie and Suematsu, Ryohei and Sageshima, Hisako and Yoshifuji, Ayumi and Ito, Kazuto and Takahashi, Saeko and Ishioka, Kota and Nakamura, Morio and Masuda, Makoto and Wakabayashi, Aya and Watanabe, Hiroki and Ueda, Suguru and Nishikawa, Masanori and Chihara, Yusuke and Takeuchi, Mayumi and Onoi, Keisuke and Shinozuka, Jun and Sueyoshi, Atsushi and Nagasaki, Yoji and Okamoto, Masaki and Ishihara, Sayoko and Shimo, Masatoshi and Tokunaga, Yoshihisa and Kusaka, Yu and Ohba, Takehiko and Isogai, Susumu and Ogawa, Aki and Inoue, Takuya and Fukuyama, Satoru and Eriguchi, Yoshihiro and Yonekawa, Akiko and Kan-o, Keiko and Matsumoto, Koichiro and Kanaoka, Kensuke and Ihara, Shoichi and Komuta, Kiyoshi and Inoue, Yoshiaki and Chiba, Shigeru and Yamagata, Kunihiro and Hiramatsu, Yuji and Kai, Hirayasu and Asano, Koichiro and Oguma, Tsuyoshi and Ito, Yoko and Hashimoto, Satoru and Yamasaki, Masaki and Kasamatsu, Yu and Komase, Yuko and Hida, Naoya and Tsuburai, Takahiro and Oyama, Baku and Takada, Minoru and Kanda, Hidenori and Kitagawa, Yuichiro and Fukuta, Tetsuya and Miyake, Takahito and Yoshida, Shozo and Ogura, Shinji and Abe, Shinji and Kono, Yuta and Togashi, Yuki and Takoi, Hiroyuki and Kikuchi, Ryota and Ogawa, Shinichi and Ogata, Tomouki and Ishihara, Shoichiro and Kanehiro, Arihiko and Ozaki, Shinji and Fuchimo, Yasuko and Wada, Sae and Fujimoto, Nobukazu and Nishiyama, Kei and Terashima, Mariko and Beppu, Satoru and Yoshida, Kosuke and Narumoto, Osamu and Nagai, Hideaki and Ooshima, Nobuharu and Motegi, Mitsuru and Umeda, Akira and Miyagawa, Kazuya and Shimada, Hisato and Endo, Mayu and Ohira, Yoshiyuki and Watanabe, Masafumi and Inoue, Sumito and Igarashi, Akira and Sato, Masamichi and Sagara, Hironori and Tanaka, Akihiko and Ohta, Shin and Kimura, Tomoyuki and Shibata, Yoko and Tanino, Yoshinori and Nikaido, Takefumi and Minemura, Hiroyuki and Sato, Yuki and Yamada, Yuichiro and Hashino, Takuya and Shinoki, Masato and Iwagoe, Hajime and Takahashi, Hiroshi and Fujii, Kazuhiko and Kishi, Hiroto and Kanai., Masayuki and Imamura, Tomonori and Yamashita, Tatsuya and Yatomi, Masakiyo and Maeno, Toshitaka and Hayashi, Shinichi and Takahashi, Mai and Kuramochi, Mizuki and Kamimaki, Isamu and Tominaga, Yoshiteru and Ishii, Tomoo and Utsugi, Mitsuyoshi and Ono, Akihiro and Tanaka, Toru and Kashiwada, Takeru and Fujita, Kazue and Saito, Yoshinobu and Seike, Masahiro and Omae, Yosuke and Nannya, Yasuhito and Ueno, Takafumi and Takano, Tomomi and Katayama, Kazuhiko and Ai, Masumi and Kumanogoh, Atsushi and Sato, Toshiro and Hasegawa, Naoki and Tokunaga, Katsushi and Ishii, Makoto and Koike, Ryuji and Kitagawa, Yuko and Kimura, Akinori and Imoto, Seiya and Miyano, Satoru and Ogawa, Seishi and Kanai, Takanori and Okada, Yukinori},
doi = {10.1101/2021.05.17.21256513},
journal = {medRxiv},
month = {may},
title = {Japan {COVID-19} Task Force: a nation-wide consortium to elucidate host genetics of {COVID-19} pandemic in Japan},
year = {2021},
keywords = {preprint},
abstract = {To elucidate the host genetic loci affecting severity of SARS-CoV-2 infection, or Coronavirus disease 2019 (COVID-19), is an emerging issue in the face of the current devastating pandemic. Here, we report a genome-wide association study (GWAS) of COVID-19 in a Japanese population led by the Japan COVID-19 Task Force, as one of the initial discovery GWAS studies performed on a non-European population. Enrolling a total of 2,393 cases and 3,289 controls, we not only replicated previously reported COVID-19 risk variants (e.g., LZTFL1, FOXP4, ABO, and IFNAR2), but also found a variant on 5p35 (rs60200309-A at DOCK2) that was significantly associated with severe COVID-19 in younger (<65 years of age) patients with a genome-wide significant p-value of 1.2  10-8) (odds ratio = 2.01, 95\% confidence interval = 1.58-2.55). This risk allele was prevalent in East Asians, including Japanese (minor allele frequency [MAF] = 0.097), but rarely found in Europeans. Cross-population Mendelian randomization analysis made a causal inference of a number of complex human traits on COVID-19. In particular, obesity had a significant impact on severe COVID-19. The presence of the population-specific risk allele underscores the need of non-European studies of COVID-19 host genetics.}
}
@article{Koskela2021,
author = {Koskela, Jukka T and Happola, Paavo and Liu, Aoxing and {FinnGen} and Partanen, Juulia and Genovese, Giulio and Artomov, Mykyta and Myllymaki, Mikko N M and Kanai, Masahiro and Zhou, Wei and Karjalainen, Juha and Palviainen, Teemu and Ronkainen, Justiina and Sebert, Sylvain and Tukiainen, Taru and Palta, Priit and Kaprio, Jaakko and Kurki, Mitja and Ganna, Andrea and Palotie, Aarno and Laitinen, Tarja and Myllarniemi, Marjukka and Daly, Mark J},
doi = {10.1101/2021.05.07.21255988},
journal = {medRxiv},
month = {may},
title = {Genetic variant in {SPDL1} reveals novel mechanism linking pulmonary fibrosis risk and cancer protection},
year = {2021},
keywords = {preprint},
abstract = {Idiopathic Pulmonary Fibrosis (IPF) is a rare disease with poor prognosis. By contrast, cancer is common in any elderly population and a leading killer, but is now often curable. Of note, whereas IPF is driven by cellular senescence, cancer is characterized by uncontrolled cell division. Using data available from two large biobank-based studies (Finnish FinnGen study and UK biobank), we conducted a comprehensive analysis of the shared genetic background of IPF and cancer. In a population sample of 218,792 Finns with complete longitudinal health histories, we estimated the effect of individual genetic variants to the lifetime risk of IPF and cancer. We extend the analysis from IPF-GWAS to pan-cancer meta-analysis over FinnGen and UK Biobank and finally to the identification of genetic drivers of somatic chromosomal alterations. We detected six loci (SPDL1, MAD1L1, MAP2K1, RTEL1-STMN3, TERC-ACTRT3, OBFC1) associated with both IPF and cancer, all closely related to cellular division. However, each individual signal is found with opposite effects over the two diseases, termed as antagonistic pleiotropy. Several of these loci (TERC-ACTRT3, RTEL1-STMN3, OBFC1) are among the strongest inherited factors for constitutive telomere length variation and consistently indicate that shorter telomere length would increase the risk for IPF but protect from malignancy. However, a Finnish enriched SPDL1 missense variant and a common MAD1L1 intronic variant had no effect on telomere length but were shown to protect individuals from accumulation of somatic mutations. The decreased risk of cancer in SPDL1 and MAD1L1 variant carriers might result from a lower number of chromosomal alterations accumulated over time, conversely leading to fibrosis in the lung due to cellular senescence-induced inflammation. We hypothesize that the SPDL1 missense variant functions as gain-of-function mutation, leading to cellular senescence, a barrier to cancer and a driver of fibrosis in IPF. If translated to therapy, these findings might not only be able to offer relief to individuals with IPF, but also to protect from onset of cancer.}
}
@article{Nakatochi2021,
author = {Nakatochi, Masahiro and Toyoda, Yu and Kanai, Masahiro and Nakayama, Akiyoshi and Kawamura, Yusuke and Hishida, Asahi and Mikami, Haruo and Matsuo, Keitaro and Takezaki, Toshiro and Momozawa, Yukihide and {Biobank Japan Project} and Kamatani, Yoichiro and Ichihara, Sahoko and Shinomiya, Nariyoshi and Yokota, Mitsuhiro and Wakai, Kenji and Okada, Yukinori and Matsuo, Hirotaka and {Japan Uric Acid Genomics Consortium (Japan Urate)}},
doi = {10.1093/rheumatology/keab404},
month = {sep},
number = {9},
journal = {Rheumatology},
pages = {4430--4432},
title = {An {X} chromosome-wide meta-analysis based on Japanese cohorts revealed that non-autosomal variations are associated with serum urate},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/33944914)},
volume = {60},
year = {2021},
pubmed = {33944914}
}
@article{Turley2021,
author = {Turley, Patrick and Martin, Alicia R and Goldman, Grant and Li, Hui and Kanai, Masahiro and Walters, Raymond K and Jala, Jonathan B and Lin, Kuang and Millwood, Iona Y and Carey, Caitlin E and Palmer, Duncan S and Zacher, Meghan and Atkinson, Elizabeth G and Chen, Zhengming and Li, Liming and Akiyama, Masato and Okada, Yukinori and Kamatani, Yoichiro and Walters, Robin G and Callier, Shawneequa and Laibson, David and Meyer, Michelle N and Cesarini, David and Daly, Mark and Benjamin, Daniel J and Neale, Benjamin M},
doi = {10.1101/2021.04.23.441003},
journal = {bioRxiv},
month = {apr},
title = {{Multi-Ancestry} {Meta-Analysis} yields novel genetic discoveries and ancestry-specific associations},
year = {2021},
keywords = {preprint},
abstract = {We present a new method, Multi-Ancestry Meta-Analysis (MAMA), which combines genome-wide association study (GWAS) summary statistics from multiple populations to produce new summary statistics for each population, identifying novel loci that would not have been discovered in either set of GWAS summary statistics alone. In simulations, MAMA increases power with less bias and generally lower type-1 error rate than other multi-ancestry meta-analysis approaches. We apply MAMA to 23 phenotypes in East-Asian- and European-ancestry populations and find substantial gains in power. In an independent sample, novel genetic discoveries from MAMA replicate strongly. \#\#\# Competing Interest Statement A.R.M has consulted for 23andMe and Illumina, and she has received speaker fees from Genentech, Illumina, and Pfizer. B.M.N. is a member of the scientific advisory board at Deep Genomics and RBNC Therapeutics, Member of the scientific advisory committee at Milken and a consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. D.S.P. is an employee of Genomics plc, all contributions were performed prior to him joining the company.},
code = {https://github.com/JonJala/mama}
}
@article{Pirastu2021,
author = {Pirastu, Nicola and Cordioli, Mattia and Nandakumar, Priyanka and Mignogna, Gianmarco and Abdellaoui, Abdel and Hollis, Benjamin and Kanai, Masahiro and Rajagopal, Veera M and Della Briotta Parolo, Pietro and Baya, Nikolas and Carey, Caitlin E and Karjalainen, Juha and Als, Thomas D and Van der Zee, Matthijs D and Day, Felix R and Ong, Ken K and Morisaki, Takayuki and de Geus, Eco and Bellocco, Rino and Okada, Yukinori and B{\o}rglum, Anders D and Joshi, Peter and Auton, Adam and Hinds, David and Neale, Benjamin M and Walters, Raymond K and Nivard, Michel G and Perry, John R B and Ganna, Andrea},
doi = {10.1038/s41588-021-00846-7},
journal = {Nature Genetics},
month = {may},
pages = {663--671},
title = {{Genetic analyses identify widespread sex-differential participation bias}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/33888908)},
volume = {53},
year = {2021},
abstract = {Genetic association results are often interpreted with the assumption that study participation does not affect downstream analyses. Understanding the genetic basis of participation bias is challenging since it requires the genotypes of unseen individuals. Here we demonstrate that it is possible to estimate comparative biases by performing a genome-wide association study contrasting one subgroup versus another. For example, we showed that sex exhibits artifactual autosomal heritability in the presence of sex-differential participation bias. By performing a genome-wide association study of sex in approximately 3.3 million males and females, we identified over 158 autosomal loci spuriously associated with sex and highlighted complex traits underpinning differences in study participation between the sexes. For example, the body mass index-increasing allele at FTO was observed at higher frequency in males compared to females (odds ratio = 1.02, P = 4.4 $\times$ 10-36). Finally, we demonstrated how these biases can potentially lead to incorrect inferences in downstream analyses and propose a conceptual framework for addressing such biases. Our findings highlight a new challenge that genetic studies may face as sample sizes continue to grow.},
biorxiv = {10.1101/2020.03.22.001453},
pdf = {https://rdcu.be/clzCa},
pubmed = {33888908}
}
@article{Shi2021,
author = {Shi, Huwenbo and Gazal, Steven and Kanai, Masahiro and Koch, Evan M and Schoech, Armin P and Siewert, Katherine M and Kim, Samuel S and Luo, Yang and Amariuta, Tiffany and Huang, Hailiang and Okada, Yukinori and Raychaudhuri, Soumya and Sunyaev, Shamil R and Price, Alkes L},
doi = {10.1038/s41467-021-21286-1},
journal = {Nature Communications},
number = {1},
month = {feb},
pages = {1098},
title = {{Population-specific causal disease effect sizes in functionally important regions impacted by selection}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/33597505)},
volume = {12},
year = {2021},
abstract = {Many diseases exhibit population-specific causal effect sizes with trans-ethnic genetic correlations significantly less than 1, limiting trans-ethnic polygenic risk prediction. We develop a new method, S-LDXR, for stratifying squared trans-ethnic genetic correlation across genomic annotations, and apply S-LDXR to genome-wide summary statistics for 31 diseases and complex traits in East Asians (average N = 90K) and Europeans (average N = 267K) with an average trans-ethnic genetic correlation of 0.85. We determine that squared trans-ethnic genetic correlation is 0.82$\times$ (s.e. 0.01) depleted in the top quintile of background selection statistic, implying more population-specific causal effect sizes. Accordingly, causal effect sizes are more population-specific in functionally important regions, including conserved and regulatory regions. In regions surrounding specifically expressed genes, causal effect sizes are most population-specific for skin and immune genes, and least population-specific for brain genes. Our results could potentially be explained by stronger gene-environment interaction at loci impacted by selection, particularly positive selection.},
biorxiv = {10.1101/803452},
code = {https://github.com/huwenboshi/s-ldxr},
pdf = {https://rdcu.be/clOBn},
pubmed = {33597505}
}
@article{Weissbrod2021,
author = {*Weissbrod, Omer and *Kanai, Masahiro and *Shi, Huwenbo and Gazal, Steven and Peyrot, Wouter and Khera, Amit and Okada, Yukinori and {The Biobank Japan Project} and Martin, Alicia and Finucane, Hilary and Price, Alkes L},
doi = {10.1101/2021.01.19.21249483},
journal = {medRxiv},
month = {jan},
title = {Leveraging fine-mapping and non-European training data to improve cross-population polygenic risk scores},
year = {2021},
keywords = {selected},
abstract = {Polygenic risk scores (PRS) based on European training data suffer reduced accuracy in non-European target populations, exacerbating health disparities. This loss of accuracy predominantly stems from LD differences, MAF differences (including population-specific SNPs), and/or causal effect size differences. Here, we propose PolyPred, a method that improves trans-ethnic polygenic prediction by combining two complementary predictors: a new predictor that leverages functionally informed fine-mapping to estimate causal effects (instead of tagging effects), addressing LD differences; and BOLT-LMM, a published predictor. In the special case where a large training sample is available in the non-European target population (or a closely related population), we propose PolyPred+, which further incorporates the non-European training data, addressing MAF differences and causal effect size differences. We applied PolyPred to 49 diseases and complex traits in 4 UK Biobank populations using UK Biobank British training data (averageN=325K), and observed statistically significant average relative improvements in prediction accuracy vs. BOLT-LMM ranging from +7\% in South Asians to +32\% in Africans (and vs. LD-pruning + P-value thresholding (P+T) ranging from +77\% to +164\%), consistent with simulations. We applied PolyPred+ to 23 diseases and complex traits in UK Biobank East Asians using both UK Biobank British (averageN=325K) and Biobank Japan (averageN=124K) training data, and observed statistically significant average relative improvements in prediction accuracy of +24\% vs. BOLT-LMM and +12\% vs. PolyPred. In conclusion, PolyPred and PolyPred+ improve trans-ethnic polygenic prediction accuracy, ameliorating health disparities.},
code = {https://github.com/omerwe/polyfun}
}
@article{Atkinson2021,
author = {Atkinson, Elizabeth G and Maihofer, Adam X and Kanai, Masahiro and Martin, Alicia R and Karczewski, Konrad J and Santoro, Marcos L and Ulirsch, Jacob C and Kamatani, Yoichiro and Okada, Yukinori and Finucane, Hilary K and Koenen, Karestan C and Nievergelt, Caroline M and Daly, Mark J and Neale, Benjamin M},
doi = {10.1038/s41588-020-00766-y},
journal = {Nature Genetics},
month =  {feb},
number = {2},
pages = {195--204},
title = {Tractor uses local ancestry to enable the inclusion of admixed individuals in {GWAS} and to boost power},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/33462486) [PR](https://www.massgeneral.org/news/press-release/Novel-software-tool-facilitates-inclusion-of-individuals-of-diverse-ancestry-in-large-scale-genetics-studies)},
volume = {53},
year =  {2021},
abstract = {Admixed populations are routinely excluded from genomic studies due to concerns over population structure. Here, we present a statistical framework and software package, Tractor, to facilitate the inclusion of admixed individuals in association studies by leveraging local ancestry. We test Tractor with simulated and empirical two-way admixed African-European cohorts. Tractor generates accurate ancestry-specific effect-size estimates and P values, can boost genome-wide association study (GWAS) power and improves the resolution of association signals. Using a local ancestry-aware regression model, we replicate known hits for blood lipids, discover novel hits missed by standard GWAS and localize signals closer to putative causal variants.},
biorxiv = {10.1101/2020.05.17.100727},
code = {https://github.com/eatkinson/Tractor},
pdf = {https://rdcu.be/clZ2f},
pr = {https://www.massgeneral.org/news/press-release/Novel-software-tool-facilitates-inclusion-of-individuals-of-diverse-ancestry-in-large-scale-genetics-studies},
pubmed = {33462486}
}
@article{Ramo2020,
author = {R{\"a}m{\"o}, Joel T and Kiiskinen, Tuomo and Karjalainen, Juha and Krebs, Kristi and Kurki, Mitja and Havulinna, Aki S and H{\"a}m{\"a}l{\"a}inen, Eija and H{\"a}pp{\"o}l{\"a}, Paavo and Hautakangas, Heidi and {FinnGen} and Karczewski, Konrad J and Kanai, Masahiro and M{\"a}gi, Reedik and Palta, Priit and Esko, T{\~o}nu and Metspalu, Andres and Pirinen, Matti and Ripatti, Samuli and Milani, Lili and M{\"a}kitie, Antti and Daly, Mark J and Palotie, Aarno},
doi = {10.1101/2020.11.15.20227868},
journal = {medRxiv},
month = {nov},
title = {Genome-wide Screen of Otosclerosis in Population Biobanks: 18 Loci and Shared Heritability with Skeletal Structure},
year = {2020},
keywords = {preprint},
abstract = {Otosclerosis is one of the most common causes of conductive hearing loss, affecting 0.3\% of the population. It typically presents in adulthood and half of the patients have a positive family history. The pathophysiology of otosclerosis is poorly understood and treatment options are limited. A previous genome-wide association study (GWAS) identified a single association locus in an intronic region of RELN . Here, we report a meta-analysis of GWAS studies of otosclerosis in three population-based biobanks comprising 2,413 cases and 762,382 controls. We identify 15 novel risk loci (p < 5*108) and replicate the regions of RELN and two previously reported candidate genes (TGFB1 and MEPE). Implicated genes in many loci are essential for bone remodelling or mineralization. Otosclerosis is genetically correlated with height and fracture risk, and the association loci overlap with severe skeletal disorders. Our results highlight TGF1 signalling for follow-up mechanistic studies.}
}
@article{Weeks2020,
author = {Weeks, Elle M and Ulirsch, Jacob C and Cheng, Nathan Y and Trippe, Brian L and Fine, Rebecca S and Miao, Jenkai and Patwardhan, Tejal A and Kanai, Masahiro and Nasser, Joseph and Fulco, Charles P and Tashman, Katherine C and Aguet, Francois and Li, Taibo and Ordovas-Montanes, Jose and Smillie, Christopher S and Biton, Moshe and Shalek, Alex K and Ananthakrishnan, Ashwin N and Xavier, Ramnik J and Regev, Aviv and Gupta, Rajat M and Lage, Kasper and Ardlie, Kristin G and Hirschhorn, Joel N and Lander, Eric S and Engreitz, Jesse M and Finucane, Hilary K},
doi = {10.1101/2020.09.08.20190561},
journal = {medRxiv},
month = {sep},
title = {Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases},
year = {2020},
keywords = {preprint},
abstract = {Genome-wide association studies (GWAS) are a valuable tool for understanding the biology of complex traits, but the associations found rarely point directly to causal genes. Here, we introduce a new method to identify the causal genes by integrating GWAS summary statistics with gene expression, biological pathway, and predicted protein-protein interaction data. We further propose an approach that effectively leverages both polygenic and locus-specific genetic signals by combining results across multiple gene prioritization methods, increasing confidence in prioritized genes. Using a large set of gold standard genes to evaluate our approach, we prioritize 8,402 unique gene-trait pairs with greater than 75\% estimated precision across 113 complex traits and diseases, including known genes such as SORT1 for LDL cholesterol, SMIM1 for red blood cell count, and DRD2 for schizophrenia, as well as novel genes such as TTC39B for cholelithiasis. Our results demonstrate that a polygenic approach is a powerful tool for gene prioritization and, in combination with locus-specific signal, improves upon existing methods.},
code = {https://github.com/FinucaneLab/pops},
data = {https://www.finucanelab.org/data}
}
@article{Chen2020,
author = {Chen, Ming-Huei and Raffield, Laura M and Mousas, Abdou and Sakaue, Saori and Huffman, Jennifer E and Moscati, Arden and Trivedi, Bhavi and Jiang, Tao and Akbari, Parsa and Vuckovic, Dragana and Bao, Erik L and Zhong, Xue and Manansala, Regina and Laplante, V{\'e}ronique and Chen, Minhui and Lo, Ken Sin and Qian, Huijun and Lareau, Caleb A and Beaudoin, M{\'e}lissa and Hunt, Karen A and Akiyama, Masato and Bartz, Traci M and Ben-Shlomo, Yoav and Beswick, Andrew and Bork-Jensen, Jette and Bottinger, Erwin P and Brody, Jennifer A and van Rooij, Frank J A and Chitrala, Kumaraswamynaidu and Cho, Kelly and Choquet, H{\'e}l{\`e}ne and Correa, Adolfo and Danesh, John and Di Angelantonio, Emanuele and Dimou, Niki and Ding, Jingzhong and Elliott, Paul and Esko, T{\~o}nu and Evans, Michele K and Floyd, James S and Broer, Linda and Grarup, Niels and Guo, Michael H and Greinacher, Andreas and Haessler, Jeff and Hansen, Torben and Howson, Joanna M M and Huang, Qin Qin and Huang, Wei and Jorgenson, Eric and Kacprowski, Tim and K{\"a}h{\"o}nen, Mika and Kamatani, Yoichiro and Kanai, Masahiro and Karthikeyan, Savita and Koskeridis, Fotis and Lange, Leslie A and Lehtim{\"a}ki, Terho and Lerch, Markus M and Linneberg, Allan and Liu, Yongmei and Lyytik{\"a}inen, Leo-Pekka and Manichaikul, Ani and Martin, Hilary C and Matsuda, Koichi and Mohlke, Karen L and Mononen, Nina and Murakami, Yoshinori and Nadkarni, Girish N and Nauck, Matthias and Nikus, Kjell and Ouwehand, Willem H and Pankratz, Nathan and Pedersen, Oluf and Preuss, Michael and Psaty, Bruce M and Raitakari, Olli T and Roberts, David J and Rich, Stephen S and Rodriguez, Benjamin A T and Rosen, Jonathan D and Rotter, Jerome I and Schubert, Petra and Spracklen, Cassandra N and Surendran, Praveen and Tang, Hua and Tardif, Jean-Claude and Trembath, Richard C and Ghanbari, Mohsen and V{\"o}lker, Uwe and V{\"o}lzke, Henry and Watkins, Nicholas A and Zonderman, Alan B and Wilson, Peter W F and Li, Yun and Butterworth, Adam S and Gauchat, Jean-Fran{\c c}ois and Chiang, Charleston W K and Li, Bingshan and Loos, Ruth J F and Astle, William J and Evangelou, Evangelos and van Heel, David A and Sankaran, Vijay G and Okada, Yukinori and Soranzo, Nicole and Johnson, Andrew D and Reiner, Alexander P and Auer, Paul L and Lettre, Guillaume},
doi = {10.1016/j.cell.2020.06.045},
journal = {Cell},
month = {sep},
number = {5},
pages = {1198--1213.e14},
title = {{Trans-ethnic and {Ancestry-Specific} {Blood-Cell} Genetics in 746,667 Individuals from 5 Global Populations}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32888493) [PR](https://www.broadinstitute.org/news/genetic-information-can-predict-predisposition-rare-and-common-blood-diseases)},
volume = {182},
year = {2020},
abstract = {Most loci identified by GWASs have been found in populations of European ancestry (EUR). In trans-ethnic meta-analyses for 15 hematological traits in 746,667 participants, including 184,535 non-EUR individuals, we identified 5,552 trait-variant associations at p < 5 $\times$ 10-9, including 71 novel associations not found in EUR populations. We also identified 28 additional novel variants in ancestry-specific, non-EUR meta-analyses, including an IL7 missense variant in South Asians associated with lymphocyte count in vivo and IL-7 secretion levels in vitro. Fine-mapping prioritized variants annotated as functional and generated 95\% credible sets that were 30\% smaller when using the trans-ethnic as opposed to the EUR-only results. We explored the clinical significance and predictive value of trans-ethnic variants in multiple populations and compared genetic architecture and the effect of natural selection on these blood phenotypes between populations. Altogether, our results for hematological traits highlight the value of a more global representation of populations in genetic studies.},
biorxiv = {10.1101/2020.01.17.910497},
pr = {https://www.broadinstitute.org/news/genetic-information-can-predict-predisposition-rare-and-common-blood-diseases},
pubmed = {32888493}
}
@article{Vuckovic2020,
author = {Vuckovic, Dragana and Bao, Erik L and Akbari, Parsa and Lareau, Caleb A and Mousas, Abdou and Jiang, Tao and Chen, Ming-Huei and Raffield, Laura M and Tardaguila, Manuel and Huffman, Jennifer E and Ritchie, Scott C and Megy, Karyn and Ponstingl, Hannes and Penkett, Christopher J and Albers, Patrick K and Wigdor, Emilie M and Sakaue, Saori and Moscati, Arden and Manansala, Regina and Lo, Ken Sin and Qian, Huijun and Akiyama, Masato and Bartz, Traci M and Ben-Shlomo, Yoav and Beswick, Andrew and Bork-Jensen, Jette and Bottinger, Erwin P and Brody, Jennifer A and van Rooij, Frank J A and Chitrala, Kumaraswamy N and Wilson, Peter W F and Choquet, H{\'e}l{\`e}ne and Danesh, John and Di Angelantonio, Emanuele and Dimou, Niki and Ding, Jingzhong and Elliott, Paul and Esko, T{\~o}nu and Evans, Michele K and Felix, Stephan B and Floyd, James S and Broer, Linda and Grarup, Niels and Guo, Michael H and Guo, Qi and Greinacher, Andreas and Haessler, Jeff and Hansen, Torben and Howson, Joanna M M and Huang, Wei and Jorgenson, Eric and Kacprowski, Tim and K{\"a}h{\"o}nen, Mika and Kamatani, Yoichiro and Kanai, Masahiro and Karthikeyan, Savita and Koskeridis, Fotios and Lange, Leslie A and Lehtim{\"a}ki, Terho and Linneberg, Allan and Liu, Yongmei and Lyytik{\"a}inen, Leo-Pekka and Manichaikul, Ani and Matsuda, Koichi and Mohlke, Karen L and Mononen, Nina and Murakami, Yoshinori and Nadkarni, Girish N and Nikus, Kjell and Pankratz, Nathan and Pedersen, Oluf and Preuss, Michael and Psaty, Bruce M and Raitakari, Olli T and Rich, Stephen S and Rodriguez, Benjamin A T and Rosen, Jonathan D and Rotter, Jerome I and Schubert, Petra and Spracklen, Cassandra N and Surendran, Praveen and Tang, Hua and Tardif, Jean-Claude and Ghanbari, Mohsen and V{\"o}lker, Uwe and V{\"o}lzke, Henry and Watkins, Nicholas A and Weiss, Stefan and Cai, Na and Kundu, Kousik and Watt, Stephen B and Walter, Klaudia and Zonderman, Alan B and Cho, Kelly and Li, Yun and Loos, Ruth J F and Knight, Julian C and Georges, Michel and Stegle, Oliver and Evangelou, Evangelos and Okada, Yukinori and Roberts, David J and Inouye, Michael and Johnson, Andrew D and Auer, Paul L and Astle, William J and Reiner, Alexander P and Butterworth, Adam S and Ouwehand, Willem H and Lettre, Guillaume and Sankaran, Vijay G and Soranzo, Nicole},
doi = {10.1016/j.cell.2020.08.008},
journal = {Cell},
month = {sep},
number = {5},
pages = {1214--1231.e11},
title = {{The Polygenic and Monogenic Basis of Blood Traits and Diseases}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32888494) [PR](https://www.broadinstitute.org/news/genetic-information-can-predict-predisposition-rare-and-common-blood-diseases)},
volume = {182},
year = {2020},
abstract = {Blood cells play essential roles in human health, underpinning physiological processes such as immunity, oxygen transport, and clotting, which when perturbed cause a significant global health burden. Here we integrate data from UK Biobank and a large-scale international collaborative effort, including data for 563,085 European ancestry participants, and discover 5,106 new genetic variants independently associated with 29 blood cell phenotypes covering a range of variation impacting hematopoiesis. We holistically characterize the genetic architecture of hematopoiesis, assess the relevance of the omnigenic model to blood cell phenotypes, delineate relevant hematopoietic cell states influenced by regulatory genetic variants and gene networks, identify novel splice-altering variants mediating the associations, and assess the polygenic prediction potential for blood traits and clinical disorders at the interface of complex and Mendelian genetics. These results show the power of large-scale blood cell trait GWAS to interrogate clinically meaningful variants across a wide allelic spectrum of human variation.},
medrxiv = {10.1101/2020.02.02.20020065},
pdf = {https://www.cell.com/action/showPdf?pii=S0092-8674%2820%2930999-5},
pr = {https://www.broadinstitute.org/news/genetic-information-can-predict-predisposition-rare-and-common-blood-diseases},
pubmed = {32888494}
}
@article{Shirai2020,
author = {Shirai, Yuya and Honda, Suguru and Ikari, Katsunori and Kanai, Masahiro and Takeda, Yoshito and Kamatani, Yoichiro and Morisaki, Takayuki and Tanaka, Eiichi and Kumanogoh, Atsushi and Harigai, Masayoshi and Okada, Yukinori},
doi = {10.1136/annrheumdis-2020-217256},
journal = {Annals of the Rheumatic Diseases},
month = {oct},
number = {10},
pages = {1305--1309},
title = {Association of the {RPA3-UMAD1} locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32737115) [PR](https://www.amed.go.jp/news/release_20200801.html)},
volume = {79},
year = {2020},
abstract = {OBJECTIVES: The genetic background of rheumatoid arthritis-interstitial lung disease (RA-ILD) has been evaluated in Europeans, but little knowledge has been obtained in non-Europeans. This study aimed to elucidate genome-wide risk of RA-ILD in non-Europeans. METHODS: We performed an initial genome-wide association study (GWAS) of RA-ILD in the Japanese population. By conducting the meta-analysis of the three GWAS datasets of the RA cohorts and biobank of Japanese, our study included 358 RA-ILD cases and 4550 RA subjects without ILD. We then conducted the stratified analysis of the effect of the GWAS risk allele in each CT image pattern. RESULTS: We identified one novel RA-ILD risk locus at 7p21 that satisfied the genome-wide significance threshold (rs12702634 at RPA3-UMAD1, OR=2.04, 95\% CI 1.59 to 2.60, p=1.5$\times$10-8). Subsequent stratified analysis based on the CT image patterns demonstrated that the effect size of the RA-ILD risk allele (rs12702634-C) was large with the UIP pattern (OR=1.86, 95\% CI 0.97 to 3.58, p=0.062) and the probable UIP pattern (OR=2.26, 95\% CI 1.36 to 3.73, p=0.0015). CONCLUSION: We revealed one novel genetic association with RA-ILD in Japanese. The RA-ILD risk of the identified variant at RPA3-UMAD1 was relatively high in the CT image patterns related to fibrosis. Our study should contribute to elucidation of the complicated aetiology of RA-ILD.},
pdf = {https://ard.bmj.com/content/annrheumdis/79/10/1305.full.pdf},
pr = {https://www.amed.go.jp/news/release_20200801.html},
pubmed = {32737115}
}
@article{Ishigaki2020,
author = {Ishigaki, Kazuyoshi and Akiyama, Masato and Kanai, Masahiro and Takahashi, Atsushi and Kawakami, Eiryo and Sugishita, Hiroki and Sakaue, Saori and Matoba, Nana and Low, Siew-Kee and Okada, Yukinori and Terao, Chikashi and Amariuta, Tiffany and Gazal, Steven and Kochi, Yuta and Horikoshi, Momoko and Suzuki, Ken and Ito, Kaoru and Koyama, Satoshi and Ozaki, Kouichi and Niida, Shumpei and Sakata, Yasushi and Sakata, Yasuhiko and Kohno, Takashi and Shiraishi, Kouya and Momozawa, Yukihide and Hirata, Makoto and Matsuda, Koichi and Ikeda, Masashi and Iwata, Nakao and Ikegawa, Shiro and Kou, Ikuyo and Tanaka, Toshihiro and Nakagawa, Hidewaki and Suzuki, Akari and Hirota, Tomomitsu and Tamari, Mayumi and Chayama, Kazuaki and Miki, Daiki and Mori, Masaki and Nagayama, Satoshi and Daigo, Yataro and Miki, Yoshio and Katagiri, Toyomasa and Ogawa, Osamu and Obara, Wataru and Ito, Hidemi and Yoshida, Teruhiko and Imoto, Issei and Takahashi, Takashi and Tanikawa, Chizu and Suzuki, Takao and Sinozaki, Nobuaki and Minami, Shiro and Yamaguchi, Hiroki and Asai, Satoshi and Takahashi, Yasuo and Yamaji, Ken and Takahashi, Kazuhisa and Fujioka, Tomoaki and Takata, Ryo and Yanai, Hideki and Masumoto, Akihide and Koretsune, Yukihiro and Kutsumi, Hiromu and Higashiyama, Masahiko and Murayama, Shigeo and Minegishi, Naoko and Suzuki, Kichiya and Tanno, Kozo and Shimizu, Atsushi and Yamaji, Taiki and Iwasaki, Motoki and Sawada, Norie and Uemura, Hirokazu and Tanaka, Keitaro and Naito, Mariko and Sasaki, Makoto and Wakai, Kenji and Tsugane, Shoichiro and Yamamoto, Masayuki and Yamamoto, Kazuhiko and Murakami, Yoshinori and Nakamura, Yusuke and Raychaudhuri, Soumya and Inazawa, Johji and Yamauchi, Toshimasa and Kadowaki, Takashi and Kubo, Michiaki and Kamatani, Yoichiro},
doi = {10.1038/s41588-020-0640-3},
issn = {1061-4036},
journal = {Nature Genetics},
month = {jul},
number = {7},
pages = {669--679},
publisher = {Springer US},
title = {{Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32514122) [PR](https://www.riken.jp/press/2020/20200609_1/)},
volume = {52},
year = {2020},
abstract = {The overwhelming majority of participants in current genetic studies are of European ancestry. To elucidate disease biology in the East Asian population, we conducted a genome-wide association study (GWAS) with 212,453 Japanese individuals across 42 diseases. We detected 320 independent signals in 276 loci for 27 diseases, with 25 novel loci (P < 9.58 $\times$ 10-9). East Asian-specific missense variants were identified as candidate causal variants for three novel loci, and we successfully replicated two of them by analyzing independent Japanese cohorts; p.R220W of ATG16L2 (associated with coronary artery disease) and p.V326A of POT1 (associated with lung cancer). We further investigated enrichment of heritability within 2,868 annotations of genome-wide transcription factor occupancy, and identified 378 significant enrichments across nine diseases (false discovery rate < 0.05) (for example, NKX3-1 for prostate cancer). This large-scale GWAS in a Japanese population provides insights into the etiology of complex diseases and highlights the importance of performing GWAS in non-European populations.},
biorxiv = {10.1101/795948},
pdf = {https://rdcu.be/cmhb1},
pr = {https://www.riken.jp/press/2020/20200609_1/},
pubmed = {32514122}
}
@article{Sakaue2020b,
author = {Sakaue, Saori and Hirata, Jun and Kanai, Masahiro and Suzuki, Ken and Akiyama, Masato and {Lai Too}, Chun and Arayssi, Thurayya and Hammoudeh, Mohammed and {Al Emadi}, Samar and Masri, Basel K and Halabi, Hussein and Badsha, Humeira and Uthman, Imad W. and Saxena, Richa and Padyukov, Leonid and Hirata, Makoto and Matsuda, Koichi and Murakami, Yoshinori and Kamatani, Yoichiro and Okada, Yukinori},
doi = {10.1038/s41467-020-15194-z},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {1569},
publisher = {Springer US},
title = {{Dimensionality reduction reveals fine-scale structure in the Japanese population with consequences for polygenic risk prediction}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32218440) [PR](http://www.med.osaka-u.ac.jp/eng/activities/results/2020year/okadasakaue20200327)},
volume = {11},
year = {2020},
abstract = {The diversity in our genome is crucial to understanding the demographic history of worldwide populations. However, we have yet to know whether subtle genetic differences within a population can be disentangled, or whether they have an impact on complex traits. Here we apply dimensionality reduction methods (PCA, t-SNE, PCA-t-SNE, UMAP, and PCA-UMAP) to biobank-derived genomic data of a Japanese population (n = 169,719). Dimensionality reduction reveals fine-scale population structure, conspicuously differentiating adjacent insular subpopulations. We further enluciate the demographic landscape of these Japanese subpopulations using population genetics analyses. Finally, we perform phenome-wide polygenic risk score (PRS) analyses on 67 complex traits. Differences in PRS between the deconvoluted subpopulations are not always concordant with those in the observed phenotypes, suggesting that the PRS differences might reflect biases from the uncorrected structure, in a trait-dependent manner. This study suggests that such an uncorrected structure can be a potential pitfall in the clinical application of PRS.},
code = {https://github.com/saorisakaue/Genotype-dimensionality-reduction},
pdf = {https://rdcu.be/cmhcB},
pr = {http://www.med.osaka-u.ac.jp/eng/activities/results/2020year/okadasakaue20200327},
pubmed = {32218440}
}
@article{Sakaue2020a,
author = {*Sakaue, Saori and *Kanai, Masahiro and Karjalainen, Juha and Akiyama, Masato and Kurki, Mitja and Matoba, Nana and Takahashi, Atsushi and Hirata, Makoto and Kubo, Michiaki and Matsuda, Koichi and Murakami, Yoshinori and Daly, Mark J. and Kamatani, Yoichiro and Okada, Yukinori},
doi = {10.1038/s41591-020-0785-8},
issn = {1078-8956},
journal = {Nature Medicine},
month = {apr},
number = {4},
pages = {542--548},
publisher = {Springer US},
title = {{Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32251405) [PR](http://www.med.osaka-u.ac.jp/eng/activities/results/2020year/okada20200324)},
volume = {26},
year = {2020},
keywords = {selected},
abstract = {While polygenic risk scores (PRSs) are poised to be translated into clinical practice through prediction of inborn health risks1, a strategy to utilize genetics to prioritize modifiable risk factors driving heath outcome is warranted2. To this end, we investigated the association of the genetic susceptibility to complex traits with human lifespan in collaboration with three worldwide biobanks (ntotal = 675,898; BioBank Japan (n = 179,066), UK Biobank (n = 361,194) and FinnGen (n = 135,638)). In contrast to observational studies, in which discerning the cause-and-effect can be difficult, PRSs could help to identify the driver biomarkers affecting human lifespan. A high systolic blood pressure PRS was trans-ethnically associated with a shorter lifespan (hazard ratio = 1.03[1.02-1.04], Pmeta = 3.9 $\times$ 10-13) and parental lifespan (hazard ratio = 1.06[1.06-1.07], P = 2.0 $\times$ 10-86). The obesity PRS showed distinct effects on lifespan in Japanese and European individuals (Pheterogeneity = 9.5 $\times$ 10-8 for BMI). The causal effect of blood pressure and obesity on lifespan was further supported by Mendelian randomization studies. Beyond genotype-phenotype associations, our trans-biobank study offers a new value of PRSs in prioritization of risk factors that could be potential targets of medical treatment to improve population health.},
biorxiv = {10.1101/856351},
pdf = {https://rdcu.be/cmhcK},
pr = {http://www.med.osaka-u.ac.jp/eng/activities/results/2020year/okada20200324},
pubmed = {32251405}
}
@article{Ray2020,
author = {Ray, John P and de Boer, Carl G. and Fulco, Charles P and Lareau, Caleb A and Kanai, Masahiro and Ulirsch, Jacob C and Tewhey, Ryan and Ludwig, Leif S and Reilly, Steven K and Bergman, Drew T and Engreitz, Jesse M and Issner, Robbyn and Finucane, Hilary K and Lander, Eric S and Regev, Aviv and Hacohen, Nir},
doi = {10.1038/s41467-020-15022-4},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {1237},
publisher = {Springer US},
title = {{Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/32144282)},
volume = {11},
year = {2020},
abstract = {Genome-wide association studies have associated thousands of genetic variants with complex traits and diseases, but pinpointing the causal variant(s) among those in tight linkage disequilibrium with each associated variant remains a major challenge. Here, we use seven experimental assays to characterize all common variants at the multiple disease-associated TNFAIP3 locus in five disease-relevant immune cell lines, based on a set of features related to regulatory potential. Trait/disease-associated variants are enriched among SNPs prioritized based on either: (1) residing within CRISPRi-sensitive regulatory regions, or (2) localizing in a chromatin accessible region while displaying allele-specific reporter activity. Of the 15 trait/disease-associated haplotypes at TNFAIP3, 9 have at least one variant meeting one or both of these criteria, 5 of which are further supported by genetic fine-mapping. Our work provides a comprehensive strategy to characterize genetic variation at important disease-associated loci, and aids in the effort to identify trait causal genetic variants.},
pdf = {https://rdcu.be/cmhcT},
pubmed = {32144282}
}
@article{Matoba2020,
author = {Matoba, Nana and Akiyama, Masato and Ishigaki, Kazuyoshi and Kanai, Masahiro and Takahashi, Atsushi and Momozawa, Yukihide and Ikegawa, Shiro and Ikeda, Masashi and Iwata, Nakao and Hirata, Makoto and Matsuda, Koichi and Murakami, Yoshinori and Kubo, Michiaki and Kamatani, Yoichiro and Okada, Yukinori},
doi = {10.1038/s41562-019-0805-1},
isbn = {4156201908051},
issn = {2397-3374},
journal = {Nature Human Behaviour},
month = {mar},
number = {3},
pages = {308--316},
publisher = {Springer US},
title = {{GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31959922) [PR](https://www.riken.jp/press/2020/20200130_1/)},
volume = {4},
year = {2020},
abstract = {Dietary habits are important factors in our lifestyle, and confer both susceptibility to and protection from a variety of human diseases. We performed genome-wide association studies for 13 dietary habits including consumption of alcohol (ever versus never drinkers and drinks per week), beverages (coffee, green tea and milk) and foods (yoghurt, cheese, natto, tofu, fish, small whole fish, vegetables and meat) in Japanese individuals (n = 58,610-165,084) collected by BioBank Japan, the nationwide hospital-based genome cohort. Significant associations were found in nine genetic loci (MCL1-ENSA, GCKR, AGR3-AHR, ADH1B, ALDH1B1, ALDH1A1, ALDH2, CYP1A2-CSK and ADORA2A-AS1) for 13 dietary traits (P < 3.8 $\times$ 10-9). Of these, ten associations between five loci and eight traits were new findings. Furthermore, a phenome-wide association study revealed that five of the dietary trait-associated loci have pleiotropic effects on multiple human complex diseases and clinical measurements. Our findings provide new insight into the genetics of habitual consumption.},
pdf = {https://rdcu.be/cmhds},
pr = {https://www.riken.jp/press/2020/20200130_1/},
pubmed = {31959922}
}
@article{Clark2019,
author = {Clark, David W. and Okada, Yukinori and Moore, Kristjan H S and Mason, Dan and Pirastu, Nicola and Gandin, Ilaria and Mattsson, Hannele and Barnes, Catriona L K and Lin, Kuang and Zhao, Jing Hua and Deelen, Patrick and Rohde, Rebecca and Schurmann, Claudia and Guo, Xiuqing and Giulianini, Franco and Zhang, Weihua and Medina-Gomez, Carolina and Karlsson, Robert and Bao, Yanchun and Bartz, Traci M and Baumbach, Clemens and Biino, Ginevra and Bixley, Matthew J and Brumat, Marco and Chai, Jin-Fang and Corre, Tanguy and Cousminer, Diana L and Dekker, Annelot M and Eccles, David A and van Eijk, Kristel R and Fuchsberger, Christian and Gao, He and Germain, Marine and Gordon, Scott D and de Haan, Hugoline G and Harris, Sarah E and Hofer, Edith and Huerta-Chagoya, Alicia and Igartua, Catherine and Jansen, Iris E and Jia, Yucheng and Kacprowski, Tim and Karlsson, Torgny and Kleber, Marcus E and Li, Shengchao Alfred and Li-Gao, Ruifang and Mahajan, Anubha and Matsuda, Koichi and Meidtner, Karina and Meng, Weihua and Montasser, May E and van der Most, Peter J and Munz, Matthias and Nutile, Teresa and Palviainen, Teemu and Prasad, Gauri and Prasad, Rashmi B and Priyanka, Tallapragada Divya Sri and Rizzi, Federica and Salvi, Erika and Sapkota, Bishwa R and Shriner, Daniel and Skotte, Line and Smart, Melissa C and Smith, Albert Vernon and van der Spek, Ashley and Spracklen, Cassandra N and Strawbridge, Rona J and Tajuddin, Salman M and Trompet, Stella and Turman, Constance and Verweij, Niek and Viberti, Clara and Wang, Lihua and Warren, Helen R and Wootton, Robyn E and Yanek, Lisa R and Yao, Jie and Yousri, Noha A and Zhao, Wei and Adeyemo, Adebowale A and Afaq, Saima and Aguilar-Salinas, Carlos Alberto and Akiyama, Masato and Albert, Matthew L and Allison, Matthew A and Alver, Maris and Aung, Tin and Azizi, Fereidoun and Bentley, Amy R and Boeing, Heiner and Boerwinkle, Eric and Borja, Judith B and de Borst, Gert J and Bottinger, Erwin P and Broer, Linda and Campbell, Harry and Chanock, Stephen and Chee, Miao-Li and Chen, Guanjie and Chen, Yii-Der I and Chen, Zhengming and Chiu, Yen-Feng and Cocca, Massimiliano and Collins, Francis S and Concas, Maria Pina and Corley, Janie and Cugliari, Giovanni and van Dam, Rob M and Damulina, Anna and Daneshpour, Maryam S and Day, Felix R and Delgado, Graciela E and Dhana, Klodian and Doney, Alexander S F and D{\"{o}}rr, Marcus and Doumatey, Ayo P and Dzimiri, Nduna and Ebenesersd{\'{o}}ttir, S Sunna and Elliott, Joshua and Elliott, Paul and Ewert, Ralf and Felix, Janine F and Fischer, Krista and Freedman, Barry I and Girotto, Giorgia and Goel, Anuj and G{\"{o}}gele, Martin and Goodarzi, Mark O and Graff, Mariaelisa and Granot-Hershkovitz, Einat and Grodstein, Francine and Guarrera, Simonetta and Gudbjartsson, Daniel F and Guity, Kamran and Gunnarsson, Bjarni and Guo, Yu and Hagenaars, Saskia P and Haiman, Christopher A and Halevy, Avner and Harris, Tamara B and Hedayati, Mehdi and van Heel, David A and Hirata, Makoto and H{\"{o}}fer, Imo and Hsiung, Chao Agnes and Huang, Jinyan and Hung, Yi-Jen and Ikram, M Arfan and Jagadeesan, Anuradha and Jousilahti, Pekka and Kamatani, Yoichiro and Kanai, Masahiro and Kerrison, Nicola D and Kessler, Thorsten and Khaw, Kay-Tee and Khor, Chiea Chuen and de Kleijn, Dominique P V and Koh, Woon-Puay and Kolcic, Ivana and Kraft, Peter and Kr{\"{a}}mer, Bernhard K and Kutalik, Zolt{\'{a}}n and Kuusisto, Johanna and Langenberg, Claudia and Launer, Lenore J and Lawlor, Deborah A and Lee, I-Te and Lee, Wen-Jane and Lerch, Markus M and Li, Liming and Liu, Jianjun and Loh, Marie and London, Stephanie J and Loomis, Stephanie and Lu, Yingchang and Luan, Jian'an and M{\"{a}}gi, Reedik and Manichaikul, Ani W and Manunta, Paolo and M{\'{a}}sson, G{\'{i}}sli and Matoba, Nana and Mei, Xue W and Meisinger, Christa and Meitinger, Thomas and Mezzavilla, Massimo and Milani, Lili and Millwood, Iona Y and Momozawa, Yukihide and Moore, Amy and Morange, Pierre-Emmanuel and Moreno-Mac{\'{i}}as, Hortensia and Mori, Trevor A and Morrison, Alanna C and Muka, Taulant and Murakami, Yoshinori and Murray, Alison D and de Mutsert, Ren{\'{e}}e and Mychaleckyj, Josyf C and Nalls, Mike A and Nauck, Matthias and Neville, Matt J and Nolte, Ilja M and Ong, Ken K and Orozco, Lorena and Padmanabhan, Sandosh and P{\'{a}}lsson, Gunnar and Pankow, James S and Pattaro, Cristian and Pattie, Alison and Polasek, Ozren and Poulter, Neil and Pramstaller, Peter P and Quintana-Murci, Lluis and R{\"{a}}ikk{\"{o}}nen, Katri and Ralhan, Sarju and Rao, Dabeeru C and van Rheenen, Wouter and Rich, Stephen S and Ridker, Paul M and Rietveld, Cornelius A and Robino, Antonietta and van Rooij, Frank J A and Ruggiero, Daniela and Saba, Yasaman and Sabanayagam, Charumathi and Sabater-Lleal, Maria and Sala, Cinzia Felicita and Salomaa, Veikko and Sandow, Kevin and Schmidt, Helena and Scott, Laura J and Scott, William R and Sedaghati-Khayat, Bahareh and Sennblad, Bengt and van Setten, Jessica and Sever, Peter J and Sheu, Wayne H-H and Shi, Yuan and Shrestha, Smeeta and Shukla, Sharvari Rahul and Sigurdsson, Jon K and Sikka, Timo Tonis and Singh, Jai Rup and Smith, Blair H and Stan{\v{c}}{\'{a}}kov{\'{a}}, Alena and Stanton, Alice and Starr, John M and Stefansdottir, Lilja and Straker, Leon and Sulem, Patrick and Sveinbjornsson, Gardar and Swertz, Morris A and Taylor, Adele M and Taylor, Kent D and Terzikhan, Natalie and Tham, Yih-Chung and Thorleifsson, Gudmar and Thorsteinsdottir, Unnur and Tillander, Annika and Tracy, Russell P and Tusi{\'{e}}-Luna, Teresa and Tzoulaki, Ioanna and Vaccargiu, Simona and Vangipurapu, Jagadish and Veldink, Jan H and Vitart, Veronique and V{\"{o}}lker, Uwe and Vuoksimaa, Eero and Wakil, Salma M and Waldenberger, Melanie and Wander, Gurpreet S and Wang, Ya Xing and Wareham, Nicholas J and Wild, Sarah and Yajnik, Chittaranjan S and Yuan, Jian-Min and Zeng, Lingyao and Zhang, Liang and Zhou, Jie and Amin, Najaf and Asselbergs, Folkert W and Bakker, Stephan J L and Becker, Diane M and Lehne, Benjamin and Bennett, David A and van den Berg, Leonard H and Berndt, Sonja I and Bharadwaj, Dwaipayan and Bielak, Lawrence F and Bochud, Murielle and Boehnke, Mike and Bouchard, Claude and Bradfield, Jonathan P and Brody, Jennifer A and Campbell, Archie and Carmi, Shai and Caulfield, Mark J and Cesarini, David and Chambers, John C and Chandak, Giriraj Ratan and Cheng, Ching-Yu and Ciullo, Marina and Cornelis, Marilyn and Cusi, Daniele and Smith, George Davey and Deary, Ian J and Dorajoo, Rajkumar and van Duijn, Cornelia M and Ellinghaus, David and Erdmann, Jeanette and Eriksson, Johan G and Evangelou, Evangelos and Evans, Michele K and Faul, Jessica D and Feenstra, Bjarke and Feitosa, Mary and Foisy, Sylvain and Franke, Andre and Friedlander, Yechiel and Gasparini, Paolo and Gieger, Christian and Gonzalez, Clicerio and Goyette, Philippe and Grant, Struan F A and Griffiths, Lyn R and Groop, Leif and Gudnason, Vilmundur and Gyllensten, Ulf and Hakonarson, Hakon and Hamsten, Anders and van der Harst, Pim and Heng, Chew-Kiat and Hicks, Andrew A and Hochner, Hagit and Huikuri, Heikki and Hunt, Steven C and Jaddoe, Vincent W V and {De Jager}, Philip L and Johannesson, Magnus and Johansson, {\AA}sa and Jonas, Jost B and Jukema, J Wouter and Junttila, Juhani and Kaprio, Jaakko and Kardia, Sharon L. R. and Karpe, Fredrik and Kumari, Meena and Laakso, Markku and van der Laan, Sander W and Lahti, Jari and Laudes, Matthias and Lea, Rodney A and Lieb, Wolfgang and Lumley, Thomas and Martin, Nicholas G and M{\"{a}}rz, Winfried and Matullo, Giuseppe and McCarthy, Mark I and Medland, Sarah E and Merriman, Tony R and Metspalu, Andres and Meyer, Brian F and Mohlke, Karen L and Montgomery, Grant W and Mook-Kanamori, Dennis and Munroe, Patricia B and North, Kari E and Nyholt, Dale R and O'connell, Jeffery R and Ober, Carole and Oldehinkel, Albertine J and Palmas, Walter and Palmer, Colin and Pasterkamp, Gerard G and Patin, Etienne and Pennell, Craig E and Perusse, Louis and Peyser, Patricia A and Pirastu, Mario and Polderman, Tinca J. C. and Porteous, David J and Posthuma, Danielle and Psaty, Bruce M and Rioux, John D and Rivadeneira, Fernando and Rotimi, Charles and Rotter, Jerome I and Rudan, Igor and {Den Ruijter}, Hester M and Sanghera, Dharambir K and Sattar, Naveed and Schmidt, Reinhold and Schulze, Matthias B and Schunkert, Heribert and Scott, Robert A and Shuldiner, Alan R and Sim, Xueling and Small, Neil and Smith, Jennifer A and Sotoodehnia, Nona and Tai, E-Shyong and Teumer, Alexander and Timpson, Nicholas J and Toniolo, Daniela and Tregouet, David-Alexandre and Tuomi, Tiinamaija and Vollenweider, Peter and Wang, Carol A and Weir, David R and Whitfield, John B and Wijmenga, Cisca and Wong, Tien-Yin and Wright, John and Yang, Jingyun and Yu, Lei and Zemel, Babette S and Zonderman, Alan B and Perola, Markus and Magnusson, Patrik K. E. and Uitterlinden, Andr{\'{e}} G and Kooner, Jaspal S and Chasman, Daniel I and Loos, Ruth J. F. and Franceschini, Nora and Franke, Lude and Haley, Chris S and Hayward, Caroline and Walters, Robin G and Perry, John R. B. and Esko, Tnu and Helgason, Agnar and Stefansson, Kari and Joshi, Peter K and Kubo, Michiaki and Wilson, James F},
doi = {10.1038/s41467-019-12283-6},
isbn = {4146701912283},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {4957},
title = {{Associations of autozygosity with a broad range of human phenotypes}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31673082)},
volume = {10},
year = {2019},
abstract = {In many species, the offspring of related parents suffer reduced reproductive success, a phenomenon known as inbreeding depression. In humans, the importance of this effect has remained unclear, partly because reproduction between close relatives is both rare and frequently associated with confounding social factors. Here, using genomic inbreeding coefficients (FROH) for >1.4 million individuals, we show that FROH is significantly associated (p < 0.0005) with apparently deleterious changes in 32 out of 100 traits analysed. These changes are associated with runs of homozygosity (ROH), but not with common variant homozygosity, suggesting that genetic variants associated with inbreeding depression are predominantly rare. The effect on fertility is striking: FROH equivalent to the offspring of first cousins is associated with a 55\% decrease [95\% CI 44-66\%] in the odds of having children. Finally, the effects of FROH are confirmed within full-sibling pairs, where the variation in FROH is independent of all environmental confounding.},
pdf = {https://rdcu.be/cmqTL},
pubmed = {31673082}
}
@article{Leu2019,
author = {Leu, Costin and Stevelink, Remi and Smith, Alexander W and Goleva, Slavina B and Kanai, Masahiro and Ferguson, Lisa and Campbell, Ciaran and Kamatani, Yoichiro and Okada, Yukinori and Sisodiya, Sanjay M and Cavalleri, Gianpiero L and Koeleman, Bobby P C and Lerche, Holger and Jehi, Lara and Davis, Lea K and Najm, Imad M and Palotie, Aarno and Daly, Mark J and Busch, Robyn M and Lal, Dennis},
doi = {10.1093/brain/awz292},
issn = {0006-8950},
journal = {Brain},
month = {nov},
number = {11},
pages = {3473--3481},
title = {{Polygenic burden in focal and generalized epilepsies}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31608925)},
volume = {142},
year = {2019},
abstract = {Rare genetic variants can cause epilepsy, and genetic testing has been widely adopted for severe, paediatric-onset epilepsies. The phenotypic consequences of common genetic risk burden for epilepsies and their potential future clinical applications have not yet been determined. Using polygenic risk scores (PRS) from a European-ancestry genome-wide association study in generalized and focal epilepsy, we quantified common genetic burden in patients with generalized epilepsy (GE-PRS) or focal epilepsy (FE-PRS) from two independent non-Finnish European cohorts (Epi25 Consortium, n = 5705; Cleveland Clinic Epilepsy Center, n = 620; both compared to 20 435 controls). One Finnish-ancestry population isolate (Finnish-ancestry Epi25, n = 449; compared to 1559 controls), two European-ancestry biobanks (UK Biobank, n = 383 656; Vanderbilt biorepository, n = 49 494), and one Japanese-ancestry biobank (BioBank Japan, n = 168 680) were used for additional replications. Across 8386 patients with epilepsy and 622 212 population controls, we found and replicated significantly higher GE-PRS in patients with generalized epilepsy of European-ancestry compared to patients with focal epilepsy (Epi25: P = 1.64$\times$10-15; Cleveland: P = 2.85$\times$10-4; Finnish-ancestry Epi25: P = 1.80$\times$10-4) or population controls (Epi25: P = 2.35$\times$10-70; Cleveland: P = 1.43$\times$10-7; Finnish-ancestry Epi25: P = 3.11$\times$10-4; UK Biobank and Vanderbilt biorepository meta-analysis: P = 7.99$\times$10-4). FE-PRS were significantly higher in patients with focal epilepsy compared to controls in the non-Finnish, non-biobank cohorts (Epi25: P = 5.74$\times$10-19; Cleveland: P = 1.69$\times$10-6). European ancestry-derived PRS did not predict generalized epilepsy or focal epilepsy in Japanese-ancestry individuals. Finally, we observed a significant 4.6-fold and a 4.5-fold enrichment of patients with generalized epilepsy compared to controls in the top 0.5\% highest GE-PRS of the two non-Finnish European cohorts (Epi25: P = 2.60$\times$10-15; Cleveland: P = 1.39$\times$10-2). We conclude that common variant risk associated with epilepsy is significantly enriched in multiple cohorts of patients with epilepsy compared to controls-in particular for generalized epilepsy. As sample sizes and PRS accuracy continue to increase with further common variant discovery, PRS could complement established clinical biomarkers and augment genetic testing for patient classification, comorbidity research, and potentially targeted treatment.},
pdf = {https://academic.oup.com/brain/article-pdf/142/11/3473/35377751/awz292.pdf},
pubmed = {31608925}
}
@article{Tin2019,
author = {Tin, Adrienne and Marten, Jonathan and {Halperin Kuhns}, Victoria L and Li, Yong and Wuttke, Matthias and Kirsten, Holger and Sieber, Karsten B and Qiu, Chengxiang and Gorski, Mathias and Yu, Zhi and Giri, Ayush and Sveinbjornsson, Gardar and Li, Man and Chu, Audrey Y and Hoppmann, Anselm and O'Connor, Luke J and Prins, Bram and Nutile, Teresa and Noce, Damia and Akiyama, Masato and Cocca, Massimiliano and Ghasemi, Sahar and van der Most, Peter J and Horn, Katrin and Xu, Yizhe and Fuchsberger, Christian and Sedaghat, Sanaz and Afaq, Saima and Amin, Najaf and {\"{A}}rnl{\"{o}}v, Johan and Bakker, Stephan J L and Bansal, Nisha and Baptista, Daniela and Bergmann, Sven and Biggs, Mary L and Biino, Ginevra and Boerwinkle, Eric and Bottinger, Erwin P and Boutin, Thibaud S and Brumat, Marco and Burkhardt, Ralph and Campana, Eric and Campbell, Archie and Campbell, Harry and Carroll, Robert J and Catamo, Eulalia and Chambers, John C and Ciullo, Marina and Concas, Maria Pina and Coresh, Josef and Corre, Tanguy and Cusi, Daniele and Felicita, Sala Cinzia and de Borst, Martin H and {De Grandi}, Alessandro and de Mutsert, Ren{\'{e}}e and de Vries, Aiko P J and Delgado, Graciela and Demirkan, Aye and Devuyst, Olivier and Dittrich, Katalin and Eckardt, Kai-Uwe and Ehret, Georg and Endlich, Karlhans and Evans, Michele K and Gansevoort, Ron T and Gasparini, Paolo and Giedraitis, Vilmantas and Gieger, Christian and Girotto, Giorgia and G{\"{o}}gele, Martin and Gordon, Scott D and Gudbjartsson, Daniel F and Gudnason, Vilmundur and Haller, Toomas and Hamet, Pavel and Harris, Tamara B and Hayward, Caroline and Hicks, Andrew A and Hofer, Edith and Holm, Hilma and Huang, Wei and Hutri-K{\"{a}}h{\"{o}}nen, Nina and Hwang, Shih-Jen and Ikram, M Arfan and Lewis, Raychel M and Ingelsson, Erik and Jakobsdottir, Johanna and Jonsdottir, Ingileif and Jonsson, Helgi and Joshi, Peter K and Josyula, Navya Shilpa and Jung, Bettina and K{\"{a}}h{\"{o}}nen, Mika and Kamatani, Yoichiro and Kanai, Masahiro and Kerr, Shona M and Kiess, Wieland and Kleber, Marcus E and Koenig, Wolfgang and Kooner, Jaspal S and K{\"{o}}rner, Antje and Kovacs, Peter and Kr{\"{a}}mer, Bernhard K and Kronenberg, Florian and Kubo, Michiaki and K{\"{u}}hnel, Brigitte and {La Bianca}, Martina and Lange, Leslie A and Lehne, Benjamin and Lehtim{\"{a}}ki, Terho and Liu, Jun and Loeffler, Markus and Loos, Ruth J F and Lyytik{\"{a}}inen, Leo-Pekka and Magi, Reedik and Mahajan, Anubha and Martin, Nicholas G and M{\"{a}}rz, Winfried and Mascalzoni, Deborah and Matsuda, Koichi and Meisinger, Christa and Meitinger, Thomas and Metspalu, Andres and Milaneschi, Yuri and O'Donnell, Christopher J and Wilson, Otis D. and Gaziano, J Michael and Mishra, Pashupati P and Mohlke, Karen L and Mononen, Nina and Montgomery, Grant W and Mook-Kanamori, Dennis O and M{\"{u}}ller-Nurasyid, Martina and Nadkarni, Girish N and Nalls, Mike A and Nauck, Matthias and Nikus, Kjell and Ning, Boting and Nolte, Ilja M and Noordam, Raymond and O'Connell, Jeffrey R and Olafsson, Isleifur and Padmanabhan, Sandosh and Penninx, Brenda W J H and Perls, Thomas and Peters, Annette and Pirastu, Mario and Pirastu, Nicola and Pistis, Giorgio and Polasek, Ozren and Ponte, Belen and Porteous, David J and Poulain, Tanja and Preuss, Michael H and Rabelink, Ton J and Raffield, Laura M and Raitakari, Olli T and Rettig, Rainer and Rheinberger, Myriam and Rice, Kenneth M and Rizzi, Federica and Robino, Antonietta and Rudan, Igor and Krajcoviechova, Alena and Cifkova, Renata and Rueedi, Rico and Ruggiero, Daniela and Ryan, Kathleen A and Saba, Yasaman and Salvi, Erika and Schmidt, Helena and Schmidt, Reinhold and Shaffer, Christian M and Smith, Albert V. and Smith, Blair H and Spracklen, Cassandra N and Strauch, Konstantin and Stumvoll, Michael and Sulem, Patrick and Tajuddin, Salman M and Teren, Andrej and Thiery, Joachim and Thio, Chris H L and Thorsteinsdottir, Unnur and Toniolo, Daniela and T{\"{o}}njes, Anke and Tremblay, Johanne and Uitterlinden, Andr{\'{e}} G and Vaccargiu, Simona and van der Harst, Pim and van Duijn, Cornelia M and Verweij, Niek and V{\"{o}}lker, Uwe and Vollenweider, Peter and Waeber, Gerard and Waldenberger, Melanie and Whitfield, John B and Wild, Sarah H and Wilson, James F. and Yang, Qiong and Zhang, Weihua and Zonderman, Alan B and Bochud, Murielle and Wilson, James G and Pendergrass, Sarah A and Ho, Kevin and Parsa, Afshin and Pramstaller, Peter P and Psaty, Bruce M and B{\"{o}}ger, Carsten A and Snieder, Harold and Butterworth, Adam S and Okada, Yukinori and Edwards, Todd L and Stefansson, Kari and Susztak, Katalin and Scholz, Markus and Heid, Iris M and Hung, Adriana M and Teumer, Alexander and Pattaro, Cristian and Woodward, Owen M and Vitart, Veronique and K{\"{o}}ttgen, Anna},
doi = {10.1038/s41588-019-0504-x},
issn = {1061-4036},
journal = {Nature Genetics},
month = {oct},
number = {10},
pages = {1459--1474},
title = {{Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31578528)},
volume = {51},
year = {2019},
abstract = {Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via poorly understood mechanisms. We performed a trans-ancestry genome-wide association study of serum urate in 457,690 individuals, identifying 183 loci (147 previously unknown) that improve the prediction of gout in an independent cohort of 334,880 individuals. Serum urate showed significant genetic correlations with many cardiometabolic traits, with genetic causality analyses supporting a substantial role for pleiotropy. Enrichment analysis, fine-mapping of urate-associated loci and colocalization with gene expression in 47 tissues implicated the kidney and liver as the main target organs and prioritized potentially causal genes and variants, including the transcriptional master regulators in the liver and kidney, HNF1A and HNF4A. Experimental validation showed that HNF4A transactivated the promoter of ABCG2, encoding a major urate transporter, in kidney cells, and that HNF4A p.Thr139Ile is a functional variant. Transcriptional coregulation within and across organs may be a general mechanism underlying the observed pleiotropy between urate and cardiometabolic traits.},
pdf = {https://rdcu.be/cmqTP},
pubmed = {31578528}
}
@article{Akiyama2019,
author = {Akiyama, Masato and Ishigaki, Kazuyoshi and Sakaue, Saori and Momozawa, Yukihide and Horikoshi, Momoko and Hirata, Makoto and Matsuda, Koichi and Ikegawa, Shiro and Takahashi, Atsushi and Kanai, Masahiro and Suzuki, Sadao and Matsui, Daisuke and Naito, Mariko and Yamaji, Taiki and Iwasaki, Motoki and Sawada, Norie and Tanno, Kozo and Sasaki, Makoto and Hozawa, Atsushi and Minegishi, Naoko and Wakai, Kenji and Tsugane, Shoichiro and Shimizu, Atsushi and Yamamoto, Masayuki and Okada, Yukinori and Murakami, Yoshinori and Kubo, Michiaki and Kamatani, Yoichiro},
doi = {10.1038/s41467-019-12276-5},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {4393},
title = {{Characterizing rare and low-frequency height-associated variants in the Japanese population}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31562340) [PR](https://www.riken.jp/press/2019/20191002_1/)},
volume = {10},
year = {2019},
abstract = {Human height is a representative phenotype to elucidate genetic architecture. However, the majority of large studies have been performed in European population. To investigate the rare and low-frequency variants associated with height, we construct a reference panel (N = 3,541) for genotype imputation by integrating the whole-genome sequence data from 1,037 Japanese with that of the 1000 Genomes Project, and perform a genome-wide association study in 191,787 Japanese. We report 573 height-associated variants, including 22 rare and 42 low-frequency variants. These 64 variants explain 1.7\% of the phenotypic variance. Furthermore, a gene-based analysis identifies two genes with multiple height-increasing rare and low-frequency nonsynonymous variants (SLC27A3 and CYP26B1; PSKAT-O < 2.5 $\times$ 10-6). Our analysis shows a general tendency of the effect sizes of rare variants towards increasing height, which is contrary to findings among Europeans, suggesting that height-associated rare variants are under different selection pressure in Japanese and European populations.},
pdf = {https://rdcu.be/cmqTX},
pr = {https://www.riken.jp/press/2019/20191002_1/},
pubmed = {31562340}
}
@article{Wuttke2019,
author = {Wuttke, Matthias and Li, Yong and Li, Man and Sieber, Karsten B. and Feitosa, Mary F. and Gorski, Mathias and Tin, Adrienne and Wang, Lihua and Chu, Audrey Y. and Hoppmann, Anselm and Kirsten, Holger and Giri, Ayush and Chai, Jin-Fang and Sveinbjornsson, Gardar and Tayo, Bamidele O. and Nutile, Teresa and Fuchsberger, Christian and Marten, Jonathan and Cocca, Massimiliano and Ghasemi, Sahar and Xu, Yizhe and Horn, Katrin and Noce, Damia and van der Most, Peter J. and Sedaghat, Sanaz and Yu, Zhi and Akiyama, Masato and Afaq, Saima and Ahluwalia, Tarunveer S. and Almgren, Peter and Amin, Najaf and {\"{A}}rnl{\"{o}}v, Johan and Bakker, Stephan J. L. and Bansal, Nisha and Baptista, Daniela and Bergmann, Sven and Biggs, Mary L. and Biino, Ginevra and Boehnke, Michael and Boerwinkle, Eric and Boissel, Mathilde and Bottinger, Erwin P. and Boutin, Thibaud S. and Brenner, Hermann and Brumat, Marco and Burkhardt, Ralph and Butterworth, Adam S. and Campana, Eric and Campbell, Archie and Campbell, Harry and Canouil, Micka{\"{e}}l and Carroll, Robert J. and Catamo, Eulalia and Chambers, John C. and Chee, Miao-Ling and Chee, Miao-Li and Chen, Xu and Cheng, Ching-Yu and Cheng, Yurong and Christensen, Kaare and Cifkova, Renata and Ciullo, Marina and Concas, Maria Pina and Cook, James P. and Coresh, Josef and Corre, Tanguy and Sala, Cinzia Felicita and Cusi, Daniele and Danesh, John and Daw, E. Warwick and de Borst, Martin H. and {De Grandi}, Alessandro and de Mutsert, Ren{\'{e}}e and de Vries, Aiko P. J. and Degenhardt, Frauke and Delgado, Graciela and Demirkan, Ayse and {Di Angelantonio}, Emanuele and Dittrich, Katalin and Divers, Jasmin and Dorajoo, Rajkumar and Eckardt, Kai-Uwe and Ehret, Georg and Elliott, Paul and Endlich, Karlhans and Evans, Michele K. and Felix, Janine F. and Foo, Valencia Hui Xian and Franco, Oscar H. and Franke, Andre and Freedman, Barry I. and Freitag-Wolf, Sandra and Friedlander, Yechiel and Froguel, Philippe and Gansevoort, Ron T. and Gao, He and Gasparini, Paolo and Gaziano, J. Michael and Giedraitis, Vilmantas and Gieger, Christian and Girotto, Giorgia and Giulianini, Franco and G{\"{o}}gele, Martin and Gordon, Scott D. and Gudbjartsson, Daniel F. and Gudnason, Vilmundur and Haller, Toomas and Hamet, Pavel and Harris, Tamara B. and Hartman, Catharina A. and Hayward, Caroline and Hellwege, Jacklyn N. and Heng, Chew-Kiat and Hicks, Andrew A. and Hofer, Edith and Huang, Wei and Hutri-K{\"{a}}h{\"{o}}nen, Nina and Hwang, Shih-Jen and Ikram, M. Arfan and Indridason, Olafur S. and Ingelsson, Erik and Ising, Marcus and Jaddoe, Vincent W. V. and Jakobsdottir, Johanna and Jonas, Jost B. and Joshi, Peter K. and Josyula, Navya Shilpa and Jung, Bettina and K{\"{a}}h{\"{o}}nen, Mika and Kamatani, Yoichiro and Kammerer, Candace M. and Kanai, Masahiro and Kastarinen, Mika and Kerr, Shona M. and Khor, Chiea-Chuen and Kiess, Wieland and Kleber, Marcus E. and Koenig, Wolfgang and Kooner, Jaspal S. and K{\"{o}}rner, Antje and Kovacs, Peter and Kraja, Aldi T. and Krajcoviechova, Alena and Kramer, Holly and Kr{\"{a}}mer, Bernhard K. and Kronenberg, Florian and Kubo, Michiaki and K{\"{u}}hnel, Brigitte and Kuokkanen, Mikko and Kuusisto, Johanna and {La Bianca}, Martina and Laakso, Markku and Lange, Leslie A. and Langefeld, Carl D. and Lee, Jeannette Jen-Mai and Lehne, Benjamin and Lehtim{\"{a}}ki, Terho and Lieb, Wolfgang and Lim, Su-Chi and Lind, Lars and Lindgren, Cecilia M. and Liu, Jun and Liu, Jianjun and Loeffler, Markus and Loos, Ruth J. F. and Lucae, Susanne and Lukas, Mary Ann and Lyytik{\"{a}}inen, Leo-Pekka and M{\"{a}}gi, Reedik and Magnusson, Patrik K. E. and Mahajan, Anubha and Martin, Nicholas G. and Martins, Jade and M{\"{a}}rz, Winfried and Mascalzoni, Deborah and Matsuda, Koichi and Meisinger, Christa and Meitinger, Thomas and Melander, Olle and Metspalu, Andres and Mikaelsdottir, Evgenia K. and Milaneschi, Yuri and Miliku, Kozeta and Mishra, Pashupati P. and Mohlke, Karen L. and Mononen, Nina and Montgomery, Grant W. and Mook-Kanamori, Dennis O. and Mychaleckyj, Josyf C. and Nadkarni, Girish N. and Nalls, Mike A. and Nauck, Matthias and Nikus, Kjell and Ning, Boting and Nolte, Ilja M. and Noordam, Raymond and O'Connell, Jeffrey and O'Donoghue, Michelle L. and Olafsson, Isleifur and Oldehinkel, Albertine J. and Orho-Melander, Marju and Ouwehand, Willem H. and Padmanabhan, Sandosh and Palmer, Nicholette D. and Palsson, Runolfur and Penninx, Brenda W. J. H. and Perls, Thomas and Perola, Markus and Pirastu, Mario and Pirastu, Nicola and Pistis, Giorgio and Podgornaia, Anna I. and Polasek, Ozren and Ponte, Belen and Porteous, David J. and Poulain, Tanja and Pramstaller, Peter P. and Preuss, Michael H. and Prins, Bram P. and Province, Michael A. and Rabelink, Ton J. and Raffield, Laura M. and Raitakari, Olli T. and Reilly, Dermot F. and Rettig, Rainer and Rheinberger, Myriam and Rice, Kenneth M. and Ridker, Paul M. and Rivadeneira, Fernando and Rizzi, Federica and Roberts, David J. and Robino, Antonietta and Rossing, Peter and Rudan, Igor and Rueedi, Rico and Ruggiero, Daniela and Ryan, Kathleen A. and Saba, Yasaman and Sabanayagam, Charumathi and Salomaa, Veikko and Salvi, Erika and Saum, Kai-Uwe and Schmidt, Helena and Schmidt, Reinhold and Sch{\"{o}}ttker, Ben and Schulz, Christina-Alexandra and Schupf, Nicole and Shaffer, Christian M. and Shi, Yuan and Smith, Albert V. and Smith, Blair H. and Soranzo, Nicole and Spracklen, Cassandra N. and Strauch, Konstantin and Stringham, Heather M. and Stumvoll, Michael and Svensson, Per O. and Szymczak, Silke and Tai, E-Shyong and Tajuddin, Salman M. and Tan, Nicholas Y. Q. and Taylor, Kent D. and Teren, Andrej and Tham, Yih-Chung and Thiery, Joachim and Thio, Chris H. L. and Thomsen, Hauke and Thorleifsson, Gudmar and Toniolo, Daniela and T{\"{o}}njes, Anke and Tremblay, Johanne and Tzoulaki, Ioanna and Uitterlinden, Andr{\'{e}} G. and Vaccargiu, Simona and van Dam, Rob M. and van der Harst, Pim and van Duijn, Cornelia M. and {Velez Edward}, Digna R. and Verweij, Niek and Vogelezang, Suzanne and V{\"{o}}lker, Uwe and Vollenweider, Peter and Waeber, Gerard and Waldenberger, Melanie and Wallentin, Lars and Wang, Ya Xing and Wang, Chaolong and Waterworth, Dawn M. and {Bin Wei}, Wen and White, Harvey and Whitfield, John B. and Wild, Sarah H. and Wilson, James F. and Wojczynski, Mary K. and Wong, Charlene and Wong, Tien-Yin and Xu, Liang and Yang, Qiong and Yasuda, Masayuki and Yerges-Armstrong, Laura M. and Zhang, Weihua and Zonderman, Alan B. and Rotter, Jerome I. and Bochud, Murielle and Psaty, Bruce M. and Vitart, Veronique and Wilson, James G. and Dehghan, Abbas and Parsa, Afshin and Chasman, Daniel I. and Ho, Kevin and Morris, Andrew P. and Devuyst, Olivier and Akilesh, Shreeram and Pendergrass, Sarah A. and Sim, Xueling and B{\"{o}}ger, Carsten A. and Okada, Yukinori and Edwards, Todd L. and Snieder, Harold and Stefansson, Kari and Hung, Adriana M. and Heid, Iris M. and Scholz, Markus and Teumer, Alexander and K{\"{o}}ttgen, Anna and Pattaro, Cristian},
doi = {10.1038/s41588-019-0407-x},
issn = {1061-4036},
journal = {Nature Genetics},
month = {jun},
number = {6},
pages = {957--972},
title = {{A catalog of genetic loci associated with kidney function from analyses of a million individuals}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31152163)},
volume = {51},
year = {2019},
abstract = {Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic complications. Through trans-ancestry meta-analysis of genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replication (n = 1,046,070), we identified 264 associated loci (166 new). Of these, 147 were likely to be relevant for kidney function on the basis of associations with the alternative kidney function marker blood urea nitrogen (n = 416,178). Pathway and enrichment analyses, including mouse models with renal phenotypes, support the kidney as the main target organ. A genetic risk score for lower eGFR was associated with clinically diagnosed CKD in 452,264 independent individuals. Colocalization analyses of associations with eGFR among 783,978 European-ancestry individuals and gene expression across 46 human tissues, including tubulo-interstitial and glomerular kidney compartments, identified 17 genes differentially expressed in kidney. Fine-mapping highlighted missense driver variants in 11 genes and kidney-specific regulatory variants. These results provide a comprehensive priority list of molecular targets for translational research.},
pdf = {https://rdcu.be/cmqUe},
pubmed = {31152163}
}
@article{Nakatochi2019,
author = {*Nakatochi, Masahiro and *Kanai, Masahiro and *Nakayama, Akiyoshi and *Hishida, Asahi and *Kawamura, Yusuke and Ichihara, Sahoko and Akiyama, Masato and Ikezaki, Hiroaki and Furusyo, Norihiro and Shimizu, Seiko and Yamamoto, Ken and Hirata, Makoto and Okada, Rieko and Kawai, Sayo and Kawaguchi, Makoto and Nishida, Yuichiro and Shimanoe, Chisato and Ibusuki, Rie and Takezaki, Toshiro and Nakajima, Mayuko and Takao, Mikiya and Ozaki, Etsuko and Matsui, Daisuke and Nishiyama, Takeshi and Suzuki, Sadao and Takashima, Naoyuki and Kita, Yoshikuni and Endoh, Kaori and Kuriki, Kiyonori and Uemura, Hirokazu and Arisawa, Kokichi and Oze, Isao and Matsuo, Keitaro and Nakamura, Yohko and Mikami, Haruo and Tamura, Takashi and Nakashima, Hiroshi and Nakamura, Takahiro and Kato, Norihiro and Matsuda, Koichi and Murakami, Yoshinori and Matsubara, Tatsuaki and Naito, Mariko and Kubo, Michiaki and Kamatani, Yoichiro and Shinomiya, Nariyoshi and Yokota, Mitsuhiro and Wakai, Kenji and Okada, Yukinori and Matsuo, Hirotaka},
doi = {10.1038/s42003-019-0339-0},
issn = {2399-3642},
journal = {Communications Biology},
month = {dec},
number = {1},
pages = {115},
title = {{Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/30993211) [PR](http://ndmc-ipb.browse.jp/DL/researchNDMC20190408HP.pdf)},
volume = {2},
year = {2019},
abstract = {Gout is a common arthritis caused by elevated serum uric acid (SUA) levels. Here we investigated loci influencing SUA in a genome-wide meta-analysis with 121,745 Japanese subjects. We identified 8948 variants at 36 genomic loci (P<5 $\times$ 10-8) including eight novel loci. Of these, missense variants of SESN2 and PNPLA3 were predicted to be damaging to the function of these proteins; another five loci-TMEM18, TM4SF4, MXD3-LMAN2, PSORS1C1-PSORS1C2, and HNF4A-are related to cell metabolism, proliferation, or oxidative stress; and the remaining locus, LINC01578, is unknown. We also identified 132 correlated genes whose expression levels are associated with SUA-increasing alleles. These genes are enriched for the UniProt transport term, suggesting the importance of transport-related genes in SUA regulation. Furthermore, trans-ethnic meta-analysis across our own meta-analysis and the Global Urate Genetics Consortium has revealed 15 more novel loci associated with SUA. Our findings provide insight into the pathogenesis, treatment, and prevention of hyperuricemia/gout.},
pdf = {https://rdcu.be/cmqUo},
pr = {http://ndmc-ipb.browse.jp/DL/researchNDMC20190408HP.pdf},
pubmed = {30993211}
}
@article{Martin2019,
author = {Martin, Alicia R and Kanai, Masahiro and Kamatani, Yoichiro and Okada, Yukinori and Neale, Benjamin M and Daly, Mark J},
doi = {10.1038/s41588-019-0379-x},
issn = {1061-4036},
journal = {Nature Genetics},
month = {apr},
number = {4},
pages = {584--591},
title = {{Clinical use of current polygenic risk scores may exacerbate health disparities}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/30926966) [PR](https://www.broadinstitute.org/news/study-highlights-need-increase-diversity-within-genetic-data-sets)},
volume = {51},
year = {2019},
keywords = {selected},
abstract = {Polygenic risk scores (PRS) are poised to improve biomedical outcomes via precision medicine. However, the major ethical and scientific challenge surrounding clinical implementation of PRS is that those available today are several times more accurate in individuals of European ancestry than other ancestries. This disparity is an inescapable consequence of Eurocentric biases in genome-wide association studies, thus highlighting that-unlike clinical biomarkers and prescription drugs, which may individually work better in some populations but do not ubiquitously perform far better in European populations-clinical uses of PRS today would systematically afford greater improvement for European-descent populations. Early diversifying efforts show promise in leveling this vast imbalance, even when non-European sample sizes are considerably smaller than the largest studies to date. To realize the full and equitable potential of PRS, greater diversity must be prioritized in genetic studies, and summary statistics must be publically disseminated to ensure that health disparities are not increased for those individuals already most underserved.},
biorxiv = {10.1101/441261},
code = {https://github.com/armartin/prs_disparities},
pdf = {https://rdcu.be/cmqUB},
pr = {https://www.broadinstitute.org/news/study-highlights-need-increase-diversity-within-genetic-data-sets},
pubmed = {30926966}
}
@article{Matoba2019,
author = {Matoba, Nana and Akiyama, Masato and Ishigaki, Kazuyoshi and Kanai, Masahiro and Takahashi, Atsushi and Momozawa, Yukihide and Ikegawa, Shiro and Ikeda, Masashi and Iwata, Nakao and Hirata, Makoto and Matsuda, Koichi and Kubo, Michiaki and Okada, Yukinori and Kamatani, Yoichiro},
doi = {10.1038/s41562-019-0557-y},
issn = {2397-3374},
journal = {Nature Human Behaviour},
month = {may},
number = {5},
pages = {471--477},
title = {{GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/31089300) [PR](http://www.riken.jp/pr/press/2019/20190326_1/)},
volume = {3},
year = {2019},
abstract = {Cigarette smoking is a risk factor for a wide range of human diseases1. To investigate the genetic components associated with smoking behaviours in the Japanese population, we conducted a genome-wide association study of four smoking-related traits using up to 165,436 individuals. In total, we identified seven new loci, including three loci associated with the number of cigarettes per day (EPHX2-CLU, RET and CUX2-ALDH2), three loci associated with smoking initiation (DLC1, CXCL12-TMEM72-AS1 and GALR1-SALL3) and LINC01793-MIR4432HG, associated with the age of smoking initiation. Of these, three loci (LINC01793-MIR4432HG, CXCL12-TMEM72-AS1 and GALR1-SALL3) were found by conducting an additional sex-stratified genome-wide association study. This additional analysis showed heterogeneity of effects between sexes. The cross-sex linkage disequilibrium score regression2,3 analysis also indicated that the genetic component of smoking initiation was significantly different between the sexes. Cross-trait linkage disequilibrium score regression analysis and trait-relevant tissue analysis showed that the number of cigarettes per day has a specific genetic background distinct from those of the other three smoking behaviours. We also report 11 diseases that share genetic basis with smoking behaviours. Although the current study should be carefully considered owing to the lack of replication samples, our findings characterized the genetic architecture of smoking behaviours. Further studies in East Asian populations are warranted to confirm our findings.},
pdf = {https://rdcu.be/cmqU0},
pr = {http://www.riken.jp/pr/press/2019/20190326_1/},
pubmed = {31089300}
}
@article{Suzuki2019,
author = {Suzuki, Ken and Akiyama, Masato and Ishigaki, Kazuyoshi and Kanai, Masahiro and Hosoe, Jun and Shojima, Nobuhiro and Hozawa, Atsushi and Kadota, Aya and Kuriki, Kiyonori and Naito, Mariko and Tanno, Kozo and Ishigaki, Yasushi and Hirata, Makoto and Matsuda, Koichi and Iwata, Nakao and Ikeda, Masashi and Sawada, Norie and Yamaji, Taiki and Iwasaki, Motoki and Ikegawa, Shiro and Maeda, Shiro and Murakami, Yoshinori and Wakai, Kenji and Tsugane, Shoichiro and Sasaki, Makoto and Yamamoto, Masayuki and Okada, Yukinori and Kubo, Michiaki and Kamatani, Yoichiro and Horikoshi, Momoko and Yamauchi, Toshimasa and Kadowaki, Takashi},
doi = {10.1038/s41588-018-0332-4},
issn = {1061-4036},
journal = {Nature Genetics},
month = {mar},
number = {3},
pages = {379--386},
title = {{Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/30718926) [PR](https://www.amed.go.jp/news/release_20190205.html)},
volume = {51},
year = {2019},
abstract = {To understand the genetics of type 2 diabetes in people of Japanese ancestry, we conducted A meta-analysis of four genome-wide association studies (GWAS; 36,614 cases and 155,150 controls of Japanese ancestry). We identified 88 type 2 diabetes-associated loci (P 0.6) with the lead variants. Among the 28 missense variants, three previously unreported variants had distinct minor allele frequency (MAF) spectra between people of Japanese and European ancestry (MAFJPN > 0.05 versus MAFEUR < 0.01), including missense variants in genes related to pancreatic acinar cells (GP2) and insulin secretion (GLP1R). Transethnic comparisons of the molecular pathways identified from the GWAS results highlight both ethnically shared and heterogeneous effects of a series of pathways on type 2 diabetes (for example, monogenic diabetes and beta cells).},
pdf = {https://rdcu.be/cmqU2},
pr = {https://www.amed.go.jp/news/release_20190205.html},
pubmed = {30718926}
}
@article{Hirata2019,
author = {Hirata, Jun and Hosomichi, Kazuyoshi and Sakaue, Saori and Kanai, Masahiro and Nakaoka, Hirofumi and Ishigaki, Kazuyoshi and Suzuki, Ken and Akiyama, Masato and Kishikawa, Toshihiro and Ogawa, Kotaro and Masuda, Tatsuo and Yamamoto, Kenichi and Hirata, Makoto and Matsuda, Koichi and Momozawa, Yukihide and Inoue, Ituro and Kubo, Michiaki and Kamatani, Yoichiro and Okada, Yukinori},
doi = {10.1038/s41588-018-0336-0},
issn = {1061-4036},
journal = {Nature Genetics},
month = {mar},
number = {3},
pages = {470--480},
title = {{Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/30692682) [PR](http://www.med.osaka-u.ac.jp/activities/results/2019year/hirataokada1901)},
volume = {51},
year = {2019},
abstract = {To perform detailed fine-mapping of the major-histocompatibility-complex region, we conducted next-generation sequencing (NGS)-based typing of the 33 human leukocyte antigen (HLA) genes in 1,120 individuals of Japanese ancestry, providing a high-resolution allele catalog and linkage-disequilibrium structure of both classical and nonclassical HLA genes. Together with population-specific deep-whole-genome-sequencing data (n = 1,276), we conducted NGS-based HLA, single-nucleotide-variant and indel imputation of large-scale genome-wide-association-study data from 166,190 Japanese individuals. A phenome-wide association study assessing 106 clinical phenotypes identified abundant, significant genotype-phenotype associations across 52 phenotypes. Fine-mapping highlighted multiple association patterns conferring independent risks from classical HLA genes. Region-wide heritability estimates and genetic-correlation network analysis elucidated the polygenic architecture shared across the phenotypes.},
pdf = {https://rdcu.be/cmqU4},
pr = {http://www.med.osaka-u.ac.jp/activities/results/2019year/hirataokada1901},
pubmed = {30692682}
}
@article{Kanai2018b,
author = {Kanai, Masahiro and Maeda, Yuichi and Okada, Yukinori},
doi = {10.1093/bioinformatics/bty488},
issn = {1367-4803},
journal = {Bioinformatics},
month = {nov},
number = {22},
pages = {3934--3936},
title = {{Grimon: graphical interface to visualize multi-omics networks}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29931190)},
volume = {34},
year = {2018},
abstract = {Summary: Rapid advances in high-throughput sequencing technologies have enabled more efficient acquisition of massive amount of multi-omics data. However, interpretation of the underlying relationships across multi-omics networks has not been fully succeeded, partly due to the lack of effective methods in visualization. To aid interpretation of the results from such multi-omics data, we here present Grimon (Graphical interface to visualize multi-omics networks), an R package that visualizes high-dimensional multi-layered data sets in three-dimensional parallel coordinates. Grimon enables users to intuitively and interactively explore their analyzed data, helping their understanding of multiple inter-layer connections embedded in high-dimensional complex data. Availability and implementation: Grimon is freely available at https://github.com/mkanai/grimon as an R package with example omics data sets. Supplementary information: Supplementary data are available at bioinformatics online.},
code = {https://github.com/mkanai/grimon},
pdf = {https://academic.oup.com/bioinformatics/article-pdf/34/22/3934/26441493/bty488.pdf},
pubmed = {29931190}
}
@article{Horikoshi2018,
author = {Horikoshi, Momoko and Day, Felix R. and Akiyama, Masato and Hirata, Makoto and Kamatani, Yoichiro and Matsuda, Koichi and Ishigaki, Kazuyoshi and Kanai, Masahiro and Wright, Hollis and Toro, Carlos A. and Ojeda, Sergio R. and Lomniczi, Alejandro and Kubo, Michiaki and Ong, Ken K. and Perry, John. R. B.},
doi = {10.1038/s41467-018-04398-z},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {1977},
title = {{Elucidating the genetic architecture of reproductive ageing in the Japanese population}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29773799)},
volume = {9},
year = {2018},
abstract = {Population studies elucidating the genetic architecture of reproductive ageing have been largely limited to European ancestries, restricting the generalizability of the findings and overlooking possible key genes poorly captured by common European genetic variation. Here, we report 26 loci (all P < 5 $\times$ 10-8) for reproductive ageing, i.e. puberty timing or age at menopause, in a non-European population (up to 67,029 women of Japanese ancestry). Highlighted genes for menopause include GNRH1, which supports a primary, rather than passive, role for hypothalamic-pituitary GnRH signalling in the timing of menopause. For puberty timing, we demonstrate an aetiological role for receptor-like protein tyrosine phosphatases by combining evidence across population genetics and pre- and peri-pubertal changes in hypothalamic gene expression in rodent and primate models. Furthermore, our findings demonstrate widespread differences in allele frequencies and effect estimates between Japanese and European associated variants, highlighting the benefits and challenges of large-scale trans-ethnic approaches.},
biorxiv = {10.1101/182717},
pdf = {https://rdcu.be/cmqVk},
pubmed = {29773799}
}
@article{Okada2018,
author = {Okada, Yukinori and Momozawa, Yukihide and Sakaue, Saori and Kanai, Masahiro and Ishigaki, Kazuyoshi and Akiyama, Masato and Kishikawa, Toshihiro and Arai, Yasumichi and Sasaki, Takashi and Kosaki, Kenjiro and Suematsu, Makoto and Matsuda, Koichi and Yamamoto, Kazuhiko and Kubo, Michiaki and Hirose, Nobuyoshi and Kamatani, Yoichiro},
doi = {10.1038/s41467-018-03274-0},
issn = {2041-1723},
journal = {Nature Communications},
month = {dec},
number = {1},
pages = {1631},
title = {{Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29691385) [PR](http://www.riken.jp/pr/press/2018/20180424_2/)},
volume = {9},
year = {2018},
abstract = {Understanding natural selection is crucial to unveiling evolution of modern humans. Here, we report natural selection signatures in the Japanese population using 2234 high-depth whole-genome sequence (WGS) data (25.9$\times$). Using rare singletons, we identify signals of very recent selection for the past 2000-3000 years in multiple loci (ADH cluster, MHC region, BRAP-ALDH2, SERHL2). In large-scale genome-wide association study (GWAS) dataset (n = 171,176), variants with selection signatures show enrichment in heterogeneity of derived allele frequency spectra among the geographic regions of Japan, highlighted by two major regional clusters (Hondo and Ryukyu). While the selection signatures do not show enrichment in archaic hominin-derived genome sequences, they overlap with the SNPs associated with the modern human traits. The strongest overlaps are observed for the alcohol or nutrition metabolism-related traits. Our study illustrates the value of high-depth WGS to understand evolution and their relationship with disease risk.},
pdf = {https://rdcu.be/cmqVl},
pr = {http://www.riken.jp/pr/press/2018/20180424_2/},
pubmed = {29691385}
}
@article{Malik2018,
author = {Malik, Rainer and Chauhan, Ganesh and Traylor, Matthew and Sargurupremraj, Muralidharan and Okada, Yukinori and Mishra, Aniket and Rutten-Jacobs, Loes and Giese, Anne-Katrin and van der Laan, Sander W. and Gretarsdottir, Solveig and Anderson, Christopher D. and Chong, Michael and Adams, Hieab H. H. and Ago, Tetsuro and Almgren, Peter and Amouyel, Philippe and Ay, Hakan and Bartz, Traci M. and Benavente, Oscar R. and Bevan, Steve and Boncoraglio, Giorgio B. and Brown, Robert D. and Butterworth, Adam S. and Carrera, Caty and Carty, Cara L. and Chasman, Daniel I. and Chen, Wei-Min and Cole, John W. and Correa, Adolfo and Cotlarciuc, Ioana and Cruchaga, Carlos and Danesh, John and de Bakker, Paul I. W. and DeStefano, Anita L. and den Hoed, Marcel and Duan, Qing and Engelter, Stefan T. and Falcone, Guido J. and Gottesman, Rebecca F. and Grewal, Raji P. and Gudnason, Vilmundur and Gustafsson, Stefan and Haessler, Jeffrey and Harris, Tamara B. and Hassan, Ahamad and Havulinna, Aki S. and Heckbert, Susan R. and Holliday, Elizabeth G. and Howard, George and Hsu, Fang-Chi and Hyacinth, Hyacinth I. and Ikram, M. Arfan and Ingelsson, Erik and Irvin, Marguerite R. and Jian, Xueqiu and Jim{\'{e}}nez-Conde, Jordi and Johnson, Julie A. and Jukema, J. Wouter and Kanai, Masahiro and Keene, Keith L. and Kissela, Brett M. and Kleindorfer, Dawn O. and Kooperberg, Charles and Kubo, Michiaki and Lange, Leslie A. and Langefeld, Carl D. and Langenberg, Claudia and Launer, Lenore J. and Lee, Jin-Moo and Lemmens, Robin and Leys, Didier and Lewis, Cathryn M. and Lin, Wei-Yu and Lindgren, Arne G. and Lorentzen, Erik and Magnusson, Patrik K. and Maguire, Jane and Manichaikul, Ani and McArdle, Patrick F. and Meschia, James F. and Mitchell, Braxton D. and Mosley, Thomas H. and Nalls, Michael A. and Ninomiya, Toshiharu and O'Donnell, Martin J. and Psaty, Bruce M. and Pulit, Sara L. and Rannikm{\"{a}}e, Kristiina and Reiner, Alexander P. and Rexrode, Kathryn M. and Rice, Kenneth and Rich, Stephen S. and Ridker, Paul M. and Rost, Natalia S. and Rothwell, Peter M. and Rotter, Jerome I. and Rundek, Tatjana and Sacco, Ralph L. and Sakaue, Saori and Sale, Michele M. and Salomaa, Veikko and Sapkota, Bishwa R. and Schmidt, Reinhold and Schmidt, Carsten O. and Schminke, Ulf and Sharma, Pankaj and Slowik, Agnieszka and Sudlow, Cathie L. M. and Tanislav, Christian and Tatlisumak, Turgut and Taylor, Kent D. and Thijs, Vincent N. S. and Thorleifsson, Gudmar and Thorsteinsdottir, Unnur and Tiedt, Steffen and Trompet, Stella and Tzourio, Christophe and van Duijn, Cornelia M. and Walters, Matthew and Wareham, Nicholas J. and Wassertheil-Smoller, Sylvia and Wilson, James G. and Wiggins, Kerri L. and Yang, Qiong and Yusuf, Salim and Bis, Joshua C. and Pastinen, Tomi and Ruusalepp, Arno and Schadt, Eric E. and Koplev, Simon and Bj{\"{o}}rkegren, Johan L. M. and Codoni, Veronica and Civelek, Mete and Smith, Nicholas L. and Tr{\'{e}}gou{\"{e}}t, David A. and Christophersen, Ingrid E. and Roselli, Carolina and Lubitz, Steven A. and Ellinor, Patrick T. and Tai, E. Shyong and Kooner, Jaspal S. and Kato, Norihiro and He, Jiang and van der Harst, Pim and Elliott, Paul and Chambers, John C. and Takeuchi, Fumihiko and Johnson, Andrew D. and Sanghera, Dharambir K. and Melander, Olle and Jern, Christina and Strbian, Daniel and Fernandez-Cadenas, Israel and Longstreth, W. T. and Rolfs, Arndt and Hata, Jun and Woo, Daniel and Rosand, Jonathan and Pare, Guillaume and Hopewell, Jemma C. and Saleheen, Danish and Stefansson, Kari and Worrall, Bradford B. and Kittner, Steven J. and Seshadri, Sudha and Fornage, Myriam and Markus, Hugh S. and Howson, Joanna M. M. and Kamatani, Yoichiro and Debette, Stephanie and Dichgans, Martin},
doi = {10.1038/s41588-018-0058-3},
issn = {1061-4036},
journal = {Nature Genetics},
month = {mar},
number = {4},
pages = {524--537},
title = {{Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29531354) [PR](http://www.riken.jp/pr/press/2018/20180313_1/)},
volume = {50},
year = {2018},
abstract = {Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown. We conducted a multiancestry genome-wide-association meta-analysis in 521,612 individuals (67,162 cases and 454,450 controls) and discovered 22 new stroke risk loci, bringing the total to 32. We further found shared genetic variation with related vascular traits, including blood pressure, cardiac traits, and venous thromboembolism, at individual loci (n = 18), and using genetic risk scores and linkage-disequilibrium-score regression. Several loci exhibited distinct association and pleiotropy patterns for etiological stroke subtypes. Eleven new susceptibility loci indicate mechanisms not previously implicated in stroke pathophysiology, with prioritization of risk variants and genes accomplished through bioinformatics analyses using extensive functional datasets. Stroke risk loci were significantly enriched in drug targets for antithrombotic therapy.},
pdf = {https://rdcu.be/cmqVm},
pr = {http://www.riken.jp/pr/press/2018/20180313_1/},
pubmed = {29531354}
}
@article{Kanai2018a,
author = {Kanai, Masahiro and Akiyama, Masato and Takahashi, Atsushi and Matoba, Nana and Momozawa, Yukihide and Ikeda, Masashi and Iwata, Nakao and Ikegawa, Shiro and Hirata, Makoto and Matsuda, Koichi and Kubo, Michiaki and Okada, Yukinori and Kamatani, Yoichiro},
doi = {10.1038/s41588-018-0047-6},
issn = {1061-4036},
journal = {Nature Genetics},
month = {feb},
number = {3},
pages = {390--400},
title = {{Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29403010) [PR](http://www.riken.jp/pr/press/2018/20180206_1/) [RIKEN Research Highlight](http://www.riken.jp/en/research/rikenresearch/highlights/20180427_FY20180002/)},
volume = {50},
year = {2018},
keywords = {selected},
abstract = {Clinical measurements can be viewed as useful intermediate phenotypes to promote understanding of complex human diseases. To acquire comprehensive insights into the underlying genetics, here we conducted a genome-wide association study (GWAS) of 58 quantitative traits in 162,255 Japanese individuals. Overall, we identified 1,407 trait-associated loci (P < 5.0 $\times$ 10-8), 679 of which were novel. By incorporating 32 additional GWAS results for complex diseases and traits in Japanese individuals, we further highlighted pleiotropy, genetic correlations, and cell-type specificity across quantitative traits and diseases, which substantially expands the current understanding of the associated genetics and biology. This study identified both shared polygenic effects and cell-type specificity, represented by the genetic links among clinical measurements, complex diseases, and relevant cell types. Our findings demonstrate that even without prior biological knowledge of cross-phenotype relationships, genetics corresponding to clinical measurements successfully recapture those measurements' relevance to diseases, and thus can contribute to the elucidation of unknown etiology and pathogenesis.},
pdf = {https://rdcu.be/clzFn},
pr = {http://www.riken.jp/pr/press/2018/20180206_1/},
pubmed = {29403010}
}
@article{Hirata2018,
author = {Hirata, Jun and Hirota, Tomomitsu and Ozeki, Takeshi and Kanai, Masahiro and Sudo, Takeaki and Tanaka, Toshihiro and Hizawa, Nobuyuki and Nakagawa, Hidemi and Sato, Shinichi and Mushiroda, Taisei and Saeki, Hidehisa and Tamari, Mayumi and Okada, Yukinori},
doi = {10.1016/j.jid.2017.10.001},
issn = {0022202X},
journal = {Journal of Investigative Dermatology},
month = {mar},
number = {3},
pages = {542--548},
title = {{Variants at HLA-A , HLA-C , and HLA-DQB1 confer risk of psoriasis vulgaris in Japanese}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/29031612)},
volume = {138},
year = {2018},
abstract = {Psoriasis vulgaris (PsV) is an autoimmune disease of skin and joints with heterogeneity in epidemiologic and genetic landscapes of global populations. We conducted an initial genome-wide association study and a replication study of PsV in the Japanese population (606 PsV cases and 2,052 controls). We identified significant associations of the single nucleotide polymorphisms with PsV risk at TNFAIP3-interacting protein 1and the major histocompatibility complex region (P = 3.7 $\times$ 10-10 and 6.6 $\times$ 10-15, respectively). By updating the HLA imputation reference panel of Japanese (n = 908) to expand HLA gene coverage, we fine-mapped the HLA variants associated with PsV risk. Although we confirmed the PsV risk of HLA-C*06:02 (odds ratio = 6.36, P = 0.0015), its impact was relatively small compared with those in other populations due to rare allele frequency in Japanese (0.4\% in controls). Alternatively, HLA-A*02:07, which corresponds to the cysteine residue at HLA-A amino acid position 99 (HLA-A Cys99), demonstrated the most significant association with PsV (odds ratio = 4.61, P = 1.2 $\times$ 10-10). In addition to HLA-A*02:07 and HLA-C*06:02, stepwise conditional analysis identified an independent PsV risk of HLA-DQ$\beta$1 Asp57 (odds ratio = 2.19, P = 1.9 $\times$ 10-6). Our PsV genome-wide association study in Japanese highlighted the genetic architecture of PsV, including the identification of HLA risk variants.},
pdf = {https://www.jidonline.org/action/showPdf?pii=S0022-202X%2817%2933037-3},
pubmed = {29031612}
}
@article{Akiyama2017,
author = {Akiyama, Masato and Okada, Yukinori and Kanai, Masahiro and Takahashi, Atsushi and Momozawa, Yukihide and Ikeda, Masashi and Iwata, Nakao and Ikegawa, Shiro and Hirata, Makoto and Matsuda, Koichi and Iwasaki, Motoki and Yamaji, Taiki and Sawada, Norie and Hachiya, Tsuyoshi and Tanno, Kozo and Shimizu, Atsushi and Hozawa, Atsushi and Minegishi, Naoko and Tsugane, Shoichiro and Yamamoto, Masayuki and Kubo, Michiaki and Kamatani, Yoichiro},
doi = {10.1038/ng.3951},
issn = {1061-4036},
journal = {Nature Genetics},
month = {sep},
number = {10},
pages = {1458--1467},
title = {{Genome-wide association study identifies 112 new loci for body mass index in the Japanese population}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/28892062) [PR](http://www.riken.jp/pr/press/2017/20170912_1/)},
volume = {49},
year = {2017},
abstract = {Obesity is a risk factor for a wide variety of health problems. In a genome-wide association study (GWAS) of body mass index (BMI) in Japanese people (n = 173,430), we found 85 loci significantly associated with obesity (P < 5.0 $\times$ 10-8), of which 51 were previously unknown. We conducted trans-ancestral meta-analyses by integrating these results with the results from a GWAS of Europeans and identified 61 additional new loci. In total, this study identifies 112 novel loci, doubling the number of previously known BMI-associated loci. By annotating associated variants with cell-type-specific regulatory marks, we found enrichment of variants in CD19+ cells. We also found significant genetic correlations between BMI and lymphocyte count (P = 6.46 $\times$ 10-5, rg = 0.18) and between BMI and multiple complex diseases. These findings provide genetic evidence that lymphocytes are relevant to body weight regulation and offer insights into the pathogenesis of obesity.},
pdf = {https://rdcu.be/cmqVZ},
pr = {http://www.riken.jp/pr/press/2017/20170912_1/},
pubmed = {28892062}
}
@article{Sudo2017,
author = {Sudo, T and Okada, Y and Ozaki, K and Urayama, K and Kanai, M and Kobayashi, H and Gokyu, M and Izumi, Y and Tanaka, T},
doi = {10.1177/0022034517715432},
issn = {0022-0345},
journal = {Journal of Dental Research},
month = {sep},
number = {10},
pages = {1100--1105},
title = {{Association of NOD2 Mutations with Aggressive Periodontitis}},
url = {[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/28682159) [PR](http://www.tmd.ac.jp/press-release/20170706_1/index.html)},
volume = {96},
year = {2017},
abstract = {Aggressive periodontitis (AgP) is characterized by rapid alveolar bone destruction and tooth loss early in life, and its etiology remains unclear. To explore the genetic risk factors of AgP, we performed genome-wide single-nucleotide polymorphism genotyping for identity-by-descent mapping and identified 32 distinct candidate loci, followed by whole exome sequencing with 2 pedigrees of AgP consisting of 3 cases and 1 control in 1 family and 2 sibling cases in the other. After variant filtering procedures and validation by targeted Sanger sequencing, we identified 2 missense mutations at 16q12 in NOD2 (p.Ala110Thr and p.Arg311Trp), which encodes nucleotide-binding oligomerization domain protein 2. We further examined 94 genetically unrelated AgP patients by targeted sequencing of NOD2 and found that 2 patients among them also carried the p.Arg311Trp variant. Furthermore, we found 3 additional missense mutations in this gene (p.His370Tyr, p.Arg459Cys, and p.Ala868Thr). These mutations either had not been previously observed or are extremely rare (frequency <0.001) in Asian populations. NOD2 plays a crucial role in innate immunity as an intracellular receptor initiating nuclear factor $\kappa$B-dependent and mitogen-activated protein kinase-dependent gene transcription. These results demonstrated NOD2 as a novel gene involved in AgP.},
pr = {http://www.tmd.ac.jp/press-release/20170706_1/index.html},
pubmed = {28682159}
}
@article{Okada2016b,
author = {Okada, Yukinori and Suzuki, Akari and Ikari, Katsunori and Terao, Chikashi and Kochi, Yuta and Ohmura, Koichiro and Higasa, Koichiro and Akiyama, Masato and Ashikawa, Kyota and Kanai, Masahiro and Hirata, Jun and Suita, Naomasa and Teo, Yik-Ying and Xu, Huji and Bae, Sang-Cheol and Takahashi, Atsushi and Momozawa, Yukihide and Matsuda, Koichi and Momohara, Shigeki and Taniguchi, Atsuo and Yamada, Ryo and Mimori, Tsuneyo and Kubo, Michiaki and Brown, Matthew A. and Raychaudhuri, Soumya and Matsuda, Fumihiko and Yamanaka, Hisashi and Kamatani, Yoichiro and Yamamoto, Kazuhiko},
doi = {10.1016/j.ajhg.2016.06.019},
issn = {00029297},
journal = {The American Journal of Human Genetics},
month = {aug},
number = {2},
pages = {366--374},
publisher = {ElsevierCompany.},
title = {{Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis}},
url = {[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27486778) [PR](http://www.riken.jp/pr/press/2016/20160805_1/)},
volume = {99},
year = {2016},
abstract = {Despite the progress in human leukocyte antigen (HLA) causal variant mapping, independent localization of major histocompatibility complex (MHC) risk from classical HLA genes is challenging. Here, we conducted a large-scale MHC fine-mapping analysis of rheumatoid arthritis (RA) in a Japanese population (6,244 RA cases and 23,731 controls) population by using HLA imputation, followed by a multi-ethnic validation study including east Asian and European populations (n = 7,097 and 23,149, respectively). Our study identified an independent risk of a synonymous mutation at HLA-DOA, a non-classical HLA gene, on anti-citrullinated protein autoantibody (ACPA)-positive RA risk (p = 1.4 $\times$ 10(-9)), which demonstrated a cis-expression quantitative trait loci (cis-eQTL) effect on HLA-DOA expression. Trans-ethnic comparison revealed different linkage disequilibrium (LD) patterns in HLA-DOA and HLA-DRB1, explaining the observed HLA-DOA variant risk heterogeneity among ethnicities, which was most evident in the Japanese population. Although previous HLA fine-mapping studies have identified amino acid polymorphisms of the classical HLA genes as driving genetic susceptibility to disease, our study additionally identifies the dosage contribution of a non-classical HLA gene to disease etiology. Our study contributes to the understanding of HLA immunology in human diseases and suggests the value of incorporating additional ancestry in MHC fine-mapping.},
pdf = {https://www.cell.com/ajhg/pdfExtended/S0002-9297(16)30223-3},
pr = {http://www.riken.jp/pr/press/2016/20160805_1/},
pubmed = {27486778}
}
@article{Kanai2016,
author = {Kanai, Masahiro and Tanaka, Toshihiro and Okada, Yukinori},
doi = {10.1038/jhg.2016.72},
issn = {1434-5161},
journal = {Journal of Human Genetics},
month = {oct},
number = {10},
pages = {861--866},
title = {{Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set}},
url = {[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27305981)},
volume = {61},
year = {2016},
abstract = {To assess the statistical significance of associations between variants and traits, genome-wide association studies (GWAS) should employ an appropriate threshold that accounts for the massive burden of multiple testing in the study. Although most studies in the current literature commonly set a genome-wide significance threshold at the level of P=5.0 $\times$ 10-8, the adequacy of this value for respective populations has not been fully investigated. To empirically estimate thresholds for different ancestral populations, we conducted GWAS simulations using the 1000 Genomes Phase 3 data set for Africans (AFR), Europeans (EUR), Admixed Americans (AMR), East Asians (EAS) and South Asians (SAS). The estimated empirical genome-wide significance thresholds were Psig=3.24 $\times$ 10-8 (AFR), 9.26 $\times$ 10-8 (EUR), 1.83 $\times$ 10-7 (AMR), 1.61 $\times$ 10-7 (EAS) and 9.46 $\times$ 10-8 (SAS). We additionally conducted trans-ethnic meta-analyses across all populations (ALL) and all populations except for AFR ($\Delta$AFR), which yielded Psig=3.25 $\times$ 10-8 (ALL) and 4.20 $\times$ 10-8 ($\Delta$AFR). Our results indicate that the current threshold (P=5.0 $\times$ 10-8) is overly stringent for all ancestral populations except for Africans; however, we should employ a more stringent threshold when conducting a meta-analysis, regardless of the presence of African samples.},
code = {https://github.com/mkanai/GWAS_threshold_scripts},
pdf = {https://rdcu.be/cmqWl},
pubmed = {27305981}
}
@article{Okada2016a,
author = {Okada, Yukinori and Muramatsu, Tomoki and Suita, Naomasa and Kanai, Masahiro and Kawakami, Eiryo and Iotchkova, Valentina and Soranzo, Nicole and Inazawa, Johji and Tanaka, Toshihiro},
doi = {10.1038/srep22223},
issn = {2045-2322},
journal = {Scientific Reports},
month = {mar},
pages = {22223},
title = {{Significant impact of miRNAtarget gene networks on genetics of human complex traits}},
url = {[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26927695) [PR](http://www.tmd.ac.jp/archive-tmdu/kouhou/20160301.pdf)},
volume = {6},
year = {2016},
abstract = {The impact of microRNA (miRNA) on the genetics of human complex traits, especially in the context of miRNA-target gene networks, has not been fully assessed. Here, we developed a novel analytical method, MIGWAS, to comprehensively evaluate enrichment of genome-wide association study (GWAS) signals in miRNA-target gene networks. We applied the method to the GWAS results of the 18 human complex traits from >1.75 million subjects, and identified significant enrichment in rheumatoid arthritis (RA), kidney function, and adult height (P < 0.05/18 = 0.0028, most significant enrichment in RA with P = 1.7 $\times$ 10(-4)). Interestingly, these results were consistent with current literature-based knowledge of the traits on miRNA obtained through the NCBI PubMed database search (adjusted P = 0.024). Our method provided a list of miRNA and target gene pairs with excess genetic association signals, part of which included drug target genes. We identified a miRNA (miR-4728-5p) that downregulates PADI2, a novel RA risk gene considered as a promising therapeutic target (rs761426, adjusted P = 2.3 $\times$ 10(-9)). Our study indicated the significant impact of miRNA-target gene networks on the genetics of human complex traits, and provided resources which should contribute to drug discovery and nucleic acid medicine.},
pdf = {https://rdcu.be/cmqWo},
pr = {http://www.tmd.ac.jp/archive-tmdu/kouhou/20160301.pdf},
pubmed = {26927695}
}
@article{Okada2015,
author = {Okada, Yukinori and Momozawa, Yukihide and Ashikawa, Kyota and Kanai, Masahiro and Matsuda, Koichi and Kamatani, Yoichiro and Takahashi, Atsushi and Kubo, Michiaki},
doi = {10.1038/ng.3310},
issn = {1061-4036},
journal = {Nature Genetics},
month = jun,
number = {7},
pages = {798--802},
publisher = {Nature Publishing Group},
title = {{Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese}},
url = {[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26029868) [PR](http://www.riken.jp/pr/press/2015/20150602_1/)},
volume = {47},
year = {2015},
abstract = {To fine map association signals of human leukocyte antigen (HLA) variants in the major histocompatibility complex (MHC) region, we constructed a Japanese population-specific reference panel (n = 908). We conducted trans-ancestry comparisons of linkage disequilibrium (LD) and haplotype structure for HLA variants using an entropy-based LD measurement, , and a visualization tool to capture high-dimensional variables. Our Japanese reference panel exhibited stronger LD between HLA genes than European or other East Asian populations, characterized by one population-specific common long-range HLA haplotype. We applied HLA imputation to genome-wide association study (GWAS) data for Graves' disease in Japanese (n = 9,003) and found that amino acid polymorphisms of multiple class I and class II HLA genes independently contribute to disease risk (HLA-DPB1, HLA-A, HLA-B and HLA-DRB1; P < 2.3 $\times$ 10(-6)), with the strongest impact at HLA-DPB1 (P = 1.6 $\times$ 10(-42)). Our study illustrates the value of population-specific HLA reference panels.},
pdf = {https://rdcu.be/cmqWr},
pr = {http://www.riken.jp/pr/press/2015/20150602_1/},
pubmed = {26029868}
}
